Submitted URL: http://url1224.newsletter1.docwirenews.com/ls/click?upn=BHNHavGA59-2FSceekr9zzDar48W-2BtOrLmW3ZQ4H15ej-2F-2FY0xpBTVMicw7-2BUDIbXAqDIp5PPQgC...
Effective URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralu...
Submission: On May 05 via api from US — Scanned from DE

Summary

This website contacted 41 IPs in 5 countries across 32 domains to perform 191 HTTP transactions. The main IP is 172.67.73.241, located in United States and belongs to CLOUDFLARENET, US. The main domain is www.docwirenews.com. The Cisco Umbrella rank of the primary domain is 756460.
TLS certificate: Issued by Cloudflare Inc ECC CA-3 on June 18th 2021. Valid for: a year.
This is the only time www.docwirenews.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 1 167.89.118.83 11377 (SENDGRID)
40 172.67.73.241 13335 (CLOUDFLAR...)
1 2606:4700::68... 13335 (CLOUDFLAR...)
1 2606:4700::68... 13335 (CLOUDFLAR...)
6 2a00:1450:400... 15169 (GOOGLE)
3 104.16.90.50 13335 (CLOUDFLAR...)
2 205.201.46.12 14618 (AMAZON-AES)
5 2a00:1450:400... 15169 (GOOGLE)
9 54.173.3.48 14618 (AMAZON-AES)
2 2a00:1450:400... 15169 (GOOGLE)
10 2a00:1450:400... 15169 (GOOGLE)
2 2606:4700::68... 13335 (CLOUDFLAR...)
2 2a03:2880:f02... 32934 (FACEBOOK)
12 18.204.255.196 14618 (AMAZON-AES)
6 143.204.101.166 16509 (AMAZON-02)
7 2a00:1450:400... 15169 (GOOGLE)
1 104.26.11.16 13335 (CLOUDFLAR...)
12 142.250.179.162 15169 (GOOGLE)
3 2a00:1450:400... 15169 (GOOGLE)
3 2a00:1450:400... 15169 (GOOGLE)
3 2a03:2880:f12... 32934 (FACEBOOK)
12 151.101.66.133 54113 (FASTLY)
2 84.17.46.53 60068 (CDN77 ^_^)
1 2a00:1450:400... 15169 (GOOGLE)
2 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
4 2600:9000:215... 16509 (AMAZON-02)
1 199.232.188.157 54113 (FASTLY)
5 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 104.244.42.3 13414 (TWITTER)
1 104.244.42.197 13414 (TWITTER)
2 2600:9000:215... 16509 (AMAZON-02)
1 35.188.42.15 15169 (GOOGLE)
4 38.91.45.7 398989 (DEEPINTENT)
3 6 34.102.246.198 15169 (GOOGLE)
2 4 185.33.221.50 29990 (ASN-APPNEX)
1 143.204.98.79 16509 (AMAZON-02)
1 2600:9000:215... 16509 (AMAZON-02)
12 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
191 41
Apex Domain
Subdomains
Transfer
41 docwirenews.com
url1224.newsletter1.docwirenews.com
www.docwirenews.com — Cisco Umbrella Rank: 756460
524 KB
23 googlesyndication.com
pagead2.googlesyndication.com — Cisco Umbrella Rank: 119
tpc.googlesyndication.com — Cisco Umbrella Rank: 171
d8de1464cb804dbfc0611e46f65d9c7b.safeframe.googlesyndication.com
358 KB
14 doubleclick.net
securepubads.g.doubleclick.net — Cisco Umbrella Rank: 245
googleads.g.doubleclick.net — Cisco Umbrella Rank: 65
stats.g.doubleclick.net — Cisco Umbrella Rank: 175
190 KB
13 cloudfront.net
d10lpsik1i8c69.cloudfront.net
d1rx8vrt2hn1hc.cloudfront.net
d12xoj7p9moygp.cloudfront.net
d3t3ozftmdmh3i.cloudfront.net
18 MB
12 anchor.fm
anchor.fm — Cisco Umbrella Rank: 21660
41 KB
12 medtargetsystem.com
www.medtargetsystem.com — Cisco Umbrella Rank: 14926
128 KB
9 hcn.health
aim-tag.hcn.health — Cisco Umbrella Rank: 836086
229 KB
7 google.com
adservice.google.com — Cisco Umbrella Rank: 128
www.google.com — Cisco Umbrella Rank: 20
2 KB
7 gstatic.com
fonts.gstatic.com
167 KB
6 lhmos.com
trc.lhmos.com — Cisco Umbrella Rank: 19718
616 B
6 googleapis.com
fonts.googleapis.com — Cisco Umbrella Rank: 111
7 KB
5 googletagservices.com
www.googletagservices.com — Cisco Umbrella Rank: 227
166 KB
4 adnxs.com
secure.adnxs.com — Cisco Umbrella Rank: 612
3 KB
4 deepintent.com
match.deepintent.com — Cisco Umbrella Rank: 1295
163 B
3 google.de
adservice.google.de — Cisco Umbrella Rank: 5351
www.google.de — Cisco Umbrella Rank: 3632
1 KB
3 facebook.com
www.facebook.com — Cisco Umbrella Rank: 100
3 KB
3 google-analytics.com
www.google-analytics.com — Cisco Umbrella Rank: 101
40 KB
3 embed.ly
cdn.embed.ly — Cisco Umbrella Rank: 18651
7 KB
2 omappapi.com
a.omappapi.com — Cisco Umbrella Rank: 6386
57 KB
2 facebook.net
connect.facebook.net — Cisco Umbrella Rank: 195
114 KB
2 fontawesome.com
pro.fontawesome.com — Cisco Umbrella Rank: 9585
103 KB
2 googletagmanager.com
www.googletagmanager.com — Cisco Umbrella Rank: 142
86 KB
2 magnetmail.net
tracking.magnetmail.net — Cisco Umbrella Rank: 83370
3 KB
1 dmdtrueidentity.com
web-static.dmdtrueidentity.com
31 KB
1 sentry.io
sentry.io — Cisco Umbrella Rank: 386
399 B
1 t.co
t.co — Cisco Umbrella Rank: 563
338 B
1 twitter.com
analytics.twitter.com — Cisco Umbrella Rank: 800
356 B
1 ads-twitter.com
static.ads-twitter.com — Cisco Umbrella Rank: 963
10 KB
1 googleadservices.com
partner.googleadservices.com — Cisco Umbrella Rank: 940
416 B
1 luckyorange.net
settings.luckyorange.net — Cisco Umbrella Rank: 9818
2 KB
1 bootstrapcdn.com
stackpath.bootstrapcdn.com — Cisco Umbrella Rank: 3175
25 KB
1 jsdelivr.net
cdn.jsdelivr.net — Cisco Umbrella Rank: 574
2 KB
191 32
Domain Requested by
40 www.docwirenews.com www.docwirenews.com
12 tpc.googlesyndication.com pagead2.googlesyndication.com
tpc.googlesyndication.com
securepubads.g.doubleclick.net
12 anchor.fm www.docwirenews.com
d1rx8vrt2hn1hc.cloudfront.net
12 www.medtargetsystem.com www.docwirenews.com
www.medtargetsystem.com
aim-tag.hcn.health
11 securepubads.g.doubleclick.net www.googletagservices.com
securepubads.g.doubleclick.net
www.docwirenews.com
10 pagead2.googlesyndication.com www.docwirenews.com
pagead2.googlesyndication.com
tpc.googlesyndication.com
www.googletagservices.com
9 aim-tag.hcn.health www.docwirenews.com
aim-tag.hcn.health
7 fonts.gstatic.com fonts.googleapis.com
6 trc.lhmos.com 3 redirects www.docwirenews.com
www.medtargetsystem.com
aim-tag.hcn.health
6 d10lpsik1i8c69.cloudfront.net www.docwirenews.com
d10lpsik1i8c69.cloudfront.net
6 fonts.googleapis.com www.docwirenews.com
d1rx8vrt2hn1hc.cloudfront.net
5 www.google.com www.docwirenews.com
tpc.googlesyndication.com
securepubads.g.doubleclick.net
5 www.googletagservices.com www.docwirenews.com
www.googletagmanager.com
securepubads.g.doubleclick.net
4 secure.adnxs.com 2 redirects www.docwirenews.com
4 match.deepintent.com www.medtargetsystem.com
www.docwirenews.com
aim-tag.hcn.health
4 d1rx8vrt2hn1hc.cloudfront.net anchor.fm
d1rx8vrt2hn1hc.cloudfront.net
3 www.facebook.com www.docwirenews.com
3 www.google-analytics.com www.googletagmanager.com
www.google-analytics.com
anchor.fm
3 cdn.embed.ly www.docwirenews.com
2 d12xoj7p9moygp.cloudfront.net d1rx8vrt2hn1hc.cloudfront.net
2 adservice.google.com pagead2.googlesyndication.com
securepubads.g.doubleclick.net
2 adservice.google.de pagead2.googlesyndication.com
securepubads.g.doubleclick.net
2 a.omappapi.com www.docwirenews.com
a.omappapi.com
2 googleads.g.doubleclick.net pagead2.googlesyndication.com
2 connect.facebook.net www.docwirenews.com
connect.facebook.net
2 pro.fontawesome.com www.docwirenews.com
pro.fontawesome.com
2 www.googletagmanager.com www.docwirenews.com
2 tracking.magnetmail.net www.docwirenews.com
tracking.magnetmail.net
1 d8de1464cb804dbfc0611e46f65d9c7b.safeframe.googlesyndication.com securepubads.g.doubleclick.net
1 d3t3ozftmdmh3i.cloudfront.net www.docwirenews.com
1 web-static.dmdtrueidentity.com aim-tag.hcn.health
1 sentry.io d1rx8vrt2hn1hc.cloudfront.net
1 t.co www.docwirenews.com
1 analytics.twitter.com www.docwirenews.com
1 www.google.de www.docwirenews.com
1 static.ads-twitter.com www.docwirenews.com
1 stats.g.doubleclick.net www.google-analytics.com
1 partner.googleadservices.com pagead2.googlesyndication.com
1 settings.luckyorange.net d10lpsik1i8c69.cloudfront.net
1 stackpath.bootstrapcdn.com www.docwirenews.com
1 cdn.jsdelivr.net www.docwirenews.com
1 url1224.newsletter1.docwirenews.com 1 redirects
191 42
Subject Issuer Validity Valid
sni.cloudflaressl.com
Cloudflare Inc ECC CA-3
2021-06-18 -
2022-06-17
a year crt.sh
upload.video.google.com
GTS CA 1C3
2022-04-18 -
2022-07-11
3 months crt.sh
*.embed.ly
Sectigo RSA Domain Validation Secure Server CA
2022-02-15 -
2023-02-22
a year crt.sh
*.magnetmail.net
AlphaSSL CA - SHA256 - G2
2022-03-31 -
2023-05-02
a year crt.sh
*.g.doubleclick.net
GTS CA 1C3
2022-04-11 -
2022-07-04
3 months crt.sh
aim-tag-web.prod.taiga.cloud
Amazon
2021-12-13 -
2023-01-11
a year crt.sh
*.google-analytics.com
GTS CA 1C3
2022-04-11 -
2022-07-04
3 months crt.sh
*.fontawesome.com
DigiCert TLS RSA SHA256 2020 CA1
2021-12-01 -
2023-01-01
a year crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA
2022-02-12 -
2022-05-13
3 months crt.sh
medtargetsystem.com
Amazon
2021-11-20 -
2022-12-19
a year crt.sh
*.cloudfront.net
Amazon
2022-02-01 -
2023-01-31
a year crt.sh
*.gstatic.com
GTS CA 1C3
2022-04-18 -
2022-07-11
3 months crt.sh
anchor.fm
R3
2022-03-25 -
2022-06-23
3 months crt.sh
a.omappapi.com
R3
2022-04-30 -
2022-07-29
3 months crt.sh
*.google.de
GTS CA 1C3
2022-04-18 -
2022-07-11
3 months crt.sh
*.google.com
GTS CA 1C3
2022-04-18 -
2022-07-11
3 months crt.sh
ads-twitter.com
DigiCert TLS RSA SHA256 2020 CA1
2021-07-21 -
2022-07-26
a year crt.sh
www.google.com
GTS CA 1C3
2022-04-18 -
2022-07-11
3 months crt.sh
www.google.de
GTS CA 1C3
2022-04-18 -
2022-07-11
3 months crt.sh
*.twitter.com
DigiCert TLS Hybrid ECC SHA384 2020 CA1
2022-03-07 -
2023-03-06
a year crt.sh
t.co
DigiCert TLS Hybrid ECC SHA384 2020 CA1
2022-03-07 -
2023-03-06
a year crt.sh
sentry.io
DigiCert SHA2 Secure Server CA
2020-06-02 -
2022-06-07
2 years crt.sh
*.deepintent.com
Go Daddy Secure Certificate Authority - G2
2022-05-02 -
2023-06-03
a year crt.sh
web-static.dmdtrueidentity.com
Amazon
2022-01-03 -
2023-02-01
a year crt.sh
trc.lhmos.com
GTS CA 1D4
2022-04-10 -
2022-07-09
3 months crt.sh
tpc.googlesyndication.com
GTS CA 1C3
2022-04-18 -
2022-07-11
3 months crt.sh

This page contains 16 frames:

Primary Page: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Frame ID: F48C15B5FAAAD66810759C3DDA254793
Requests: 114 HTTP requests in this frame

Frame: https://googleads.g.doubleclick.net/pagead/html/r20220503/r20190131/zrt_lookup.html
Frame ID: A0D98D60865DC4CF31F892A19C4B0A84
Requests: 1 HTTP requests in this frame

Frame: https://www.facebook.com/plugins/like.php?href=https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/&layout=button_count&show_faces=false&width=105&action=like&colorscheme=light&height=21
Frame ID: 008B343F8B4A4D997972591E68330FDC
Requests: 1 HTTP requests in this frame

Frame: https://anchor.fm/the-uromigos/embed/episodes/Episode-155-ASCO-GU-2022-ARASENS-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer-e1ehuoa
Frame ID: 1A589626D9542FBDE4344BA43FD715BD
Requests: 22 HTTP requests in this frame

Frame: https://googleads.g.doubleclick.net/pagead/ads?client=ca-pub-3350439833258580&output=html&adk=1812271804&adf=3025194257&lmt=1651775810&plat=1%3A16777216%2C9%3A32776%2C16%3A8388608%2C17%3A32%2C24%3A32%2C25%3A32%2C30%3A1081344%2C32%3A32&format=0x0&url=https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D&ea=0&pra=5&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXSxmYWxzZV0.&dt=1651775809874&bpp=3&bdt=856&idt=243&shv=r20220503&mjsv=m202204270101&ptt=9&saldr=aa&abxe=1&nras=1&correlator=1115353859529&frm=20&pv=2&ga_vid=1837915677.1651775810&ga_sid=1651775810&ga_hid=733354313&ga_fc=1&u_tz=0&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=-12245933&ady=-12245933&biw=1600&bih=1200&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44761044&oid=2&pvsid=1956160238184584&pem=117&tmod=1945741225&uas=0&nvt=1&eae=2&fc=1920&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C1600%2C1200&vis=1&rsz=%7C%7Cs%7C&abl=NS&fu=32768&bc=31&ifi=1&uci=a!1&fsb=1&dtd=259
Frame ID: D8A5EE3576CAFB6D7D80C21775EECFA1
Requests: 1 HTTP requests in this frame

Frame: https://d10lpsik1i8c69.cloudfront.net/js/clickstream.js?v=ce8f9a1
Frame ID: 31296A7B79A8177BDAF4E9B793640FC4
Requests: 3 HTTP requests in this frame

Frame: https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D&_sid=8d27a7f7-ab48-49db-97f5-691b4c538684&_vid=b7b9c3f1-0936-4c7c-87c0-ab638be64bc3&_ak=45-381-6BCF239E&_flash=false&_th=1651775810|1651775810|1
Frame ID: 570C75FDF4BD55ECF23530661CF2B93B
Requests: 7 HTTP requests in this frame

Frame: https://www.medtargetsystem.com/iframe/transition?client-origin=https%3A%2F%2Fwww.docwirenews.com&timestamp=1651775809972
Frame ID: B4947C76C008671BF65963EA8CFE116E
Requests: 3 HTTP requests in this frame

Frame: https://aim-tag.hcn.health/iframe.html?client-origin=https%3A%2F%2Fwww.docwirenews.com&pageview-id=53864740-cca2-11ec-bddd-278631a15be6&stps=%7B%7D&timestamp=1651775809972
Frame ID: CFE4139F6EB90C679127D474CCE62112
Requests: 9 HTTP requests in this frame

Frame: https://www.facebook.com/tr/
Frame ID: B71C3BC0BB114BF465F2E21DC239CBC6
Requests: 1 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Frame ID: 8F5BD8E7EEE4211E87612CBE77A5B0B0
Requests: 3 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/aframe
Frame ID: D60A88228949B684F5C699EEA6949BBF
Requests: 2 HTTP requests in this frame

Frame: https://d8de1464cb804dbfc0611e46f65d9c7b.safeframe.googlesyndication.com/safeframe/1-0-38/html/container.html
Frame ID: 09322DA8E00BDA28E12BC42C6C90333D
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvZczaxvfp4KRmyYIf3r3de7xwtxhlZxuBvldk2jzs2gRNbyiumlZGxlh5LM0UzeP2AbHVwIrvqASRKN9manBzKsNceB7oNZ0x-phyIk9PM5NHm8L9nPk-NSxxfRiyflkq4j_--vp1ycQ2yTnWNcTxqhu1fDdi00Tju4p9eyhIMk_fJ-KQeFyW9OQlnJLGypsBq_H1lQYt5b2s0RVW9f-G6-W2BQX3uUO7gCrXo7H8hkw4VOqyKEq6L8VdneOASQjBWbTl8OtNIDec7uDvvut-jruygb6tZ__JfDwgZz9iOYmBnKouii7TlER6OyuxJG87Q2q0W5Cp_&sig=Cg0ArKJSzIPFHFWXpIxHEAE&uach_m=[UACH]&adurl=
Frame ID: 7AD9FABE2CD7FCC220CF403946E0DB15
Requests: 9 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvk_o19ikuU2eiC0GaZhDnmjBn1_0KWWN1T-uwS3Agewu6xZNsIDlbw28FFrX1MnS8-WNunZYcgXA7cr6DAjX9JfZ_5phTzE7UkMXzAuuZRb24YyI737j9YMv4Vo1rtUhJmuAA4-r3WgbKH5V4HcowOQ7AuKyXQlE37XyZ_lEupDVV8NWGbDtTenIr9CRCKZ3kfUYPX8XE56fWYmz-tHTRDe3xIt2U2iSewABo5ciyTK7MlQ25dduneh6PfIySH6xE0raKRae2_MEHGdTjI5_9PpiDCOttfyQfnWNttISBGg3wEX_FEncmY12W9mYSull7BOjCs6ReAAJ_FuH8RHtE&sig=Cg0ArKJSzN2ewoalDCeYEAE&uach_m=[UACH]&adurl=
Frame ID: A68B1CA1461470DE30530A9B3E33385F
Requests: 9 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvQabmylq4-_Tf5EpkpmE0ucE7o_Dkpn529rca5_R4Jzn9zvu2zECrLQhRs0zC3FUeX9eK7bi8dE2nZumQMLoWlJI6Gi8_gBBF1BAzsBzwRks5J62Qu9Yk4y9-ow89-1z5qv8h_nCT0eIRfeHcB8_JfKitJ-d6CcBOdOg3TLxRjDYRqYfKT05AZFa5ZhCg_3wDGdiBhbtuD3X7UeJirZ-fdUpjvW_116RxlQCbdhuwMUqOjep1KzTADudjIT97PdaDF2g9lk9GeFLUw7jebWJeY680MoQNIbVEnxtg2QVScZgk0MQdcJ7gYc7uJ8PAnYiP6Js-7tVeHWak8nSe_UQ&sig=Cg0ArKJSzJxI0SNYT8EPEAE&uach_m=[UACH]&adurl=
Frame ID: B316E949F3E925E34BDE2567DF9A62CD
Requests: 9 HTTP requests in this frame

Screenshot

Page Title

Episode 155: ASCO GU 2022 ARASENS trial of darolutamide and chemo vs chemo alone in hormone sensitive advanced prostate cancer - Docwire News

Page URL History Show full URLs

  1. http://url1224.newsletter1.docwirenews.com/ls/click?upn=BHNHavGA59-2FSceekr9zzDar48W-2BtOrLmW3ZQ4H15ej-2F-2FY0xpBTVMicw... HTTP 302
    https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-ara... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • <link rel=["']stylesheet["'] [^>]+/wp-(?:content|includes)/
  • /wp-(?:content|includes)/
  • wp-embed\.min\.js\?ver=([\d.]+)

Overall confidence: 100%
Detected patterns
  • <link[^>]* href=[^>]*?bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.css

Overall confidence: 100%
Detected patterns
  • adnxs\.(?:net|com)

Overall confidence: 100%
Detected patterns
  • googletagservices\.com/tag/js/gpt(?:_mobile)?\.js

Overall confidence: 100%
Detected patterns
  • //connect\.facebook\.([a-z]+)/[^/]*/[a-z]*\.js

Overall confidence: 100%
Detected patterns
  • fingerprint(\d)?(?:\.min)?\.js

Overall confidence: 100%
Detected patterns
  • <link[^>]* href=[^>]+(?:([\d.]+)/)?(?:css/)?font-awesome(?:\.min)?\.css
  • <link[^>]* href=[^>]*?(?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)
  • (?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:.*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)

Overall confidence: 100%
Detected patterns
  • googlesyndication\.com/

Overall confidence: 100%
Detected patterns
  • google-analytics\.com/(?:ga|urchin|analytics)\.js

Overall confidence: 100%
Detected patterns
  • <link[^>]* href=[^>]+fonts\.(?:googleapis|google)\.com

Overall confidence: 100%
Detected patterns
  • googletagmanager\.com/gtm\.js
  • googletagmanager\.com/gtag/js

Overall confidence: 100%
Detected patterns
  • ([\d.]+)?/modernizr(?:\.([\d.]+))?.*\.js

Overall confidence: 100%
Detected patterns
  • jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

Overall confidence: 100%
Detected patterns
  • jquery[.-]migrate(?:-([\d.]+))?(?:\.min)?\.js(?:\?ver=([\d.]+))?

Overall confidence: 100%
Detected patterns
  • //cdn\.jsdelivr\.net/

Page Statistics

191
Requests

97 %
HTTPS

54 %
IPv6

32
Domains

42
Subdomains

41
IPs

5
Countries

21084 kB
Transfer

26603 kB
Size

29
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. http://url1224.newsletter1.docwirenews.com/ls/click?upn=BHNHavGA59-2FSceekr9zzDar48W-2BtOrLmW3ZQ4H15ej-2F-2FY0xpBTVMicw7-2BUDIbXAqDIp5PPQgCPpywcAx1VjXH9kXxLtKHaVZQ8Q6D-2FtTWMl7RToz8ZfXzt7m508A7QEpS0aJCYradudnMC-2F5mg6YJANPUo3MjGY83adhslCYxDndgUPwfBqQDFv9c8ogSEyrxlrS0jLBeu0sINLYF0nakydKCnR3UEtHduny0PTEhkEdVQa9Xy73XA2IjGLnCjGSsNbh07x4P5MdXQo5DvlkiO7h4mUq7tgev0G9zwvC-2F5GwHPe9LwH1-2B99lO3QRUUsD7WcUzCSiTOrv-2F48jXAocRRzVulF39fXfKSYdhMnf2STOXIXM2q3Y7EhU6bYRQL7Ie1YeCgWneiZRAfEQp-2F69urLi13SHm-2Bwc1sxTzGS3Br8-3DL7Ou_r4u0jzlWE0Sk7xh7f1DgEUNhbRT1lCPys5So4kV9ZLbbfyfBRuXwm9l2lLK1pyrSK-2Flud6-2BTmGFa4tbd7j0AR2e6RsTho-2FiA-2Bm0dwnnjVQiIFUf13cVQGTvZ8M0deI-2BLRkzG91QrkGxaYvSk7MCb3Xo2wmCLjtIKffKcvvwdLTNbWzWaGf1Dve5Pd5J5dgWSe9kECDcv5h-2BmMnue51GoyPKQKnpSV7n-2BZC2rCHGlrK-2BlKPj7Kl34zI7etD4TFozKf9liF6vv2AzF3WCho6wfTsDqYW-2BnKAx8IW4xADgEFBM63S5NSk3OXJLh156dcg-2B2jOaSFdNn9tp0TVGcXPUOO9OfaT6jSSx8nVwK-2Bu48lKSeb6FDzYJVsn1na5SjDhB0Z595Ynstw-2FIxMIWo3OAuytFL1ZG99dgRn1mgOA10F-2F-2FrLxTQybH36oNEWbCWsn6T3H-2FS-2Fr5nn2CSiELUm7vje4s8PqhMbQp3ArwGRGEq3GDbGilYWsGZN3lK74Tjchy-2F91C9VBFrtXm4AUypGOqGE4VJ1BlATRGvLJJdcC7SCQPcXm06SG2IjTUsD6rs1Hoflcz8QUPqlAqBaZwfuJe66rNcr-2FVS7y0UVGWEDb1A-2FQNJFNs8ePSfTywiDFxNPKaI0PN5iN-2FvErmAOcdtGg2gVsazMSZXeNcvjUEWtOmIooduO9g1bOLnOCMg0UEtI5vLj9iZAJsHlOFPs9cBkIfJgXFVxriM3xOg3KHMS0xIBDRVt2-2Fj5OCcAVnTuRJRoQwL9fdsjMPvyalRTssR8H4EP1-2BOfUumfsCuUVP5rWFW6yvBDOkFRUq8KbOAe5PIGtofJCajA81F8fEdCHMCVo-2BQ9MhhuavlX2o-2BsN3eWp8OFyYZHqCdPAaHk2NpZ5CWxYqNVE11i-2B1PGzKGh9dK5pSkrIIscUMBeFPnhhgAxtKmepKN5MNRxdjUzJgdWqDXwI1ypxKyW14gVjDkGEDNJhlF-2BnSjSGO0e0CeWeg-2F0SACxRw-3D HTTP 302
    https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 111
  • https://trc.lhmos.com/enrich/data/jsonp?mcode=15710&mid=47&&callback=__jp1 HTTP 302
  • https://secure.adnxs.com/getuidp?callback=__jp1
Request Chain 113
  • https://trc.lhmos.com/uid/set?dgid=UNK&mcode=15710&mid=47 HTTP 302
  • https://secure.adnxs.com/getuidu?https://trc.lhmos.com/uid/save/?uid=$UID&dgid=UNK&mcode=15710&mid=47 HTTP 307
  • https://secure.adnxs.com/bounce?%2Fgetuidu%3Fhttps%3A%2F%2Ftrc.lhmos.com%2Fuid%2Fsave%2F%3Fuid%3D%24UID%26dgid%3DUNK%26mcode%3D15710%26mid%3D47 HTTP 302
  • https://trc.lhmos.com/uid/save/?uid=8450328796284604864&dgid=UNK&mcode=15710&mid=47
Request Chain 125
  • https://trc.lhmos.com/enrich/data/jsonp?mcode=15710&mid=47&&callback=__v4jp1 HTTP 302
  • https://secure.adnxs.com/getuidp?callback=__v4jp1

191 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request /
www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/
Redirect Chain
  • http://url1224.newsletter1.docwirenews.com/ls/click?upn=BHNHavGA59-2FSceekr9zzDar48W-2BtOrLmW3ZQ4H15ej-2F-2FY0xpBTVMicw7-2BUDIbXAqDIp5PPQgCPpywcAx1VjXH9kXxLtKHaVZQ8Q6D-2FtTWMl7RToz8ZfXzt7m508A7QEpS...
  • https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-ca...
170 KB
35 KB
Document
General
Full URL
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare / WP Engine
Resource Hash
cabe31cebbff91ee3c41ad4bdcaab3444730d3468efaf502f9a68aed027907d0

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

cache-control
max-age=600, must-revalidate
cf-cache-status
DYNAMIC
cf-ray
706b957528728fd1-FRA
content-encoding
br
content-type
text/html; charset=UTF-8
date
Thu, 05 May 2022 18:36:48 GMT
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
expires
Thu, 19 Nov 1981 08:52:00 GMT
link
<https://www.docwirenews.com/wp-json/>; rel="https://api.w.org/" <https://www.docwirenews.com/wp-json/wp/v2/posts/5654079>; rel="alternate"; type="application/json" <https://www.docwirenews.com/?p=5654079>; rel=shortlink
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
pragma
no-cache
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=htAVlT%2FUSU8j%2B6jFqxwcrqOfsae18XgPD%2FtgBYiXxMNp4wF2rWMyEE7vqJ3NGIOtwIAzo1yUXcXdQ%2FYi%2FKeoP%2FC0rjwP2VlUu1fdXI0p5UB%2BM2CgSPaZVFp2MBLJWVbyx36PT%2FQ%3D"}],"group":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding Accept-Encoding Accept-Encoding,Cookie
x-cache
HIT: 256
x-cache-group
normal
x-cacheable
SHORT
x-orig-cache-control
no-store, no-cache, must-revalidate
x-powered-by
WP Engine

Redirect headers

Connection
keep-alive
Content-Length
341
Content-Type
text/html; charset=utf-8
Date
Thu, 05 May 2022 18:36:48 GMT
Location
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Server
nginx
X-Robots-Tag
noindex, nofollow
js.cookie.min.js
cdn.jsdelivr.net/npm/js-cookie@2/src/
2 KB
2 KB
Script
General
Full URL
https://cdn.jsdelivr.net/npm/js-cookie@2/src/js.cookie.min.js
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:5914 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
39b8fe6364621725ff90431a34af0f87976d95c00cbfd1d0f3711a3f1fa1a07b
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
age
33208
x-jsd-version
2.2.1
x-cache
HIT, HIT
cross-origin-resource-policy
cross-origin
strict-transport-security
max-age=31536000; includeSubDomains; preload
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-served-by
cache-fra19150-FRA, cache-hhn4049-HHN
timing-allow-origin
*
x-jsd-version-type
version
server
cloudflare
etag
W/"79f-7pVBzxqV0qiF+LFDoQXKqgjKnJ0"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=mzDarZNt8xVUR8KmLywax%2FOUfcweQN7Ba4vE6g19zJ7ysf%2BOX04mLEV9sEF20TfOeo993tfNfPdLj16fL15vS1%2BwDyvZOErMDRQSzVzV9Z1qk2E%2BiVnpSe4qSSQypaRxkyG3tU2PQePevkZTg3s%3D"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
access-control-expose-headers
*
cache-control
public, max-age=604800, s-maxage=43200
cf-ray
706b95777bf5995c-FRA
iframeSizer.min.js
www.docwirenews.com/wp-content/themes/Newspaper-child/js/
20 KB
6 KB
Script
General
Full URL
https://www.docwirenews.com/wp-content/themes/Newspaper-child/js/iframeSizer.min.js
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
ca62dbc70ac7bff56184e3a04b4278cbe4a01123ad075d88d93eee9ed66dd19f

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Fri, 24 Jul 2020 15:29:40 GMT
server
cloudflare
age
8678855
etag
W/"5f1afe64-4f69"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=5m88wyHE44kb5EzECygIywee2Lte9iZbl7j4XF63Q3pAec%2FVnlETlWmG1GqnACtj2B1h%2FnfEdtLUe4GyCqtJB0Y5FobgcMQbun5q4KkhIHUPy1pOlpFCU7SeIHpca%2FgZrSnQEjE%3D"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray
706b9576da6f8fd1-FRA
newspaper.woff
www.docwirenews.com/wp-content/themes/Newspaper/images/icons/
19 KB
19 KB
Font
General
Full URL
https://www.docwirenews.com/wp-content/themes/Newspaper/images/icons/newspaper.woff?14
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b420750157155826f2ef022f425579bca244f39d0a91ece03c5b3cbae5e52334

Request headers

Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Origin
https://www.docwirenews.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
cf-cache-status
HIT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age
8678855
content-length
19432
last-modified
Sat, 06 Apr 2019 02:06:12 GMT
server
cloudflare
etag
"5ca80994-4be8"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=ZrIqxrHmLqfTRWSfgvwLD8o2N%2FoPe9NW56vWo5hazxHbBeTbU6L2NqX51JAyFnt0pcS1KyaTk0zR3b22Q8Ut2gxZ9%2Fhwo2urAhHYTkD4TSBRYdrhJIrksittVlf%2BedmWyiy1Q%2B4%3D"}],"group":"cf-nel","max_age":604800}
content-type
font/woff
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
cf-ray
706b9576da708fd1-FRA
cv.css
www.docwirenews.com/wp-content/plugins/content-views-query-and-display-post-page/public/assets/css/
76 KB
12 KB
Stylesheet
General
Full URL
https://www.docwirenews.com/wp-content/plugins/content-views-query-and-display-post-page/public/assets/css/cv.css?ver=2.4.0.2
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
77a5a3c2fbe6cdac60de52da4ae031af394dc417a6411cebea42c9c7b873eccf

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age
8678855
cf-polished
origSize=78058
last-modified
Tue, 12 Oct 2021 19:05:02 GMT
server
cloudflare
etag
W/"6165dc5e-130ea"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=q1mY36Ci%2FtwlThUGa33pFyPoaKt20O%2FCT0ZcqemTxmZ2C218AZdFCMX9mMyx%2Ft25d%2BtuDDRrSQx45zX7slBwHp4Rv96ab6Q0B6BifmkraGChPisT7YzUUUfmJvHliJ%2Fv9VjPJF0%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
cf-ray
706b9576da728fd1-FRA
cf-bgj
minify
style.min.css
www.docwirenews.com/wp-includes/css/dist/block-library/
79 KB
11 KB
Stylesheet
General
Full URL
https://www.docwirenews.com/wp-includes/css/dist/block-library/style.min.css?ver=5.8.4
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
9110fc122dda3067c424d9b8ff7747e2030b0bd9298f69a3683d399ad3373a6a

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Wed, 01 Sep 2021 04:05:58 GMT
server
cloudflare
age
3557567
etag
W/"612efc26-13abe"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=nGVj9aXsEzuN4LyiJn9dAHE8pXt60sg3nWjaP9CKr%2B6%2F7kgL5O6h0ar1GedM1cRQVuug3pcb6puVsbwoQGG8%2BdtY%2B5L8l%2FgRVsU3PU1yjVeFH1b%2B5FikVJadHKRZNMdiy6cF6Kg%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray
706b9576da738fd1-FRA
styles.css
www.docwirenews.com/wp-content/plugins/contact-form-7/includes/css/
2 KB
1 KB
Stylesheet
General
Full URL
https://www.docwirenews.com/wp-content/plugins/contact-form-7/includes/css/styles.css?ver=5.5.2
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
fb12708d973e6b9354f367a6780e5a166b0da7d2721d856da7f9d57130883eaa

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age
8678855
cf-polished
origSize=2731
last-modified
Mon, 25 Oct 2021 06:30:42 GMT
server
cloudflare
etag
W/"61764f12-aab"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=c%2BISvwpJ2ndaFaPlRumKG5YIn2fuTgQBPHPxCDHf4Tm%2FG0EcoNq42JdafIgI6x9FtDJOYRQJXm0zNjHzAvZbeem3yfMLW2QDwtRZH2Y6XWfQzu2%2F2WGaTLTQyM4LR1u6X4Vvpd0%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
cf-ray
706b9576da758fd1-FRA
cf-bgj
minify
ctf-styles.min.css
www.docwirenews.com/wp-content/plugins/custom-twitter-feeds/css/
15 KB
3 KB
Stylesheet
General
Full URL
https://www.docwirenews.com/wp-content/plugins/custom-twitter-feeds/css/ctf-styles.min.css?ver=1.8.3
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
6a360fb959551957e70a7cd4da97893c04b98d9a8378fc548aee38adac30ac97

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Tue, 19 Oct 2021 14:39:38 GMT
server
cloudflare
age
8678855
etag
W/"616ed8aa-3a6f"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=VMD70L%2BP5MVSeoXxLyVUPCPA1G5I4FsTUX8ElmG9ykXJ6ewG6v%2F9t6hG8zSzodu8PKCRILzEJUIhn4d805q5Lkd0vvjh7cDAGAuB9QTSSndpWXfc95o2q43WTRC%2FwWejCPuiSmo%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray
706b9576da768fd1-FRA
quiz-maker-public.css
www.docwirenews.com/wp-content/plugins/quiz-maker/public/css/
44 KB
8 KB
Stylesheet
General
Full URL
https://www.docwirenews.com/wp-content/plugins/quiz-maker/public/css/quiz-maker-public.css?ver=6.2.8.4
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
2b8d36c5cf5a63302ddc2c3c20e97d4a8315a69e1015c75486495997fb8a56c5

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age
8678855
cf-polished
origSize=54667
last-modified
Tue, 14 Dec 2021 21:48:25 GMT
server
cloudflare
etag
W/"61b91129-d58b"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=6FLxN9IVbG%2BoWdAi9ds%2FgvzHUoO0rw2vE2FA7JPKHwjoROjAd01%2BQn2IbBnsdVxQ0uKiRtIrDVSwFNKVA1QscXdTLLGwMErfuRFHHVgeRfWcsQxz51nPaCUEExvQVc%2FCRZ%2Bdv7w%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
cf-ray
706b9576da778fd1-FRA
cf-bgj
minify
normalize.css
www.docwirenews.com/wp-content/plugins/team-showcase-old/css/
2 KB
1 KB
Stylesheet
General
Full URL
https://www.docwirenews.com/wp-content/plugins/team-showcase-old/css/normalize.css?ver=5.8.4
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
db5548e8b688d720be784e0416dc46f7de937704794befb16db112e61e65ff58

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age
3557567
cf-polished
origSize=1825
last-modified
Sun, 05 Sep 2021 04:39:42 GMT
server
cloudflare
etag
W/"61344a0e-721"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=2XdZUOeZuN8OMnneEKPNG9XDreA8mNqu6oOP20fd9xkdUhONKbzF4p6bixZB9To0u6Ez%2BWenoSvyxqDF20M%2BmxNdjNti9s8U%2FHluCSsm0MaoH8%2BIQX7JR3Zd5T7orRUQ0WlMbHo%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
cf-ray
706b9576da798fd1-FRA
cf-bgj
minify
font-awesome.css
www.docwirenews.com/wp-content/plugins/team-showcase-old/css/
23 KB
6 KB
Stylesheet
General
Full URL
https://www.docwirenews.com/wp-content/plugins/team-showcase-old/css/font-awesome.css?ver=5.8.4
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
1ea4dfe698af85b8c0be2bea33995932214934666bf103846330a3ed3fda3ce0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age
3557567
cf-polished
origSize=28747
last-modified
Sun, 05 Sep 2021 04:39:42 GMT
server
cloudflare
etag
W/"61344a0e-704b"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=CPkrzPURmTEI4FFPjR9PLIwUtuYmW08HVJ8CQzduGuAXtCZhlkFo5dEN5dlB5UlYp9FDFCL9nc6jgtcS%2Bu%2BiYiZJ3bT8BtYxVQEgOzmVW8IGU1Bv8WQys8fZPmWQRaFwqfqtf%2FQ%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
cf-ray
706b9576da7a8fd1-FRA
cf-bgj
minify
featherlight.css
www.docwirenews.com/wp-content/plugins/team-showcase-old/css/
1 KB
839 B
Stylesheet
General
Full URL
https://www.docwirenews.com/wp-content/plugins/team-showcase-old/css/featherlight.css?ver=5.8.4
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
91cf311d196adf1ab2c011d291e81650b3e437fc796bfc1028d0afe586ff7271

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age
3557567
cf-polished
origSize=3301
last-modified
Sun, 05 Sep 2021 04:39:42 GMT
server
cloudflare
etag
W/"61344a0e-ce5"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=7lnzZKNhXWtq771TDVxGVLTYul%2FbBMICllbzzTzzJjNGgAu1Pt05jUI9EIjLJgMUmpRDqAzXMbzvwxV6QFONUZBGTkbomiZ%2F%2FOzbIL9s%2BeSVSDOAKPdw2PQ%2FnV0SIpy6VMEyYt8%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
cf-ray
706b9576da7d8fd1-FRA
cf-bgj
minify
style1.css
www.docwirenews.com/wp-content/plugins/team-showcase-old/css/
2 KB
774 B
Stylesheet
General
Full URL
https://www.docwirenews.com/wp-content/plugins/team-showcase-old/css/style1.css?ver=5.8.4
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
a210556f62ee96d27f2eaa52b97d3ae930dd5e88daf1868fd3bd6c52520a36ba

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age
3557567
cf-polished
origSize=2170
last-modified
Sun, 05 Sep 2021 04:39:42 GMT
server
cloudflare
etag
W/"61344a0e-87a"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=2G2Rg2BIHrC0cQ%2FYpBMImlCNlsEMoKVuyzdI0fL%2B8fDxh6Ra2fIFViqjw%2BimaDH2isfcZdjdA1W8oiETo%2FI6Jv%2F59LMAAr8vvTJSsX6gm%2FDnW07A90l524hzyIAdIz1MXAdyIpQ%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
cf-ray
706b95770ab68fd1-FRA
cf-bgj
minify
bootstrap.min.css
stackpath.bootstrapcdn.com/bootstrap/4.4.1/css/
156 KB
25 KB
Stylesheet
General
Full URL
https://stackpath.bootstrapcdn.com/bootstrap/4.4.1/css/bootstrap.min.css?ver=5.8.4
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:acf , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
2ff5b959fa9f6b4b1d04d20a37d706e90039176ab1e2a202994d9580baeebfd6
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
cdn-edgestorageid
864
age
4804183
cdn-cachedat
03/08/2022 20:52:45
cdn-pullzone
252412
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
cdn-proxyver
1.02
timing-allow-origin
*
access-control-allow-origin
*
last-modified
Mon, 25 Jan 2021 22:04:09 GMT
server
cloudflare
cdn-requestpullcode
200
etag
W/"7cc40c199d128af6b01e74a28c5900b0"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/css; charset=utf-8
cdn-cache
HIT
vary
Accept-Encoding
cache-control
public, max-age=31919000
cdn-uid
b1941f61-b576-4f40-80de-5677acb38f74
cdn-requestid
efa71407bdd957d626d17655db9cc763
cf-ray
706b95777f6e9c01-FRA
cdn-requestcountrycode
DE
cdn-status
200
cdn-requestpullsuccess
True
css2
fonts.googleapis.com/
11 KB
790 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css2?family=Raleway%3Aital%2Cwght%400%2C100%3B0%2C200%3B0%2C300%3B0%2C400%3B0%2C600%3B0%2C700%3B1%2C500&display=swap&ver=5.8.4
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80f::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
84334581198186a7f6eb1567b3d083d8dcf35c4d313a0ad4df77c57a6c5d64d5
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Thu, 05 May 2022 18:36:49 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
date
Thu, 05 May 2022 18:36:49 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Thu, 05 May 2022 18:36:49 GMT
css2
fonts.googleapis.com/
417 B
828 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css2?family=Permanent+Marker&display=swap&ver=5.8.4
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80f::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
3bfa4b5c73e0fdad00c5ff6afdce1248cf86a5d821578076d761dd7c4b360001
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Thu, 05 May 2022 17:57:10 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
date
Thu, 05 May 2022 18:36:49 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Thu, 05 May 2022 18:36:49 GMT
css2
fonts.googleapis.com/
1 KB
464 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css2?family=Spartan%3Awght%40300%3B400&display=swap&ver=5.8.4
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80f::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
9627b3a167d05ecb347c32df7621b5de707f09381c6748a11f1560e0978674b6
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Thu, 05 May 2022 18:36:49 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
date
Thu, 05 May 2022 18:36:49 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Thu, 05 May 2022 18:36:49 GMT
css
fonts.googleapis.com/
31 KB
1 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Roboto%3A300%2C400%2C400italic%2C500%2C500italic%2C700%2C900%7CMontserrat%3A400%7COpen+Sans%3A300italic%2C400%2C400italic%2C600%2C600italic%2C700&ver=8.7.1
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80f::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
da5a785e3e09a6d5d9f388d317e5c11ed3f7671e3212500617d6d3a28b917760
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Thu, 05 May 2022 18:36:49 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
date
Thu, 05 May 2022 18:36:49 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Thu, 05 May 2022 18:36:49 GMT
js_composer.min.css
www.docwirenews.com/wp-content/plugins/js_composer/assets/css/
451 KB
46 KB
Stylesheet
General
Full URL
https://www.docwirenews.com/wp-content/plugins/js_composer/assets/css/js_composer.min.css?ver=5.4.5
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
f46bb0aafc668b4a997c8f2bf2b9612722575d5123d728ee15924ae9b2b9e1b1

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Sat, 06 Apr 2019 02:07:08 GMT
server
cloudflare
age
4217450
etag
W/"5ca809cc-70d6e"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=yZMyH8VXEmWxsglvqXNDA%2FNKfigxLg5HrXiNlQ3fas7vUksyATFSHBr%2BHrzXfA9iXZIF59U0oP5nB7bZU9QIosult9RWEseBU1S7laGtOMhv9QyTXwISE8lBFX4w%2F3nuexAk%2BRc%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray
706b95770ab88fd1-FRA
style.css
www.docwirenews.com/wp-content/themes/Newspaper/
887 KB
99 KB
Stylesheet
General
Full URL
https://www.docwirenews.com/wp-content/themes/Newspaper/style.css?ver=8.7.1
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
f969d1b155fb348651a8818fc5715aa8db1801abc883706419431886484ad55a

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age
8678855
cf-polished
origSize=1144351
last-modified
Tue, 24 Nov 2020 13:14:28 GMT
server
cloudflare
etag
W/"5fbd0734-11761f"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=w0CIdxSaCBPOPwdVoBarAHl8ZQtvWLq4WWV8VuF0ZCy%2BoHe8S0klk%2B0MQU%2FBMvBmheKXsOZ5X8GNXmZ33QNodFPX3Rz4Mjh5aNsOX9l%2Fikje9RMMwmYW64HYK2FdfVndfttFPgI%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
cf-ray
706b95770aba8fd1-FRA
cf-bgj
minify
style.css
www.docwirenews.com/wp-content/themes/Newspaper-child/
893 B
783 B
Stylesheet
General
Full URL
https://www.docwirenews.com/wp-content/themes/Newspaper-child/style.css?ver=all
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
53b75fb20f3ce17c4e0458a9e1982cc50d7b55a4c70fa80efa5438d4071a76f6

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age
8678855
cf-polished
origSize=1700
last-modified
Mon, 11 Jan 2021 23:02:12 GMT
server
cloudflare
etag
W/"5ffcd8f4-6a4"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=HHmZ4hTOEI5lnB%2BEwPrXrv8%2B%2FpYuPGnX8e9K3CmzXfZHN5zJP5vkZ%2BXoL0a6rmKAGOlCG%2FlOM6DfQkZUJ0HHN8%2BFMjQLdBlDAbG3ELIGyEUNGn94lkBKV5Cb6CqmPYqNGLSNhlM%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
cf-ray
706b95770abb8fd1-FRA
cf-bgj
minify
jquery.preview-0.3.2.css
cdn.embed.ly/
4 KB
1 KB
Stylesheet
General
Full URL
https://cdn.embed.ly/jquery.preview-0.3.2.css?ver=5.8.4
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.90.50 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
647617ea2eae411e58d3933fd03f3fa779cce6e7565c1c97be0fd73cd411b87a

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
gzip
cf-cache-status
HIT
age
300354
x-amz-request-id
7Y037TYWG6VW0TN2
x-amz-id-2
3dIBFpMAJNT9kMwVZfc1yQEDRcIIQFq71GLRfGgWO/cPry4ep9Xi7ITagOpIdMi0v+GGxib0LwU=
last-modified
Thu, 11 Apr 2013 15:34:37 GMT
server
cloudflare
etag
W/"38d1c2f99f696db78ccb4b5d93f58e3e"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css
cache-control
public, max-age=604800
x-amz-version-id
null
cf-ray
706b95777809996c-FRA
expires
Thu, 12 May 2022 18:36:49 GMT
jquery.min.js
www.docwirenews.com/wp-includes/js/jquery/
87 KB
32 KB
Script
General
Full URL
https://www.docwirenews.com/wp-includes/js/jquery/jquery.min.js?ver=3.6.0
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
bd4de6a3fc0fb68d6f76ba7b93514b96a92e585c295b5351c31ad92a4b0777ea

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Wed, 10 Mar 2021 15:07:24 GMT
server
cloudflare
age
8678855
etag
W/"6048e0ac-15db1"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=HWKNmfeQjVGeKZ9NJ%2FhKsqRrx1V8OC7HHKLrcTlCRksZpJkG71%2Fw09aDieOGn%2B1L6fAOrw7pvP2SSZakX3%2Fuu4FHSo2np7UPNUCed73koEoM1SyU3K3ylFFrD4LEoHnwAOPzg1k%3D"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray
706b95770abc8fd1-FRA
jquery-migrate.min.js
www.docwirenews.com/wp-includes/js/jquery/
11 KB
4 KB
Script
General
Full URL
https://www.docwirenews.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=3.3.2
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
029e0a2e809fd6b5dbe76abe8b7a74936be306c9a8c27c814c4d44aa54623300

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Wed, 18 Nov 2020 09:06:06 GMT
server
cloudflare
age
8678855
etag
W/"5fb4e3fe-2bd8"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=9HeCVgpZhKwJR%2B782TxYOxDsSI1T3a%2Boi6njJWQ7flAR1ru0Mj2AUo6lAr5zipAzJGPEt%2BXJIfmAcSuP7lJFqPdx2L30b5JPRZzxkijrJIAVfzPq3JPE286SWsrvYc2Uqjb16nY%3D"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray
706b95770abe8fd1-FRA
ai-jquery.js
www.docwirenews.com/wp-content/plugins/ad-inserter-pro/includes/js/
0
440 B
Script
General
Full URL
https://www.docwirenews.com/wp-content/plugins/ad-inserter-pro/includes/js/ai-jquery.js?ver=5.8.4
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
cf-cache-status
HIT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age
3557567
content-length
0
last-modified
Tue, 28 Jan 2020 20:03:09 GMT
server
cloudflare
etag
"5e30937d-0"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=ri2jv21jIpt17sj%2FLtgpG1FNt6%2BlgldqQa1yAR5hWgynR41bIqclpI2v90wXn6lqo%2BM115Wj1gS%2Bsxg9NS9w%2Bwzp7PUOwKMEHBM2OOgKoo1H0ewUMa17QbspSyO0oAk7m23%2Bqak%3D"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
cf-ray
706b95770ac08fd1-FRA
modernizr.custom.js
www.docwirenews.com/wp-content/plugins/team-showcase-old/js/
8 KB
4 KB
Script
General
Full URL
https://www.docwirenews.com/wp-content/plugins/team-showcase-old/js/modernizr.custom.js?ver=1.0
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
5f390868021105457637ad976e9a64b926feab20dec5db5a4c23a7ee2651dd00

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Sun, 05 Sep 2021 04:39:42 GMT
server
cloudflare
age
6212068
etag
W/"61344a0e-20b3"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=6bIS8%2BHpjAIsjDNcjIj7i1zv%2BfQGmF0gUXR1TUr%2FF%2BYPuYtw5NMB%2B6vSAGLG9gJ0onpawa2yontLk3qbUWBvnyGuft5JOm9f5jeGzmYgdojSb9F%2Biqt0znm0ft%2BH4k%2F0onTu6SU%3D"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray
706b95770ac38fd1-FRA
classie.js
www.docwirenews.com/wp-content/plugins/team-showcase-old/js/
2 KB
1 KB
Script
General
Full URL
https://www.docwirenews.com/wp-content/plugins/team-showcase-old/js/classie.js?ver=1.0
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
9477ec4f89eb231b413a95b7438ababe1800c2cff84bb08283dedadf565731f1

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Sun, 05 Sep 2021 04:39:42 GMT
server
cloudflare
age
6209661
etag
W/"61344a0e-7b4"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=jgcXskWcqAeFvxVm9KGT3IxV3jWrZBRez0Ct2RefPyIKH9gXjgLIwngOjF7szYTzC2IjjWCokJ3g8LmLe8W%2By%2FrMj83N50vripBPZvdlyV8xcaKuYN43RmMRV510I9K%2FSFLTP8M%3D"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray
706b95770ac68fd1-FRA
featherlight.js
www.docwirenews.com/wp-content/plugins/team-showcase-old/js/
22 KB
8 KB
Script
General
Full URL
https://www.docwirenews.com/wp-content/plugins/team-showcase-old/js/featherlight.js?ver=1.0
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b663419733f90e316eda931466ed2777ac88965474ff4cb1cb8ce4e78f4aa87d

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Sun, 05 Sep 2021 04:39:42 GMT
server
cloudflare
age
6209661
etag
W/"61344a0e-58b0"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=Z62LFBhtzjDnXFAX4ivJx%2Bj2BtdmoCBv0mI7qR0MZxQnHJkLCgRpJPsbn1s2RBOcYm50hshCbZGKbalumn%2Fhd2p4qPRlrvIK0HdJiYSykWsIYphtxHvHsWGJt8rXjrgV1RwB%2F2c%3D"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray
706b95770ac78fd1-FRA
main.js
www.docwirenews.com/wp-content/plugins/team-showcase-old/js/
402 B
485 B
Script
General
Full URL
https://www.docwirenews.com/wp-content/plugins/team-showcase-old/js/main.js?ver=1.0
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
9e5be76a54305abc8f2c42bebac029f5451989fc6e0ece9b9942e6deee17a499

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Sun, 05 Sep 2021 04:39:42 GMT
server
cloudflare
age
6209661
etag
W/"61344a0e-192"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=6jnixuYicAR6dg6T9QjPFLi9a6S7yEjQWJsgwJmW8snWUqEOHS7jl9%2FkI4GgOiLYfRtBMn6Wg3Ql8fQGT00DuSH0VtrwqKFwX1J3skmOZEMloRr0pZl0nAjMzwSBRBAsAAQgH4w%3D"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray
706b95770ac88fd1-FRA
jquery.embedly-3.0.5.min.js
cdn.embed.ly/
5 KB
2 KB
Script
General
Full URL
https://cdn.embed.ly/jquery.embedly-3.0.5.min.js?ver=063035
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.90.50 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
71fc7c424e7c8d3857b43de8b9c55bb444d142e18cf2caf807d00dffa880e9f5

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
gzip
cf-cache-status
HIT
age
289599
x-amz-request-id
KNFDJT2C0WRWSGKB
x-amz-id-2
Wzz2hfZiJvm1vu7pOy5+EnW3lTOQcaLpAqWEP9YvvC+kzArh68hjQiZC/EgC3yhJpoAHjIsCeRs=
last-modified
Wed, 05 Jun 2013 20:19:57 GMT
server
cloudflare
etag
W/"fc9b1330e2be58e710c8888a40a98974"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
cache-control
public, max-age=604800
x-amz-version-id
null
cf-ray
706b9577780c996c-FRA
expires
Thu, 12 May 2022 18:36:49 GMT
jquery.preview-0.3.2.min.js
cdn.embed.ly/
9 KB
4 KB
Script
General
Full URL
https://cdn.embed.ly/jquery.preview-0.3.2.min.js?ver=063035
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.90.50 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
2d87b35eb9b380e5dfc4b843d8a0c1ac3dd63823b46adf751291771e3aa64731

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
gzip
cf-cache-status
HIT
age
192463
x-amz-request-id
3M1PCWV894A20AGW
x-amz-id-2
C9no0/U/i6MtUPvOMPOZvC+lG2iZIKKBUJyGHsNcq/7Sf2Ra2YY3sIQtzHERb7zA53iUbZx2qcI=
last-modified
Thu, 11 Apr 2013 15:34:36 GMT
server
cloudflare
etag
W/"86fdba641d6544cd742c17f4b498453a"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
cache-control
public, max-age=604800
x-amz-version-id
null
cf-ray
706b9577780a996c-FRA
expires
Thu, 12 May 2022 18:36:49 GMT
wp_cat_rss_style.css
www.docwirenews.com/wp-content/plugins/category-specific-rss-feed-menu/
505 B
497 B
Stylesheet
General
Full URL
https://www.docwirenews.com/wp-content/plugins/category-specific-rss-feed-menu/wp_cat_rss_style.css
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
35326805f720702a299fc344ec4195afc1aa5bf8c35b48f43758dcf1d65fcf0d

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age
8678855
cf-polished
origSize=799
last-modified
Thu, 27 Jun 2019 20:00:32 GMT
server
cloudflare
etag
W/"5d152060-31f"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=y1nSIF4z%2FMoExwhtWwVVDlERCmPFY%2BHVveL3dnBPWpD2nqOeOivJs9LRU42bP0iqulQT3oRR63zcv7iIjbLRpxg%2F7jNbhOGO5LtAT83BjyeEEBZ5WgEpZX7iWzAwY4qDimIN%2FFw%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
cf-ray
706b95770ac58fd1-FRA
cf-bgj
minify
css
fonts.googleapis.com/
2 KB
650 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Open+Sans+Condensed:300
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80f::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
2de2d128c538b2dee38646421206b3b6a6cf6ef2ae713b4d7a415d37cdad89c5
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Thu, 05 May 2022 17:03:52 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
date
Thu, 05 May 2022 18:36:49 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Thu, 05 May 2022 18:36:49 GMT
MagnetLeads.js
tracking.magnetmail.net/
2 KB
2 KB
Script
General
Full URL
https://tracking.magnetmail.net/MagnetLeads.js
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_CBC
Server
205.201.46.12 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
mail.46.12.mmsend.com
Software
Microsoft-IIS/8.0 / ASP.NET
Resource Hash
666af3013700ed16bfc348050da6e011bc2550d695d4d5ae9e6102b1c9f3b249

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

Date
Thu, 05 May 2022 18:36:49 GMT
X-mID
2395
Last-Modified
Mon, 19 Jul 2021 19:16:57 GMT
Server
Microsoft-IIS/8.0
X-Powered-By
ASP.NET
Vary
Origin
Access-Control-Allow-Methods
GET,POST
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Cache-Control
private
Access-Control-Allow-Credentials
true
Accept-Ranges
bytes
Content-Length
1661
ETag
"95512fa4d27cd71:0"
Expires
Thu, 05 May 2022 18:37:49 GMT
gpt.js
www.googletagservices.com/tag/js/
82 KB
28 KB
Script
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
7f0add71db45904ae4073c6d05e9239fb6f4594f8f2d5c9e5396ba19af91cf54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
28483
x-xss-protection
0
server
sffe
etag
"1206 / 435 of 1000 / last-modified: 1651748848"
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Thu, 05 May 2022 18:36:49 GMT
client.js
aim-tag.hcn.health/js/
119 KB
119 KB
Script
General
Full URL
https://aim-tag.hcn.health/js/client.js?dl=aimDataLayer
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.173.3.48 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-173-3-48.compute-1.amazonaws.com
Software
awselb/2.0 /
Resource Hash
480f397c789e71eb1b26783fd2f2fccc633e123bfa4d008fe0c90251dee4e7dd

Request headers

Referer
https://www.docwirenews.com/
Origin
https://www.docwirenews.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 05 May 2022 18:36:50 GMT
server
awselb/2.0
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
*
cache-control
no-cache, no-store, private, max-age=0, must-revalidate
content-length
121855
expires
-1
js
www.googletagmanager.com/gtag/
104 KB
40 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=UA-117435438-1
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
c5169748b2762c6fd376689b4f6f01cb8d3a8afaeb000f606be663b2999eb0da
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
vary
Accept-Encoding
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
40728
x-xss-protection
0
last-modified
Thu, 05 May 2022 18:00:00 GMT
server
Google Tag Manager
strict-transport-security
max-age=31536000; includeSubDomains
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
expires
Thu, 05 May 2022 18:36:49 GMT
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/
158 KB
55 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
2f1c07997789a0f8d255e184e4bc22eae502fcd72ee5bb3c479d0c5736e83ea2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
gzip
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
56047
x-xss-protection
0
server
cafe
etag
2533295682169712694
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=3600
timing-allow-origin
*
expires
Thu, 05 May 2022 18:36:49 GMT
DocWirenews_network_logo.png
www.docwirenews.com/wp-content/uploads/2020/07/
8 KB
8 KB
Image
General
Full URL
https://www.docwirenews.com/wp-content/uploads/2020/07/DocWirenews_network_logo.png
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
7ac0b8116a71acffcf9b8f4ee138185fbae6f1d1718f832ab54350768ca0d1d9

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:50 GMT
cf-cache-status
MISS
last-modified
Thu, 16 Jul 2020 19:13:48 GMT
server
cloudflare
etag
"5f10a6ec-2070"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=2qY7XeDUGyMCD8WQaaCVDo%2BGAVeRCRleGQgaM%2BLXI5Fm%2BcjtWHX7sWb1KP3RtRXvlY8NA5RJDNpD0XphZCaAvEvepgr7HT8o9jRiFvjTGurhVFhY%2BR1nSV8PwhgePPbt8vhOxAQ%3D"}],"group":"cf-nel","max_age":604800}
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
accept-ranges
bytes
cf-ray
706b957a5f308fd1-FRA
content-length
8304
GU-Oncology-Now_logo-1.png
www.docwirenews.com/wp-content/uploads/2021/01/
6 KB
6 KB
Image
General
Full URL
https://www.docwirenews.com/wp-content/uploads/2021/01/GU-Oncology-Now_logo-1.png
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
74b478189aecb06a6091f240ea6fe4db18bd18a155396c5a6f937d1362ee38a9

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:50 GMT
cf-cache-status
MISS
last-modified
Tue, 19 Jan 2021 16:31:04 GMT
server
cloudflare
etag
"60070948-17bb"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=%2Btfp1He3dHh4n84WHJz6BFwjhruDdIbAmrPmOhW2CxO8BwQBlHYAwT0jKiOcNqdj7eQralPST6jsHz55YTxlDfIlDpzcHACpPbkItSvBBClIejgrEbrogNrW6dJsL8d84zODrvk%3D"}],"group":"cf-nel","max_age":604800}
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
accept-ranges
bytes
cf-ray
706b957a6f368fd1-FRA
content-length
6075
all.css
pro.fontawesome.com/releases/v5.10.0/css/
153 KB
29 KB
Stylesheet
General
Full URL
https://pro.fontawesome.com/releases/v5.10.0/css/all.css
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:1734 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
2af905d92cfd34b5413126a54f639da408166cbbcb54318e413ad5e10b5bf6ec

Request headers

Referer
https://www.docwirenews.com/
Origin
https://www.docwirenews.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
gzip
vary
Origin, Access-Control-Request-Headers, Access-Control-Request-Method, Accept-Encoding
cf-cache-status
MISS
x-amz-request-id
W41Z5CG28FRWHB3M
x-amz-id-2
h2aFlKuFlUpiqpMFvRVyvQ8rreLk7ACvr1HgcloaKlgN4WIk8Io4cR4XSw/34t7N2f5cu0KxUi4=
last-modified
Mon, 28 Jun 2021 16:54:32 GMT
server
cloudflare
etag
W/"aa1272633e7e552395d147a499bad186"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=31556926
cf-ray
706b9578b9095c80-FRA
The-Uromigos_TM-1.png
www.docwirenews.com/wp-content/uploads/2021/07/
17 KB
17 KB
Image
General
Full URL
https://www.docwirenews.com/wp-content/uploads/2021/07/The-Uromigos_TM-1.png
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
c9e78186ef9b5852aaf07589c16b8c13be4e8cf79350e7f189b8042754ff3873

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:50 GMT
cf-cache-status
MISS
last-modified
Thu, 15 Jul 2021 21:03:54 GMT
server
cloudflare
etag
"60f0a2ba-432e"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=6HatHaoSpK4s6VUaGTFBLN3%2F2Bbx4JL64Opr4PzzEjdmQ3IOZXp2wycBlcKyrRX9wSz4jV2flHlNaxf03%2FVNtvmBYyLKBeHckkxuqSQTN2os%2B1gWt1CGvLkFSiO3O9o9FoFeKaE%3D"}],"group":"cf-nel","max_age":604800}
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
accept-ranges
bytes
cf-ray
706b957a7f5c8fd1-FRA
content-length
17198
uromigos-4-%E2%80%93-2.png
www.docwirenews.com/wp-content/uploads/2021/05/
87 KB
87 KB
Image
General
Full URL
https://www.docwirenews.com/wp-content/uploads/2021/05/uromigos-4-%E2%80%93-2.png
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e1f828c90f2b721a26f355fc998bc5a54e591c64f5b28d7734ee6282907b42b2

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:50 GMT
cf-cache-status
MISS
last-modified
Thu, 20 May 2021 12:32:57 GMT
server
cloudflare
etag
"60a656f9-15a32"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=im370LphyO51bv%2F1KYU1YT%2FpWXaVngcNcK9Wo2ioFJFaEJxIIJqm35QU86z8Eg4uluAEq59yetyUBzufKK3NhVGvlDGtatM9IFkK%2Bm8IGCDGmXK%2B3iGc6d3QmRUjd4s6qrG1ccE%3D"}],"group":"cf-nel","max_age":604800}
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
accept-ranges
bytes
cf-ray
706b957a7f5d8fd1-FRA
content-length
88626
3122074-1626815620474-d912b3a97e36e.jpg
www.docwirenews.com/wp-content/uploads/2021/08/
25 KB
26 KB
Image
General
Full URL
https://www.docwirenews.com/wp-content/uploads/2021/08/3122074-1626815620474-d912b3a97e36e.jpg
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
05f043843f43cbdb6309cd8472f7df40ed735736990cde699f57a1af2df0cd13

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:50 GMT
cf-cache-status
MISS
last-modified
Tue, 31 Aug 2021 11:28:11 GMT
server
cloudflare
etag
"612e124b-6563"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=sb8wIQHNxy%2F76pSe2BuGJeflb5eeTBsKl6ZkpJK2o5VU0%2FMOkycSzIZSppOaanBQj9JSw3G9IXYEgTyB43Ol4mmMz3SO2xNApnH7aHuF839xEEBkMVdymbqJ3m67oxWhb2uoZ7s%3D"}],"group":"cf-nel","max_age":604800}
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
accept-ranges
bytes
cf-ray
706b957a7f618fd1-FRA
content-length
25955
email-decode.min.js
www.docwirenews.com/cdn-cgi/scripts/5c5dd728/cloudflare-static/
1 KB
1 KB
Script
General
Full URL
https://www.docwirenews.com/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
2595496fe48df6fcf9b1bc57c29a744c121eb4dd11566466bc13d2e52e6bbcc8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 29 Apr 2022 17:17:34 GMT
server
cloudflare
etag
W/"626c1dae-4d7"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
x-frame-options
DENY
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=guj8U19H1CcHKfpqHcUPSWAtRmN%2FxkgBmx0KzepUr7stA8oGkxHAqP%2BdusaJTUZ7u0QilCvzv6fgaYFJ98JfXwv5nJCzh3klMupCVNfDe1Ofd5aenmlgJ9m7g2fFMVmy20ZnxxY%3D"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript
cache-control
max-age=172800, public
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray
706b957a2ec48fd1-FRA
vary
Accept-Encoding
expires
Sat, 07 May 2022 18:36:49 GMT
cv.js
www.docwirenews.com/wp-content/plugins/content-views-query-and-display-post-page/public/assets/js/
23 KB
7 KB
Script
General
Full URL
https://www.docwirenews.com/wp-content/plugins/content-views-query-and-display-post-page/public/assets/js/cv.js?ver=2.4.0.2
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
8be3ffe5523bec1b0c3336590a969ba5a8a9e93d879558ffe7157f17f248ecbf

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Tue, 12 Oct 2021 19:05:02 GMT
server
cloudflare
age
8678854
etag
W/"6165dc5e-5cbf"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=kf6jRh0Zd%2BomTnXLcou3eUoK%2BMvCaXnX9vYXngHqv0HUNonfttjmB%2BQc5xgaAllEWCjZyCfrFc31yMgylcmQPCO%2FqOPmbPVpSYM6csTFXl9nd6vZv%2BsRiZc2XhKfBkTGN1xhhek%3D"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray
706b957a4ee58fd1-FRA
tagdiv_theme.min.js
www.docwirenews.com/wp-content/themes/Newspaper/js/
203 KB
49 KB
Script
General
Full URL
https://www.docwirenews.com/wp-content/themes/Newspaper/js/tagdiv_theme.min.js?ver=8.7.1
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
566ee6e2492e7fcfa4d4ab6075d32a3e6326ce1ddda600b5a8b5f94e0a400009

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Sat, 06 Apr 2019 00:57:30 GMT
server
cloudflare
age
8678854
etag
W/"5ca7f97a-32bed"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=DC6QosV7MF3EnU2x8Rj54dcAUGtsVcBUburKEc1v8%2Fuu%2BwYaLjz4Gu2w9iWsqZH7w0hm2XfOVgLzLuZf1Rn4sPuDUhHY3Y5v1bAuJgqTax9U8oeBhop6rlsoLK18ctU%2F3lTmtEE%3D"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray
706b957a4eea8fd1-FRA
comment-reply.min.js
www.docwirenews.com/wp-includes/js/
3 KB
2 KB
Script
General
Full URL
https://www.docwirenews.com/wp-includes/js/comment-reply.min.js?ver=5.8.4
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
143ce443c390db3b8598f951de20bd04623859a581a15b8cde43ebfa1f8ec103

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Thu, 18 Mar 2021 17:48:23 GMT
server
cloudflare
age
3557567
etag
W/"60539267-ba8"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=2dSlEmC6Jw%2Fv7vu6xg3CZsJYN0FAnG7zM39ODHwC%2BQ1TA5Aeth4T81BxtPWQ8Vpx5%2FTKNUELjFkUWm9XUDPFu4aK%2FWqSW9Sajt3LSVKmG85kHREIX8F5anRuzaRZYR%2Bs57qWZB0%3D"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray
706b957a5f238fd1-FRA
new-tab.js
www.docwirenews.com/wp-content/plugins/page-links-to/dist/
24 KB
9 KB
Script
General
Full URL
https://www.docwirenews.com/wp-content/plugins/page-links-to/dist/new-tab.js?ver=3.3.5
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
d455ab882af3a742e6c9680578e6a590681bda99e34847f550f1f41a7d167969

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Tue, 19 Oct 2021 14:47:31 GMT
server
cloudflare
age
8678854
etag
W/"616eda83-609e"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=YhO6ihoWa%2BEMrypP0X6J92r%2Fk0QTs4rOk82Az5T%2BqNur4RHupx8Mz8mnvBnFjBjPwtnsKjwhj041M8lAPw5FwDxpZ2Nb5Ekuil6dpQyhySVun62AdDohYqmrYL%2B8dXFPtw4xpyQ%3D"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray
706b957a5f278fd1-FRA
custom_aim.js
www.docwirenews.com/wp-content/plugins//docwire-api/js/
1 KB
839 B
Script
General
Full URL
https://www.docwirenews.com/wp-content/plugins//docwire-api/js/custom_aim.js?ver=063035
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b99dbed3efd1e83649f0168775ef1707650881f6b65de5949b14d1b884cf6e86

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:50 GMT
content-encoding
br
cf-cache-status
MISS
last-modified
Sun, 24 Nov 2019 18:46:10 GMT
server
cloudflare
etag
W/"5ddacff2-596"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=BoW%2FIvqFQU5xT19LBrbNwxn269j6vQDO1pug4shvoljoofOn7Ly82Gxa0C9x9iTz8DJ9LxoD%2B0S6mffZilSRj1BzzAIIuW0vqOv6ys89UWUkgFAED1aGovBYv0M3ew66AhCiVt0%3D"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray
706b957a5f2a8fd1-FRA
custom-embed-admin.js
www.docwirenews.com/wp-content/plugins/docwire-api/js/
670 B
704 B
Script
General
Full URL
https://www.docwirenews.com/wp-content/plugins/docwire-api/js/custom-embed-admin.js?ver=063035
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
9d375e3609029414ba6d25767e6ddd6ad8ac2403d3421ea58e52ce37a397d1ba

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:50 GMT
content-encoding
br
cf-cache-status
MISS
last-modified
Sat, 06 Apr 2019 02:05:33 GMT
server
cloudflare
etag
W/"5ca8096d-29e"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=%2FmZ53ib7e2F3bevjhMwXaG4ABo1xmyW5A%2FlN4W%2F49VsM%2FVbku6HLVIXa0jKwA9hWgY7hPjsYwuAebvIplRIA%2F%2F%2B0woMzVy4ioRcGDj%2FlMXl4pcqXzTl%2BGX%2B%2BL0tHGI3l3m2wkYM%3D"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray
706b957a5f2c8fd1-FRA
wp-embed.min.js
www.docwirenews.com/wp-includes/js/
1 KB
1 KB
Script
General
Full URL
https://www.docwirenews.com/wp-includes/js/wp-embed.min.js?ver=5.8.4
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
5be614bce53f767993a5f5f14a6badd6aae6bf3af7cbdbf4d31520de49e27991

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Wed, 06 Jan 2021 15:29:24 GMT
server
cloudflare
age
2655148
etag
W/"5ff5d754-592"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=SyGJU%2BpYOZiEdvEdw%2BasEcuoQ6W2QGADKqEqYABkyxR%2F7smfYj9ZAr8iAPkX11hbeNxDoNCy2mugj1jC13%2B6%2BfPNP%2BcwFT7IurmARkJ72aS3WSuweX%2F5dg1MTvBcV%2FMFded23BA%3D"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray
706b957a5f2e8fd1-FRA
wp-emoji-release.min.js
www.docwirenews.com/wp-includes/js/
18 KB
5 KB
Script
General
Full URL
https://www.docwirenews.com/wp-includes/js/wp-emoji-release.min.js?ver=5.8.4
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
def5de6254be138b8b35d680d1fdd8b07827d03b8626daebfeeb4157ec330ea7

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Tue, 08 Jun 2021 22:15:12 GMT
server
cloudflare
age
673527
etag
W/"60bfebf0-4705"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=tsgxmKcTprECGXVJ36UDuHWSApCuCTWPJ8ycLLG02caxs9CgHUfEVO5vxX%2FvsrPRTyzb1wCyfqrsoiwtWveTEFHVwUxlMPOXK5gRKEIYBgPBiRcRl1LGm0Lj3COY%2Bh4pUU%2Bs2GE%3D"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray
706b957a7f638fd1-FRA
fbevents.js
connect.facebook.net/en_US/
99 KB
27 KB
Script
General
Full URL
https://connect.facebook.net/en_US/fbevents.js
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f02d:100:face:b00c:0:3 Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
b819b3ac2fe5857b7026a609f9115f0d50a7d6e8085ba5987d70ed6baaa41f4e
Security Headers
Name Value
Content-Security-Policy default-src facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com data: blob: 'self';script-src *.fbcdn.net *.facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;connect-src *.fbcdn.net *.facebook.net wss://*.fbcdn.net attachment.fbsbx.com blob: 'self';block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c&minimize=0;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

content-security-policy
default-src facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com data: blob: 'self';script-src *.fbcdn.net *.facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;connect-src *.fbcdn.net *.facebook.net wss://*.fbcdn.net attachment.fbsbx.com blob: 'self';block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c&minimize=0;
content-encoding
gzip
x-content-type-options
nosniff
document-policy
force-load-at-top
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400,h3-29=":443"; ma=86400
content-length
26311
x-xss-protection
0
pragma
public
x-fb-debug
oLXIpgOC4A5g5ZnCV0dGQVTEzb/pZ7jm+9pW0sNkRvcXuI5s/TJAAMmiYYGXsyCAh4lGL2Vs+QSxSm2gSevZnA==
x-fb-trip-id
917726464
x-frame-options
DENY
date
Thu, 05 May 2022 18:36:49 GMT
strict-transport-security
max-age=31536000; preload; includeSubDomains
content-type
application/x-javascript; charset=utf-8
vary
Accept-Encoding
cache-control
public, max-age=1200
x-fb-rlafr
0
priority
u=3,i
expires
Sat, 01 Jan 2000 00:00:00 GMT
visit-page
tracking.magnetmail.net/llXR6IQg9Uu7LqwCSsph7w/
0
757 B
Script
General
Full URL
https://tracking.magnetmail.net/llXR6IQg9Uu7LqwCSsph7w/visit-page?_=1651775809611
Requested by
Host: tracking.magnetmail.net
URL: https://tracking.magnetmail.net/MagnetLeads.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_CBC
Server
205.201.46.12 , United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
mail.46.12.mmsend.com
Software
Microsoft-IIS/8.0 / ASP.NET
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

Pragma
no-cache
Date
Thu, 05 May 2022 18:36:49 GMT
X-mID
3323
Server
Microsoft-IIS/8.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Origin
Access-Control-Allow-Methods
GET,POST
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Content-Length
0
Expires
-1
beacon.js
www.medtargetsystem.com/javascript/
224 KB
55 KB
Script
General
Full URL
https://www.medtargetsystem.com/javascript/beacon.js?1651775809615
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.204.255.196 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-18-204-255-196.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) /
Resource Hash
ea59be86ad1a976cc2064ba5a7e5bacb82fe4c0f26c6b5f756ee4d806f711bdb

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
gzip
last-modified
Thu, 14 Apr 2022 14:50:01 GMT
server
Apache/2.4.7 (Ubuntu)
etag
"37eb5-5dc9e68939840-gzip"
vary
X-Forwarded-Proto,Accept-Encoding
content-type
application/javascript
accept-ranges
bytes
content-length
56188
gtm.js
www.googletagmanager.com/
123 KB
47 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-WR3NX75
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
e34e194233070afb2fbda65411803009bb1f8a9f2e9702725fd42585190e1d0d
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
br
vary
Accept-Encoding
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
47137
x-xss-protection
0
last-modified
Thu, 05 May 2022 18:00:00 GMT
server
Google Tag Manager
strict-transport-security
max-age=31536000; includeSubDomains
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
expires
Thu, 05 May 2022 18:36:49 GMT
w.js
d10lpsik1i8c69.cloudfront.net/
5 KB
3 KB
Script
General
Full URL
https://d10lpsik1i8c69.cloudfront.net/w.js
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
143.204.101.166 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-101-166.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
2ef6b24ec78bb3ac4bdfa91d2abf4d9f2d4b543ad54c411d50e4307fc8677110

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:15:17 GMT
content-encoding
gzip
last-modified
Tue, 01 Mar 2022 22:59:53 GMT
server
AmazonS3
age
1294
etag
W/"eb0a40c00c97d9640177205882172295"
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
via
1.1 32c8da10203574baccb74b8f771a7ffa.cloudfront.net (CloudFront)
cache-control
max-age=3600
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
nDOxT8JOg_8aAXFcGk09qvLdza3XFZSQ_auos5W-8S5srFH9jUqPgg==
truncated
/
121 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
a4b423bd3e84385d2bb624a55cddfaafe863235df9791628cb4fc0a9472d3f76

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

Content-Type
image/png
JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCtr6Hw5aXo.woff2
fonts.gstatic.com/s/montserrat/v24/
12 KB
13 KB
Font
General
Full URL
https://fonts.gstatic.com/s/montserrat/v24/JTUHjIg1_i6t8kCHKm4532VJOt5-QNFgpCtr6Hw5aXo.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto%3A300%2C400%2C400italic%2C500%2C500italic%2C700%2C900%7CMontserrat%3A400%7COpen+Sans%3A300italic%2C400%2C400italic%2C600%2C600italic%2C700&ver=8.7.1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:831::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
59d09721ef5d6a8a6aa8cf8100a1eaa2ef1644bd196fc1a788ad31e16a505734
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://www.docwirenews.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Tue, 03 May 2022 17:13:57 GMT
x-content-type-options
nosniff
age
177772
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
12708
x-xss-protection
0
last-modified
Tue, 26 Apr 2022 14:37:36 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Wed, 03 May 2023 17:13:57 GMT
memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVTS-muw.woff2
fonts.gstatic.com/s/opensans/v28/
44 KB
44 KB
Font
General
Full URL
https://fonts.gstatic.com/s/opensans/v28/memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVTS-muw.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto%3A300%2C400%2C400italic%2C500%2C500italic%2C700%2C900%7CMontserrat%3A400%7COpen+Sans%3A300italic%2C400%2C400italic%2C600%2C600italic%2C700&ver=8.7.1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:831::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
88915cdc03fc5b9a20aec966fe93ee38aa3fd76bfef296e41d305271b3541c96
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://www.docwirenews.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Tue, 03 May 2022 22:45:07 GMT
x-content-type-options
nosniff
age
157902
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
44656
x-xss-protection
0
last-modified
Tue, 01 Mar 2022 22:03:03 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Wed, 03 May 2023 22:45:07 GMT
KFOmCnqEu92Fr1Mu4mxK.woff2
fonts.gstatic.com/s/roboto/v29/
15 KB
15 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v29/KFOmCnqEu92Fr1Mu4mxK.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto%3A300%2C400%2C400italic%2C500%2C500italic%2C700%2C900%7CMontserrat%3A400%7COpen+Sans%3A300italic%2C400%2C400italic%2C600%2C600italic%2C700&ver=8.7.1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:831::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
cc46322d5c4d41da447f26f7fa714827f2ec9a112968c12ef5736c7494985eca
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://www.docwirenews.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Fri, 29 Apr 2022 01:46:21 GMT
x-content-type-options
nosniff
age
579028
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
15688
x-xss-protection
0
last-modified
Wed, 22 Sep 2021 16:13:19 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 29 Apr 2023 01:46:21 GMT
KFOlCnqEu92Fr1MmEU9fBBc4.woff2
fonts.gstatic.com/s/roboto/v29/
16 KB
16 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v29/KFOlCnqEu92Fr1MmEU9fBBc4.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto%3A300%2C400%2C400italic%2C500%2C500italic%2C700%2C900%7CMontserrat%3A400%7COpen+Sans%3A300italic%2C400%2C400italic%2C600%2C600italic%2C700&ver=8.7.1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:831::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
bb46ed079c3dd3c39af5051b4ada48f29f49151dad4fa218117bad2fdb5e616f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://www.docwirenews.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Tue, 03 May 2022 14:02:01 GMT
x-content-type-options
nosniff
age
189288
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
15920
x-xss-protection
0
last-modified
Wed, 22 Sep 2021 16:13:21 GMT
server
sffe
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="apps-themes"
expires
Wed, 03 May 2023 14:02:01 GMT
memtYaGs126MiZpBA-UFUIcVXSCEkx2cmqvXlWqWuU6F.woff2
fonts.gstatic.com/s/opensans/v28/
47 KB
47 KB
Font
General
Full URL
https://fonts.gstatic.com/s/opensans/v28/memtYaGs126MiZpBA-UFUIcVXSCEkx2cmqvXlWqWuU6F.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto%3A300%2C400%2C400italic%2C500%2C500italic%2C700%2C900%7CMontserrat%3A400%7COpen+Sans%3A300italic%2C400%2C400italic%2C600%2C600italic%2C700&ver=8.7.1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:831::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
f57a038a716263766ff4d7f7d8a6ea13b22701ae6fc91e8b1b52fd8784844d23
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://www.docwirenews.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Tue, 03 May 2022 22:53:33 GMT
x-content-type-options
nosniff
age
157396
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
47836
x-xss-protection
0
last-modified
Tue, 01 Mar 2022 22:01:28 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Wed, 03 May 2023 22:53:33 GMT
/
settings.luckyorange.net/
3 KB
2 KB
Fetch
General
Full URL
https://settings.luckyorange.net/?u=https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D&s=218254
Requested by
Host: d10lpsik1i8c69.cloudfront.net
URL: https://d10lpsik1i8c69.cloudfront.net/w.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.26.11.16 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3e52a73780362427352e18a3cdbffeadeebbcfd8f4b9b65f353e1099dd5160e6
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:50 GMT
content-encoding
br
cf-cache-status
DYNAMIC
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
x-frame-options
SAMEORIGIN
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/json
access-control-allow-origin
https://www.docwirenews.com
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=DXE1mlR8S%2BIwpZuV67JzvhLYJVBfCsZaCwmNAQSjkUP6XdmkRynITJB1dSnAgiOtvQkGPA5HDcgem%2FZQ2kBNG9B3WNvKoJENo5HiRJohQ5qQjRuUe5xWzoyjFEYnrVVSQBgF9vfKt0XeJQ%3D%3D"}],"group":"cf-nel","max_age":604800}
access-control-allow-credentials
true
cf-ray
706b957bcc589bfe-FRA
access-control-allow-headers
Authorization,Content-Type,Accept,Origin,User-Agent,DNT,Cache-Control,Keep-Alive,X-Requested-With,If-Modified-Since
431376567356414
connect.facebook.net/signals/config/
306 KB
88 KB
Script
General
Full URL
https://connect.facebook.net/signals/config/431376567356414?v=2.9.58&r=stable
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f02d:100:face:b00c:0:3 Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
1f76f5d50ae8e8a8abc16f6d3f5e0cc0ac41a508e12712f4671f2adf98de7ec9
Security Headers
Name Value
Content-Security-Policy default-src facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com data: blob: 'self';script-src *.fbcdn.net *.facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;connect-src *.fbcdn.net *.facebook.net wss://*.fbcdn.net attachment.fbsbx.com blob: 'self';block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c&minimize=0;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

content-security-policy
default-src facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com data: blob: 'self';script-src *.fbcdn.net *.facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;connect-src *.fbcdn.net *.facebook.net wss://*.fbcdn.net attachment.fbsbx.com blob: 'self';block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c&minimize=0;
content-encoding
gzip
x-content-type-options
nosniff
document-policy
force-load-at-top
report-to
{"max_age":86400,"endpoints":[{"url":"https:\/\/www.facebook.com\/browser_reporting\/?minimize=0"}],"group":"coep_report"}
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400,h3-29=":443"; ma=86400
x-xss-protection
0
pragma
public
x-fb-debug
yJH7gNEaYzVOpCvnQKOo4te89gIMu7sj3Am91tOnkHEB8ujCrSni/eWmRJXYYpavtvFG7spDeGNDgPYY6dthwQ==
x-fb-trip-id
917726464
x-frame-options
DENY
cross-origin-opener-policy
same-origin-allow-popups
cross-origin-embedder-policy-report-only
require-corp;report-to="coep_report"
date
Thu, 05 May 2022 18:36:49 GMT
strict-transport-security
max-age=31536000; preload; includeSubDomains
x-content-cdn-origin-ts
1651775809970
content-type
application/x-javascript; charset=utf-8
vary
Accept-Encoding
cache-control
public, max-age=1200
x-fb-rlafr
0
priority
u=3,i
expires
Sat, 01 Jan 2000 00:00:00 GMT
pubads_impl_2022050301.js
securepubads.g.doubleclick.net/gpt/
368 KB
125 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022050301.js?cb=31067407
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.179.162 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
ams15s41-in-f2.1e100.net
Software
sffe /
Resource Hash
8cc13350e5c65223229a458ee1986bd13f4914bf953484681d70665643669c02
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 06:32:05 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
43484
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
127789
x-xss-protection
0
last-modified
Tue, 03 May 2022 08:34:29 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
public, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Fri, 05 May 2023 06:32:05 GMT
ppub_config
securepubads.g.doubleclick.net/pagead/
41 B
693 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/pagead/ppub_config?ippd=www.docwirenews.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.179.162 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
ams15s41-in-f2.1e100.net
Software
cafe /
Resource Hash
84350fe19ee411d3a77e664ffca12fd873827f5b1fb8548a8afee1709fd6a146
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

timing-allow-origin
*
date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private, max-age=3600, stale-while-revalidate=3600
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/json; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
55
x-xss-protection
0
expires
Thu, 05 May 2022 18:36:49 GMT
analytics.js
www.google-analytics.com/
49 KB
20 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-WR3NX75
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:808::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
a1925038db769477ab74b4df34350c35688a795bb718727b0f4292a4a78a6210
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Wed, 13 Apr 2022 21:02:38 GMT
server
Golfe2
age
1060
date
Thu, 05 May 2022 18:19:09 GMT
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
20006
expires
Thu, 05 May 2022 20:19:09 GMT
show_ads_impl_with_ama_fy2019.js
pagead2.googlesyndication.com/pagead/managed/js/adsense/m202204270101/
308 KB
110 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202204270101/show_ads_impl_with_ama_fy2019.js?client=ca-pub-3350439833258580&plah=www.docwirenews.com
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
1757455defe66b925664e2798a9a61bde734830aad45e01cfe2ee76b2538b712
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:49 GMT
content-encoding
gzip
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
112666
x-xss-protection
0
server
cafe
etag
13855325883375746089
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
expires
Thu, 05 May 2022 18:36:49 GMT
zrt_lookup.html
googleads.g.doubleclick.net/pagead/html/r20220503/r20190131/ Frame A0D9
10 KB
5 KB
Document
General
Full URL
https://googleads.g.doubleclick.net/pagead/html/r20220503/r20190131/zrt_lookup.html
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:803::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
42b853168bb627593eb95b83db66183f7b3bd442db24c37398f1958d1451acd6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.docwirenews.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

age
73581
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
cache-control
public, max-age=1209600
content-encoding
gzip
content-length
4421
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Wed, 04 May 2022 22:10:28 GMT
etag
1428802124239944296
expires
Wed, 18 May 2022 22:10:28 GMT
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
server
cafe
timing-allow-origin
*
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
like.php
www.facebook.com/plugins/ Frame 008B
0
3 KB
Document
General
Full URL
https://www.facebook.com/plugins/like.php?href=https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/&layout=button_count&show_faces=false&width=105&action=like&colorscheme=light&height=21
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f12d:181:face:b00c:0:25de Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Content-Security-Policy default-src data: blob: 'self' https://*.fbsbx.com 'unsafe-inline' *.facebook.com 'unsafe-eval' *.fbcdn.net;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.google.com 127.0.0.1:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self' connect.facebook.net;style-src fonts.googleapis.com *.fbcdn.net data: *.facebook.com 'unsafe-inline';connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net wss://*.facebook.com:* wss://*.whatsapp.com:* wss://*.fbcdn.net attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' wss://gateway.facebook.com wss://edge-chat.facebook.com wss://snaptu-d.facebook.com wss://kaios-d-test.facebook.com/ wss://kaios-d.facebook.com/ v.whatsapp.net *.fbsbx.com *.fb.com;font-src data: *.gstatic.com *.facebook.com *.fbcdn.net *.fbsbx.com;img-src *.fbcdn.net *.facebook.com data: https://*.fbsbx.com *.tenor.co media.tenor.com facebook.com *.cdninstagram.com fbsbx.com fbcdn.net *.giphy.com connect.facebook.net *.carriersignal.info blob: android-webview-video-poster: googleads.g.doubleclick.net www.googleadservices.com *.whatsapp.net *.fb.com *.oculuscdn.com;media-src *.cdninstagram.com blob: *.fbcdn.net *.fbsbx.com www.facebook.com *.facebook.com https://*.giphy.com data:;frame-src *.doubleclick.net *.google.com *.facebook.com www.googleadservices.com *.fbsbx.com fbsbx.com data: www.instagram.com *.fbcdn.net https://paywithmybank.com;worker-src blob: *.facebook.com data:;block-all-mixed-content;upgrade-insecure-requests;
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.docwirenews.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
cache-control
private, no-cache, no-store, must-revalidate
content-length
0
content-security-policy
default-src data: blob: 'self' https://*.fbsbx.com 'unsafe-inline' *.facebook.com 'unsafe-eval' *.fbcdn.net;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.google.com 127.0.0.1:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self' connect.facebook.net;style-src fonts.googleapis.com *.fbcdn.net data: *.facebook.com 'unsafe-inline';connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net wss://*.facebook.com:* wss://*.whatsapp.com:* wss://*.fbcdn.net attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' wss://gateway.facebook.com wss://edge-chat.facebook.com wss://snaptu-d.facebook.com wss://kaios-d-test.facebook.com/ wss://kaios-d.facebook.com/ v.whatsapp.net *.fbsbx.com *.fb.com;font-src data: *.gstatic.com *.facebook.com *.fbcdn.net *.fbsbx.com;img-src *.fbcdn.net *.facebook.com data: https://*.fbsbx.com *.tenor.co media.tenor.com facebook.com *.cdninstagram.com fbsbx.com fbcdn.net *.giphy.com connect.facebook.net *.carriersignal.info blob: android-webview-video-poster: googleads.g.doubleclick.net www.googleadservices.com *.whatsapp.net *.fb.com *.oculuscdn.com;media-src *.cdninstagram.com blob: *.fbcdn.net *.fbsbx.com www.facebook.com *.facebook.com https://*.giphy.com data:;frame-src *.doubleclick.net *.google.com *.facebook.com www.googleadservices.com *.fbsbx.com fbsbx.com data: www.instagram.com *.fbcdn.net https://paywithmybank.com;worker-src blob: *.facebook.com data:;block-all-mixed-content;upgrade-insecure-requests;
content-security-policy-report-only
default-src data: blob: 'self' https://*.fbsbx.com 'unsafe-inline' *.facebook.com 'unsafe-eval' *.fbcdn.net;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.google.com 127.0.0.1:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self' connect.facebook.net;style-src fonts.googleapis.com *.fbcdn.net data: *.facebook.com 'unsafe-inline';connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net wss://*.facebook.com:* wss://*.whatsapp.com:* wss://*.fbcdn.net attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' wss://gateway.facebook.com wss://edge-chat.facebook.com wss://snaptu-d.facebook.com wss://kaios-d-test.facebook.com/ wss://kaios-d.facebook.com/ v.whatsapp.net *.fbsbx.com *.fb.com;font-src data: *.gstatic.com *.facebook.com *.fbcdn.net *.fbsbx.com;img-src *.fbcdn.net *.facebook.com data: https://*.fbsbx.com *.tenor.co media.tenor.com facebook.com *.cdninstagram.com fbsbx.com fbcdn.net *.giphy.com connect.facebook.net *.carriersignal.info blob: android-webview-video-poster: googleads.g.doubleclick.net www.googleadservices.com *.whatsapp.net *.fb.com *.oculuscdn.com;media-src *.cdninstagram.com blob: *.fbcdn.net *.fbsbx.com www.facebook.com *.facebook.com https://*.giphy.com data:;frame-src *.doubleclick.net *.google.com *.facebook.com www.googleadservices.com *.fbsbx.com fbsbx.com data: www.instagram.com *.fbcdn.net https://paywithmybank.com;worker-src blob: *.facebook.com data:;report-uri https://www.facebook.com/csp/reporting/?minimize=0;
content-type
text/html;charset=utf-8
cross-origin-embedder-policy-report-only
require-corp;report-to="coep_report"
cross-origin-opener-policy
same-origin-allow-popups
date
Thu, 05 May 2022 18:36:50 GMT
expires
Sat, 01 Jan 2000 00:00:00 GMT
nel
{"report_to":"network-errors","max_age":3600,"failure_fraction":0.01}
pragma
no-cache
priority
u=3,i
report-to
{"max_age":86400,"endpoints":[{"url":"https:\/\/www.facebook.com\/browser_reporting\/?minimize=0"}],"group":"coep_report"}, {"max_age":3600,"endpoints":[{"url":"https:\/\/www.facebook.com\/ajax\/browser_error_reports\/?device_level=unknown"}],"group":"network-errors"}
x-content-type-options
nosniff
x-fb-debug
bk+40tQNDzN3c4zjI2y8a2HIe1b71JHeEOUIAqs6owNW/WzwF0kyyKHBSzBDTpYbDpxaNVm9zYCmb9nmBpi8iQ==
x-xss-protection
0
fa-brands-400.woff2
pro.fontawesome.com/releases/v5.10.0/webfonts/
73 KB
73 KB
Font
General
Full URL
https://pro.fontawesome.com/releases/v5.10.0/webfonts/fa-brands-400.woff2
Requested by
Host: pro.fontawesome.com
URL: https://pro.fontawesome.com/releases/v5.10.0/css/all.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:1734 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
03a811b7e81f930c938141ba6c0a439f59acfe1a3c4a6768b7901741a32b459e

Request headers

Referer
https://pro.fontawesome.com/releases/v5.10.0/css/all.css
Origin
https://www.docwirenews.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:50 GMT
vary
Origin, Access-Control-Request-Headers, Access-Control-Request-Method, Accept-Encoding
cf-cache-status
MISS
x-amz-request-id
ZWQEHYKV8NMVV57K
content-length
74668
x-amz-id-2
KuewxDHQUIvrzN6NWNhbAyphkxZRV4sH6xxtkouyaLa98gSbIEBLR5dtjUnJa+8yoBEFpslYoSI=
last-modified
Mon, 28 Jun 2021 16:56:06 GMT
server
cloudflare
etag
"2de2a530b2c689d8dc9548acfcf670a1"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
font/woff2
access-control-allow-origin
*
cache-control
max-age=31556926
accept-ranges
bytes
cf-ray
706b957c388f5c80-FRA
Episode-155-ASCO-GU-2022-ARASENS-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer-e1ehuoa
anchor.fm/the-uromigos/embed/episodes/ Frame 1A58
17 KB
6 KB
Document
General
Full URL
https://anchor.fm/the-uromigos/embed/episodes/Episode-155-ASCO-GU-2022-ARASENS-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer-e1ehuoa
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.66.133 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/ Express
Resource Hash
e2b3bc57eb669015d66df77b7669ad9856a831a013938b28b809cf109b5ca855
Security Headers
Name Value
Strict-Transport-Security max-age=86400

Request headers

Referer
https://www.docwirenews.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

accept-ranges
bytes
age
0
cache-control
public, s-maxage=120, max-age=0
content-encoding
gzip
content-language
de
content-length
5496
content-type
text/html; charset=utf-8
date
Thu, 05 May 2022 18:36:50 GMT
etag
W/"42fe-+ft3Upc8AaIhoykRc2l1+IQgsgQ"
strict-transport-security
max-age=86400
vary
Accept-Language, Accept-Encoding
via
1.1 varnish, 1.1 varnish
x-cache
MISS, MISS
x-cache-hits
0, 0
x-powered-by
Express
x-served-by
cache-iad-kiad7000079-IAD, cache-hhn4083-HHN
KFOlCnqEu92Fr1MmWUlfBBc4.woff2
fonts.gstatic.com/s/roboto/v29/
15 KB
15 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v29/KFOlCnqEu92Fr1MmWUlfBBc4.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto%3A300%2C400%2C400italic%2C500%2C500italic%2C700%2C900%7CMontserrat%3A400%7COpen+Sans%3A300italic%2C400%2C400italic%2C600%2C600italic%2C700&ver=8.7.1
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:831::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
0eaeadb58e6995ba85eccb6198aaef77eeb1d4b66699e4e1f3fc10eb6adfcdb9
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://www.docwirenews.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Wed, 04 May 2022 17:56:19 GMT
x-content-type-options
nosniff
age
88831
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
15828
x-xss-protection
0
last-modified
Wed, 22 Sep 2021 16:13:28 GMT
server
sffe
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="apps-themes"
expires
Thu, 04 May 2023 17:56:19 GMT
api.min.js
a.omappapi.com/app/js/
193 KB
54 KB
Script
General
Full URL
https://a.omappapi.com/app/js/api.min.js
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
84.17.46.53 Amsterdam, Netherlands, ASN60068 (CDN77 ^_^, GB),
Reverse DNS
unn-84-17-46-53.cdn77.com
Software
BunnyCDN-AMS1-879 /
Resource Hash
b77f6fa10a82b4f583ce0ad71b79b0522b7bf784b63b7a6e6aa4256facc586ec

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:50 GMT
content-encoding
br
cdn-edgestorageid
549
perma-cache
HIT
cdn-storageserver
DE-51
cdn-cachedat
04/12/2022 15:55:52
cdn-pullzone
293267
access-control-allow-headers
Server, x-goog-meta-frames, Content-Length, Content-Type, Range, X-Requested-With, If-Modified-Since, If-None-Match
cdn-requestpullcode
200
server
BunnyCDN-AMS1-879
access-control-allow-origin
*
last-modified
Tue, 12 Apr 2022 15:54:22 GMT
cdn-proxyver
1.02
cdn-fileserver
305
etag
W/"6255a0ae-3027e"
vary
Accept-Encoding, Accept-Encoding
content-type
application/javascript
cdn-cache
HIT
access-control-expose-headers
Server, x-goog-meta-frames, Content-Length, Content-Type, Range, X-Requested-With, If-Modified-Since, If-None-Match
cache-control
public, max-age=31919000
cdn-uid
efcab737-66db-4b75-ab55-ed485d5a01dd
cdn-requestid
5aa85ae081988cd66452d7462489d3c8
cdn-requestcountrycode
DE
cdn-status
200
cdn-requestpullsuccess
True
collect
www.google-analytics.com/j/
2 B
22 B
XHR
General
Full URL
https://www.google-analytics.com/j/collect?v=1&_v=j96&a=733354313&t=pageview&_s=1&dl=https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D&ul=en-us&de=UTF-8&dt=Episode%20155%3A%20ASCO%20GU%202022%20ARASENS%20trial%20of%20darolutamide%20and%20chemo%20vs%20chemo%20alone%20in%20hormone%20sensitive%20advanced%20prostate%20cancer%20-%20Docwire%20News&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=YEBAAEABAAAAAC~&jid=1866326617&gjid=1191022852&cid=1837915677.1651775810&tid=UA-117435438-1&_gid=1655574837.1651775810&_r=1&gtm=2wg540WR3NX75&z=2041335833
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:808::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
de3246094525b21a870fc7d2a67490d0132535c6fa5993755c549f1a9d1bd8af
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.docwirenews.com/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Thu, 05 May 2022 18:36:50 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.docwirenews.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
www.facebook.com/tr/
44 B
297 B
Image
General
Full URL
https://www.facebook.com/tr/?id=431376567356414&ev=PageView&dl=https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D&rl=&if=false&ts=1651775810057&sw=1600&sh=1200&v=2.9.58&r=stable&ec=0&o=30&fbp=fb.1.1651775810053.2063725742&it=1651775809785&coo=false&exp=p0&rqm=GET
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f12d:181:face:b00c:0:25de Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:50 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
cache-control
no-cache, must-revalidate, max-age=0
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length
44
expires
Thu, 05 May 2022 18:36:50 GMT
cookie.js
partner.googleadservices.com/gampad/
219 B
416 B
Script
General
Full URL
https://partner.googleadservices.com/gampad/cookie.js?domain=www.docwirenews.com&callback=_gfp_s_&client=ca-pub-3350439833258580
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202204270101/show_ads_impl_with_ama_fy2019.js?client=ca-pub-3350439833258580&plah=www.docwirenews.com
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.179.162 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
ams15s41-in-f2.1e100.net
Software
cafe /
Resource Hash
1422f750934c3d94248fa47c641bda86ce26949a17af8e017e5ccbdb1d663681
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:50 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
content-type
text/javascript; charset=UTF-8
cache-control
private
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
201
x-xss-protection
0
integrator.js
adservice.google.de/adsid/
107 B
792 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.docwirenews.com
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202204270101/show_ads_impl_with_ama_fy2019.js?client=ca-pub-3350439833258580&plah=www.docwirenews.com
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:828::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

timing-allow-origin
*
date
Thu, 05 May 2022 18:36:50 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3="googleads.g.doubleclick.net:443"; ma=2592000,h3=":443"; ma=2592000,h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
100
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
107 B
549 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.docwirenews.com
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202204270101/show_ads_impl_with_ama_fy2019.js?client=ca-pub-3350439833258580&plah=www.docwirenews.com
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

timing-allow-origin
*
date
Thu, 05 May 2022 18:36:50 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
100
x-xss-protection
0
gen_204
pagead2.googlesyndication.com/pagead/
0
20 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=ach_evt&url=https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D&tn=DIV&cls=code-block%20code-block-3%20ai-viewport-1%20ai-center-h%20ai-close&ign=false&pw=1600&ph=1200&x=0&y=1130.4
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 05 May 2022 18:36:50 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
googleads.g.doubleclick.net/pagead/ Frame D8A5
0
19 B
Document
General
Full URL
https://googleads.g.doubleclick.net/pagead/ads?client=ca-pub-3350439833258580&output=html&adk=1812271804&adf=3025194257&lmt=1651775810&plat=1%3A16777216%2C9%3A32776%2C16%3A8388608%2C17%3A32%2C24%3A32%2C25%3A32%2C30%3A1081344%2C32%3A32&format=0x0&url=https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D&ea=0&pra=5&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXSxmYWxzZV0.&dt=1651775809874&bpp=3&bdt=856&idt=243&shv=r20220503&mjsv=m202204270101&ptt=9&saldr=aa&abxe=1&nras=1&correlator=1115353859529&frm=20&pv=2&ga_vid=1837915677.1651775810&ga_sid=1651775810&ga_hid=733354313&ga_fc=1&u_tz=0&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=-12245933&ady=-12245933&biw=1600&bih=1200&scr_x=0&scr_y=0&eid=44759875%2C44759926%2C44759837%2C44761044&oid=2&pvsid=1956160238184584&pem=117&tmod=1945741225&uas=0&nvt=1&eae=2&fc=1920&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C1600%2C1200&vis=1&rsz=%7C%7Cs%7C&abl=NS&fu=32768&bc=31&ifi=1&uci=a!1&fsb=1&dtd=259
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202204270101/show_ads_impl_with_ama_fy2019.js?client=ca-pub-3350439833258580&plah=www.docwirenews.com
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:803::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.docwirenews.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
cache-control
private
content-length
0
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Thu, 05 May 2022 18:36:50 GMT
expires
Thu, 05 May 2022 18:36:50 GMT
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
server
cafe
timing-allow-origin
*
x-content-type-options
nosniff
x-xss-protection
0
collect
stats.g.doubleclick.net/j/
4 B
445 B
XHR
General
Full URL
https://stats.g.doubleclick.net/j/collect?t=dc&aip=1&_r=3&v=1&_v=j96&tid=UA-117435438-1&cid=1837915677.1651775810&jid=1866326617&gjid=1191022852&_gid=1655574837.1651775810&_u=YEBAAEAAAAAAAC~&z=1919525046
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:400c:c0b::9c Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
84e01419bd81f32ac6df0f75f49c604fda9172000a3ae432b3c47b2a6a712d80
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.docwirenews.com/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
strict-transport-security
max-age=10886400; includeSubDomains; preload
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
date
Thu, 05 May 2022 18:36:50 GMT
content-type
text/plain
access-control-allow-origin
https://www.docwirenews.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4
expires
Fri, 01 Jan 1990 00:00:00 GMT
bundle-8b03e8b9bcd02b6064f0.css
d1rx8vrt2hn1hc.cloudfront.net/builds/ Frame 1A58
269 KB
51 KB
Stylesheet
General
Full URL
https://d1rx8vrt2hn1hc.cloudfront.net/builds/bundle-8b03e8b9bcd02b6064f0.css
Requested by
Host: anchor.fm
URL: https://anchor.fm/the-uromigos/embed/episodes/Episode-155-ASCO-GU-2022-ARASENS-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer-e1ehuoa
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2156:2200:1e:f77c:1000:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
4f272e4a8aa61059749567037399c7a0a8d5922a58a6545b1f5cee5a00539433

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://anchor.fm/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 15:07:12 GMT
content-encoding
gzip
last-modified
Thu, 05 May 2022 14:48:11 GMT
server
AmazonS3
age
12578
etag
W/"02ae2cae14fd3bfd34d55a242c25e840"
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
via
1.1 e64eb476d8f76c461d21278e018e194e.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
KfIdIfx3KlaibcqWgqjKF-owuOIKrjF7275-Jvqvw68R7Ir38pKYJw==
ProfileEpisodeContainer-8b03e8b9bcd02b6064f0.css
d1rx8vrt2hn1hc.cloudfront.net/builds/ Frame 1A58
32 KB
6 KB
Stylesheet
General
Full URL
https://d1rx8vrt2hn1hc.cloudfront.net/builds/ProfileEpisodeContainer-8b03e8b9bcd02b6064f0.css
Requested by
Host: anchor.fm
URL: https://anchor.fm/the-uromigos/embed/episodes/Episode-155-ASCO-GU-2022-ARASENS-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer-e1ehuoa
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2156:2200:1e:f77c:1000:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
7c6951c9b3eb54d791d7ae7b77b078d271c8b15f395a05980b80244b05575d3a

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://anchor.fm/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 15:34:53 GMT
content-encoding
gzip
last-modified
Thu, 05 May 2022 14:48:04 GMT
server
AmazonS3
age
10918
etag
W/"98fac8595c2b95e402559c7e336b5cd5"
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
via
1.1 e64eb476d8f76c461d21278e018e194e.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
PMBoK6CtChec1Xpb7Poi6s3NB0C3MpXhQDmaOx8fi0lnnR0LjTOnlg==
bundle-8b03e8b9bcd02b6064f0.js
d1rx8vrt2hn1hc.cloudfront.net/builds/ Frame 1A58
18 MB
18 MB
Script
General
Full URL
https://d1rx8vrt2hn1hc.cloudfront.net/builds/bundle-8b03e8b9bcd02b6064f0.js
Requested by
Host: anchor.fm
URL: https://anchor.fm/the-uromigos/embed/episodes/Episode-155-ASCO-GU-2022-ARASENS-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer-e1ehuoa
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2156:2200:1e:f77c:1000:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
ad4421527b6614c20eed1f96c1abc70fdca905decd525c54d54d21d4eb7c1a8e

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://anchor.fm/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 15:07:12 GMT
via
1.1 e64eb476d8f76c461d21278e018e194e.cloudfront.net (CloudFront)
last-modified
Thu, 05 May 2022 14:48:14 GMT
server
AmazonS3
age
12578
etag
"17aa3f593366cc2a8f4ccfbf41855279-3"
x-cache
Hit from cloudfront
content-type
application/javascript
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
content-length
18675915
x-amz-cf-id
7_r424ztMoM5638xgkdZ2pjvPj_J-WJxsDvBYzeFpBBr_4-o5YOYzQ==
api.min.css
a.omappapi.com/app/js/
18 KB
3 KB
Stylesheet
General
Full URL
https://a.omappapi.com/app/js/api.min.css
Requested by
Host: a.omappapi.com
URL: https://a.omappapi.com/app/js/api.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
84.17.46.53 Amsterdam, Netherlands, ASN60068 (CDN77 ^_^, GB),
Reverse DNS
unn-84-17-46-53.cdn77.com
Software
BunnyCDN-AMS1-879 /
Resource Hash
4b99a75a42582fd22e780855dfb50880df624ce43988616f4b19dc7ba90f1250

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:50 GMT
content-encoding
br
cdn-edgestorageid
459
perma-cache
HIT
cdn-storageserver
DE-165
cdn-cachedat
04/12/2022 15:55:52
cdn-pullzone
293267
access-control-allow-headers
Server, x-goog-meta-frames, Content-Length, Content-Type, Range, X-Requested-With, If-Modified-Since, If-None-Match
cdn-requestpullcode
200
server
BunnyCDN-AMS1-879
access-control-allow-origin
*
last-modified
Tue, 12 Apr 2022 15:54:22 GMT
cdn-proxyver
1.02
cdn-fileserver
340
etag
W/"6255a0ae-464c"
vary
Accept-Encoding, Accept-Encoding
content-type
text/css
cdn-cache
HIT
access-control-expose-headers
Server, x-goog-meta-frames, Content-Length, Content-Type, Range, X-Requested-With, If-Modified-Since, If-None-Match
cache-control
public, max-age=31919000
cdn-uid
efcab737-66db-4b75-ab55-ed485d5a01dd
cdn-requestid
6481a3952feccbb7705ebf0aa6f06770
cdn-requestcountrycode
DE
cdn-status
200
cdn-requestpullsuccess
True
uwt.js
static.ads-twitter.com/
28 KB
10 KB
Script
General
Full URL
https://static.ads-twitter.com/uwt.js
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.232.188.157 Munich, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
93cc545f534a75a876beccc35125e563e20bb9857714482547fc151f07d57595

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:50 GMT
content-encoding
gzip
last-modified
Tue, 03 May 2022 16:26:14 GMT
etag
"1ce6e12fa6e9b18909e94a06df1ef9cb+gzip+gzip"
vary
Accept-Encoding,Host
x-tw-cdn
FT
p3p
CP="CAO DSP LAW CURa ADMa DEVa TAIa PSAa PSDa IVAa IVDa OUR BUS IND UNI COM NAV INT"
cache-control
no-cache
x-cache
HIT, HIT
accept-ranges
bytes
content-type
application/javascript; charset=utf-8
content-length
9561
x-served-by
cache-iad-kjyo7100161-IAD, cache-muc13933-MUC
clickstream.js
d10lpsik1i8c69.cloudfront.net/js/ Frame 3129
287 KB
92 KB
Script
General
Full URL
https://d10lpsik1i8c69.cloudfront.net/js/clickstream.js?v=ce8f9a1
Requested by
Host: d10lpsik1i8c69.cloudfront.net
URL: https://d10lpsik1i8c69.cloudfront.net/w.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
143.204.101.166 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-101-166.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
92f65d433b40a4c4719b742357563d08b1c16d6396571933da9f02f9ef7424d8

Request headers

Referer
Origin
https://www.docwirenews.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Fri, 01 Apr 2022 00:47:30 GMT
content-encoding
gzip
vary
Accept-Encoding,Origin,Access-Control-Request-Headers,Access-Control-Request-Method
age
3001761
x-cache
Hit from cloudfront
access-control-allow-origin
*
last-modified
Tue, 01 Mar 2022 22:59:52 GMT
server
AmazonS3
etag
W/"16e967413dfa0346be281513c77581b9"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
application/javascript
via
1.1 6b4954a8411e7b2a232537f8000c5c9c.cloudfront.net (CloudFront)
cache-control
max-age=31536000
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
TROfkHoz4-UwDFTDzZMWmInLAnOf7AlbNHS6h7RESHBDHPb-XtSWUA==
KFOkCnqEu92Fr1Mu51xIIzI.woff2
fonts.gstatic.com/s/roboto/v29/
17 KB
17 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v29/KFOkCnqEu92Fr1Mu51xIIzI.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto%3A300%2C400%2C400italic%2C500%2C500italic%2C700%2C900%7CMontserrat%3A400%7COpen+Sans%3A300italic%2C400%2C400italic%2C600%2C600italic%2C700&ver=8.7.1
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:831::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
46375ee9192c1e0f6eabe4d32b2a48b996b93037f7b4beb970df5b87359548fd
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://www.docwirenews.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Fri, 29 Apr 2022 01:28:33 GMT
x-content-type-options
nosniff
age
580097
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
17304
x-xss-protection
0
last-modified
Wed, 22 Sep 2021 16:13:19 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 29 Apr 2023 01:28:33 GMT
/
www.medtargetsystem.com/beacon/portal/ Frame 570C
457 B
796 B
Document
General
Full URL
https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D&_sid=8d27a7f7-ab48-49db-97f5-691b4c538684&_vid=b7b9c3f1-0936-4c7c-87c0-ab638be64bc3&_ak=45-381-6BCF239E&_flash=false&_th=1651775810|1651775810|1
Requested by
Host: www.medtargetsystem.com
URL: https://www.medtargetsystem.com/javascript/beacon.js?1651775809615
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.204.255.196 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-18-204-255-196.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash
1f5247a71ed1cabdf586af8d1395863b7b419450ff7180831a0e8b8048076baf

Request headers

Referer
https://www.docwirenews.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

cache-control
no-store, no-cache, must-revalidate
content-encoding
gzip
content-length
310
content-type
text/html; charset=UTF-8
date
Thu, 05 May 2022 18:36:50 GMT
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
pragma
no-cache
server
Apache/2.4.7 (Ubuntu)
vary
X-Forwarded-Proto,Accept-Encoding
x-powered-by
PHP/7.0.19-1+deb.sury.org~trusty+2
x-robots-tag
noindex
collect.gif
www.medtargetsystem.com/analytics/
0
358 B
Image
General
Full URL
https://www.medtargetsystem.com/analytics/collect.gif?e=1&aid=&vid=b7b9c3f1-0936-4c7c-87c0-ab638be64bc3&sid=8d27a7f7-ab48-49db-97f5-691b4c538684&vh=1&vt=1651775810&pt=1651775810&u=https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D&r=&t=Episode%20155%3A%20ASCO%20GU%202022%20ARASENS%20trial%20of%20darolutamide%20and%20chemo%20vs%20chemo%20alone%20in%20hormone%20sensitive%20advanced%20prostate%20cancer%20-%20Docwire%20News&p=1943.20&pm=&ab=&ak=45-381-6BCF239E
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.204.255.196 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-18-204-255-196.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 05 May 2022 18:36:50 GMT
server
Apache/2.4.7 (Ubuntu)
x-powered-by
PHP/7.0.19-1+deb.sury.org~trusty+2
vary
X-Forwarded-Proto
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
access-control-allow-origin
*
cache-control
max-age=0, no-cache, no-store
expires
0
ga-audiences
www.google.com/ads/
42 B
501 B
Image
General
Full URL
https://www.google.com/ads/ga-audiences?t=sr&aip=1&_r=4&slf_rd=1&v=1&_v=j96&tid=UA-117435438-1&cid=1837915677.1651775810&jid=1866326617&_u=YEBAAEAAAAAAAC~&z=1132718574
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:803::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 05 May 2022 18:36:50 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
ga-audiences
www.google.de/ads/
42 B
501 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?t=sr&aip=1&_r=4&slf_rd=1&v=1&_v=j96&tid=UA-117435438-1&cid=1837915677.1651775810&jid=1866326617&_u=YEBAAEAAAAAAAC~&z=1132718574
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80e::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 05 May 2022 18:36:50 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
adsct
analytics.twitter.com/i/
43 B
356 B
Image
General
Full URL
https://analytics.twitter.com/i/adsct?type=javascript&version=2.3.4&p_id=Twitter&p_user_id=0&txn_id=nzz4m&events=%5B%5B%22pageview%22%2C%7B%7D%5D%5D&tw_order_quantity=0&tw_sale_amount=0&tw_iframe_status=0&event_id=aeb423c7-f785-46e4-aa96-c21ed578bfc7&tw_document_href=https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.244.42.3 , United States, ASN13414 (TWITTER, US),
Reverse DNS
Software
tsa_o /
Resource Hash
ac8778041fdb7f2e08ceb574c9a766247ea26f1a7d90fa854c4efcf4b361a957
Security Headers
Name Value
Strict-Transport-Security max-age=631138519

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

x-response-time
113
date
Thu, 05 May 2022 18:36:50 GMT
server
tsa_o
strict-transport-security
max-age=631138519
content-type
image/gif;charset=utf-8
cache-control
no-cache, no-store, max-age=0
x-connection-hash
4e876cab59124bddd3e7651994de76b6726ff529741dd9336222daf463a495a3
content-length
43
adsct
t.co/i/
43 B
338 B
Image
General
Full URL
https://t.co/i/adsct?type=javascript&version=2.3.4&p_id=Twitter&p_user_id=0&txn_id=nzz4m&events=%5B%5B%22pageview%22%2C%7B%7D%5D%5D&tw_order_quantity=0&tw_sale_amount=0&tw_iframe_status=0&event_id=aeb423c7-f785-46e4-aa96-c21ed578bfc7&tw_document_href=https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.244.42.197 , United States, ASN13414 (TWITTER, US),
Reverse DNS
Software
tsa_o /
Resource Hash
ac8778041fdb7f2e08ceb574c9a766247ea26f1a7d90fa854c4efcf4b361a957
Security Headers
Name Value
Strict-Transport-Security max-age=0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

x-response-time
116
date
Thu, 05 May 2022 18:36:49 GMT
server
tsa_o
strict-transport-security
max-age=0
content-type
image/gif;charset=utf-8
cache-control
no-cache, no-store, max-age=0
x-connection-hash
1544f9916c01c5476ff78c0218683464710d6f41653e3305138645737de06a83
content-length
43
css
fonts.googleapis.com/ Frame 1A58
41 KB
3 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Amatic+SC:400,700|Bangers|Barrio|Chango|Courgette|Economica:400,700|Graduate|Jolly+Lodger|Josefin+Slab:300,400i,700|Lato:300,400,700|Lobster|Monoton|Montserrat:300,400,700|Old+Standard+TT:400i,700|Oswald:300,400,700|Quicksand:400,700|Raleway:300,400i,700|Seaweed+Script|Shrikhand|Source+Sans+Pro:700,900|Stint+Ultra+Expanded|Vast+Shadow|Voltaire|DM+Sans:700
Requested by
Host: d1rx8vrt2hn1hc.cloudfront.net
URL: https://d1rx8vrt2hn1hc.cloudfront.net/builds/bundle-8b03e8b9bcd02b6064f0.css
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80f::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
4ceaa496b5dc110c8719ee32eabd8dfe22556804799ca4c0607c415032c26b5c
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://d1rx8vrt2hn1hc.cloudfront.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Thu, 05 May 2022 17:46:00 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
date
Thu, 05 May 2022 18:36:50 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Thu, 05 May 2022 18:36:50 GMT
transition
www.medtargetsystem.com/iframe/ Frame B494
189 B
440 B
Document
General
Full URL
https://www.medtargetsystem.com/iframe/transition?client-origin=https%3A%2F%2Fwww.docwirenews.com&timestamp=1651775809972
Requested by
Host: aim-tag.hcn.health
URL: https://aim-tag.hcn.health/js/client.js?dl=aimDataLayer
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.204.255.196 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-18-204-255-196.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash
154c8b2314fd5ed2931752661f779f53a1a80414fc2a3db587f4f0d76f7217d2

Request headers

Referer
https://www.docwirenews.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

cache-control
no-cache, private
content-encoding
gzip
content-length
145
content-type
text/html; charset=UTF-8
date
Thu, 05 May 2022 18:36:50 GMT
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
server
Apache/2.4.7 (Ubuntu)
vary
X-Forwarded-Proto,Accept-Encoding
x-powered-by
PHP/7.0.19-1+deb.sury.org~trusty+2
x-robots-tag
noindex
iframe.html
aim-tag.hcn.health/ Frame CFE4
108 KB
108 KB
Document
General
Full URL
https://aim-tag.hcn.health/iframe.html?client-origin=https%3A%2F%2Fwww.docwirenews.com&pageview-id=53864740-cca2-11ec-bddd-278631a15be6&stps=%7B%7D&timestamp=1651775809972
Requested by
Host: aim-tag.hcn.health
URL: https://aim-tag.hcn.health/js/client.js?dl=aimDataLayer
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.173.3.48 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-173-3-48.compute-1.amazonaws.com
Software
awselb/2.0 /
Resource Hash
bbc542d0c19ee8ff166db24147ab304ceec259447b34698d6ffb2f7a4e3b7e75

Request headers

Referer
https://www.docwirenews.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

content-length
110469
content-type
text/html; charset=UTF-8
date
Thu, 05 May 2022 18:36:50 GMT
server
awselb/2.0
analytics.js
www.google-analytics.com/ Frame 1A58
49 KB
20 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: anchor.fm
URL: https://anchor.fm/the-uromigos/embed/episodes/Episode-155-ASCO-GU-2022-ARASENS-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer-e1ehuoa
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:808::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
a1925038db769477ab74b4df34350c35688a795bb718727b0f4292a4a78a6210
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://anchor.fm/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Wed, 13 Apr 2022 21:02:38 GMT
server
Golfe2
age
1061
date
Thu, 05 May 2022 18:19:09 GMT
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
20006
expires
Thu, 05 May 2022 20:19:09 GMT
maax-regular.woff2
d12xoj7p9moygp.cloudfront.net/fonts/maax/ Frame 1A58
63 KB
63 KB
Font
General
Full URL
https://d12xoj7p9moygp.cloudfront.net/fonts/maax/maax-regular.woff2
Requested by
Host: d1rx8vrt2hn1hc.cloudfront.net
URL: https://d1rx8vrt2hn1hc.cloudfront.net/builds/bundle-8b03e8b9bcd02b6064f0.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2156:6000:11:d2b:9e40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
6eb03531048be7cfd4e43d6084f3ec0b30c4e8025831854d1c6a1b811a2d30eb

Request headers

Referer
https://d1rx8vrt2hn1hc.cloudfront.net/
Origin
https://anchor.fm
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Tue, 19 Apr 2022 03:05:56 GMT
via
1.1 f6c241b75ae7d21ac836339454ab90b8.cloudfront.net (CloudFront)
vary
Origin,Access-Control-Request-Headers,Access-Control-Request-Method
age
1438255
x-cache
Hit from cloudfront
content-length
64460
last-modified
Mon, 11 Apr 2022 21:13:52 GMT
server
AmazonS3
etag
"c734ea7a77c7a3165daa3c5219a382c0"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
font/woff2
access-control-allow-origin
https://anchor.fm
access-control-allow-credentials
true
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
S4caFnPcgTG5nY7ZtTfraExLJ5Aa42j4VaElJqBwL-4fMimTNv9Kfw==
/
www.facebook.com/tr/ Frame B71C
0
18 B
Document
General
Full URL
https://www.facebook.com/tr/
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a03:2880:f12d:181:face:b00c:0:25de Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Content-Type
application/x-www-form-urlencoded
Origin
https://www.docwirenews.com
Referer
https://www.docwirenews.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

access-control-allow-credentials
true
access-control-allow-origin
https://www.docwirenews.com
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length
0
content-type
text/plain
cross-origin-resource-policy
cross-origin
date
Thu, 05 May 2022 18:36:50 GMT
priority
u=0
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
signal.js
www.medtargetsystem.com/js/build/iframe/ Frame 570C
105 KB
29 KB
Script
General
Full URL
https://www.medtargetsystem.com/js/build/iframe/signal.js?27&partners=deepIntent.1.1|lasso.2.2|
Requested by
Host: www.medtargetsystem.com
URL: https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D&_sid=8d27a7f7-ab48-49db-97f5-691b4c538684&_vid=b7b9c3f1-0936-4c7c-87c0-ab638be64bc3&_ak=45-381-6BCF239E&_flash=false&_th=1651775810|1651775810|1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.204.255.196 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-18-204-255-196.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) /
Resource Hash
466a55a39ed448091cff7fea22d4479f7713a42cf7a2121dde7285c15c87b8a1

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D&_sid=8d27a7f7-ab48-49db-97f5-691b4c538684&_vid=b7b9c3f1-0936-4c7c-87c0-ab638be64bc3&_ak=45-381-6BCF239E&_flash=false&_th=1651775810|1651775810|1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:50 GMT
content-encoding
gzip
last-modified
Thu, 14 Apr 2022 14:52:23 GMT
server
Apache/2.4.7 (Ubuntu)
etag
"1a26d-5dc9e710a57c0-gzip"
vary
X-Forwarded-Proto,Accept-Encoding
content-type
application/javascript
accept-ranges
bytes
content-length
29335
fp.js
www.medtargetsystem.com/js/build/iframe/ Frame 570C
87 KB
20 KB
Script
General
Full URL
https://www.medtargetsystem.com/js/build/iframe/fp.js?27
Requested by
Host: www.medtargetsystem.com
URL: https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D&_sid=8d27a7f7-ab48-49db-97f5-691b4c538684&_vid=b7b9c3f1-0936-4c7c-87c0-ab638be64bc3&_ak=45-381-6BCF239E&_flash=false&_th=1651775810|1651775810|1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.204.255.196 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-18-204-255-196.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) /
Resource Hash
4ec1fe0be35d1aa2e347cb10718d708139fbc1a8a429fb3650877ba976192422

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D&_sid=8d27a7f7-ab48-49db-97f5-691b4c538684&_vid=b7b9c3f1-0936-4c7c-87c0-ab638be64bc3&_ak=45-381-6BCF239E&_flash=false&_th=1651775810|1651775810|1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:50 GMT
content-encoding
gzip
last-modified
Thu, 14 Apr 2022 14:50:45 GMT
server
Apache/2.4.7 (Ubuntu)
etag
"15c76-5dc9e6b32fb40-gzip"
vary
X-Forwarded-Proto,Accept-Encoding
content-type
application/javascript
accept-ranges
bytes
content-length
20454
transition.js
www.medtargetsystem.com/js/build/iframe/ Frame B494
103 KB
21 KB
Script
General
Full URL
https://www.medtargetsystem.com/js/build/iframe/transition.js?1651775810
Requested by
Host: www.medtargetsystem.com
URL: https://www.medtargetsystem.com/iframe/transition?client-origin=https%3A%2F%2Fwww.docwirenews.com&timestamp=1651775809972
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.204.255.196 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-18-204-255-196.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) /
Resource Hash
8bfe1f6a0f176cd4690c1f380831d1796c79a8f351e653f414cfd77625667aba

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.medtargetsystem.com/iframe/transition?client-origin=https%3A%2F%2Fwww.docwirenews.com&timestamp=1651775809972
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:50 GMT
content-encoding
gzip
last-modified
Thu, 14 Apr 2022 14:51:33 GMT
server
Apache/2.4.7 (Ubuntu)
etag
"19dc3-5dc9e6e0f6740-gzip"
vary
X-Forwarded-Proto,Accept-Encoding
content-type
application/javascript
accept-ranges
bytes
content-length
20801
_itu.png
www.medtargetsystem.com/ Frame 570C
89 B
494 B
Image
General
Full URL
https://www.medtargetsystem.com/_itu.png
Requested by
Host: www.medtargetsystem.com
URL: https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D&_sid=8d27a7f7-ab48-49db-97f5-691b4c538684&_vid=b7b9c3f1-0936-4c7c-87c0-ab638be64bc3&_ak=45-381-6BCF239E&_flash=false&_th=1651775810|1651775810|1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.204.255.196 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-18-204-255-196.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash
2023d33cdcbc92384e340071f2f3a3ccbbd62712f938b15cf1fe823f93cbca59

Request headers

Referer
https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D&_sid=8d27a7f7-ab48-49db-97f5-691b4c538684&_vid=b7b9c3f1-0936-4c7c-87c0-ab638be64bc3&_ak=45-381-6BCF239E&_flash=false&_th=1651775810|1651775810|1
Origin
https://www.medtargetsystem.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

pragma
private
date
Thu, 05 May 2022 18:36:51 GMT
server
Apache/2.4.7 (Ubuntu)
x-powered-by
PHP/7.0.19-1+deb.sury.org~trusty+2
vary
X-Forwarded-Proto
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
access-control-allow-origin
*
cache-control
no-transform, max-age=0, must-revalidate, private
content-type
image/png
content-length
89
expires
-1
_itu.png
www.medtargetsystem.com/ Frame B494
89 B
494 B
Image
General
Full URL
https://www.medtargetsystem.com/_itu.png
Requested by
Host: www.medtargetsystem.com
URL: https://www.medtargetsystem.com/js/build/iframe/transition.js?1651775810
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.204.255.196 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-18-204-255-196.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash
2023d33cdcbc92384e340071f2f3a3ccbbd62712f938b15cf1fe823f93cbca59

Request headers

Referer
https://www.medtargetsystem.com/iframe/transition?client-origin=https%3A%2F%2Fwww.docwirenews.com&timestamp=1651775809972
Origin
https://www.medtargetsystem.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

pragma
private
date
Thu, 05 May 2022 18:36:50 GMT
server
Apache/2.4.7 (Ubuntu)
x-powered-by
PHP/7.0.19-1+deb.sury.org~trusty+2
vary
X-Forwarded-Proto
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
access-control-allow-origin
*
cache-control
no-transform, max-age=0, must-revalidate, private
content-type
image/png
content-length
89
expires
-1
/
sentry.io/api/1333003/envelope/ Frame 1A58
2 B
399 B
Fetch
General
Full URL
https://sentry.io/api/1333003/envelope/?sentry_key=0a700392b53f44f5acd5b0879f508c74&sentry_version=7
Requested by
Host: d1rx8vrt2hn1hc.cloudfront.net
URL: https://d1rx8vrt2hn1hc.cloudfront.net/builds/bundle-8b03e8b9bcd02b6064f0.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
35.188.42.15 Council Bluffs, United States, ASN15169 (GOOGLE, US),
Reverse DNS
15.42.188.35.bc.googleusercontent.com
Software
nginx /
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload

Request headers

Referer
https://anchor.fm/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Date
Thu, 05 May 2022 18:36:52 GMT
vary
Origin
Server
nginx
Strict-Transport-Security
max-age=31536000; includeSubDomains; preload
Content-Type
application/json
access-control-allow-origin
https://anchor.fm
access-control-expose-headers
retry-after, x-sentry-error, x-sentry-rate-limits
x-envoy-upstream-service-time
0
Connection
keep-alive
Content-Length
2
ProfileEpisodeContainer-8b03e8b9bcd02b6064f0.js
d1rx8vrt2hn1hc.cloudfront.net/builds/ Frame 1A58
783 KB
216 KB
Script
General
Full URL
https://d1rx8vrt2hn1hc.cloudfront.net/builds/ProfileEpisodeContainer-8b03e8b9bcd02b6064f0.js
Requested by
Host: d1rx8vrt2hn1hc.cloudfront.net
URL: https://d1rx8vrt2hn1hc.cloudfront.net/builds/bundle-8b03e8b9bcd02b6064f0.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2156:2200:1e:f77c:1000:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
75a11e06decd701b5774aa3ea792e19d44ec4388805adcc63f81fc7d5ae93236

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://anchor.fm/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 15:34:55 GMT
content-encoding
gzip
last-modified
Thu, 05 May 2022 14:48:07 GMT
server
AmazonS3
age
10917
etag
W/"6b71e3e691923c9053db76be3a62eaaf"
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
via
1.1 e64eb476d8f76c461d21278e018e194e.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
ytLMANfTjJno4nhFXmQps9J-j7T_COJEVow7nxIrJjLvp4Vp_VUhcQ==
/
www.medtargetsystem.com/beacon/process/ Frame 570C
60 B
386 B
XHR
General
Full URL
https://www.medtargetsystem.com/beacon/process/
Requested by
Host: www.medtargetsystem.com
URL: https://www.medtargetsystem.com/js/build/iframe/fp.js?27
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.204.255.196 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-18-204-255-196.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash
403137518183f3bf340b5ae50d8f96ca71dc7b62ed4921dc76830c301854b154

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D&_sid=8d27a7f7-ab48-49db-97f5-691b4c538684&_vid=b7b9c3f1-0936-4c7c-87c0-ab638be64bc3&_ak=45-381-6BCF239E&_flash=false&_th=1651775810|1651775810|1
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
Content-Type
application/json

Response headers

pragma
no-cache
date
Thu, 05 May 2022 18:36:51 GMT
server
Apache/2.4.7 (Ubuntu)
x-powered-by
PHP/7.0.19-1+deb.sury.org~trusty+2
vary
X-Forwarded-Proto
content-type
text/html; charset=UTF-8
cache-control
no-store, no-cache, must-revalidate
x-robots-tag
noindex
content-length
60
/
match.deepintent.com/identity/
9 B
84 B
Script
General
Full URL
https://match.deepintent.com/identity/?key=40d344a2bd75730b84c5ed85e7d46880e798cbd20d00dca40f2b2f91bb28a6d2&sid=8d27a7f7-ab48-49db-97f5-691b4c538684&&cb=__jp0
Requested by
Host: www.medtargetsystem.com
URL: https://www.medtargetsystem.com/javascript/beacon.js?1651775809615
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
38.91.45.7 , United States, ASN398989 (DEEPINTENT, US),
Reverse DNS
Software
c /
Resource Hash
ae6d2af8776955d266e742c30b24a670963a7dbbf5d7a48e910eac0d44d966da

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:51 GMT
server
c
content-length
9
content-type
application/json
getuidp
secure.adnxs.com/
Redirect Chain
  • https://trc.lhmos.com/enrich/data/jsonp?mcode=15710&mid=47&&callback=__jp1
  • https://secure.adnxs.com/getuidp?callback=__jp1
18 B
690 B
Script
General
Full URL
https://secure.adnxs.com/getuidp?callback=__jp1
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
HTTP/1.1
Server
185.33.221.50 Amsterdam, Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
728.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.21.3 /
Resource Hash
4155b39ac0ea1987072e3fc58ad7f59b0a25216c901253ba1e06922727556fb7
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

Pragma
no-cache
Date
Thu, 05 May 2022 18:36:52 GMT
X-Proxy-Origin
80.255.7.108; 80.255.7.108; 728.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net; adnxs.com
AN-X-Request-Uuid
232e0d14-88af-4b3e-9108-ef4180f9ad5a
Server
nginx/1.21.3
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/javascript; charset=utf-8
Content-Length
18
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT

Redirect headers

date
Thu, 05 May 2022 18:36:51 GMT
via
1.1 google
x-content-type-options
nosniff
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
1; mode=block
pragma
no-cache
location
https://secure.adnxs.com/getuidp?callback=__jp1
x-frame-options
DENY
access-control-max-age
3600
access-control-allow-methods
POST, GET, OPTIONS, DELETE
content-language
de-DE
access-control-allow-origin
*
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
access-control-allow-headers
x-requested-with
expires
0
store
match.deepintent.com/usersync/114/
0
16 B
Image
General
Full URL
https://match.deepintent.com/usersync/114/store?ext1=8d27a7f7-ab48-49db-97f5-691b4c538684&id=UNK
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
38.91.45.7 , United States, ASN398989 (DEEPINTENT, US),
Reverse DNS
Software
c /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:51 GMT
content-length
0
server
c
/
trc.lhmos.com/uid/save/
Redirect Chain
  • https://trc.lhmos.com/uid/set?dgid=UNK&mcode=15710&mid=47
  • https://secure.adnxs.com/getuidu?https://trc.lhmos.com/uid/save/?uid=$UID&dgid=UNK&mcode=15710&mid=47
  • https://secure.adnxs.com/bounce?%2Fgetuidu%3Fhttps%3A%2F%2Ftrc.lhmos.com%2Fuid%2Fsave%2F%3Fuid%3D%24UID%26dgid%3DUNK%26mcode%3D15710%26mid%3D47
  • https://trc.lhmos.com/uid/save/?uid=8450328796284604864&dgid=UNK&mcode=15710&mid=47
0
21 B
Image
General
Full URL
https://trc.lhmos.com/uid/save/?uid=8450328796284604864&dgid=UNK&mcode=15710&mid=47
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H3
Server
34.102.246.198 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
198.246.102.34.bc.googleusercontent.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:52 GMT
via
1.1 google
x-content-type-options
nosniff
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
1; mode=block
pragma
no-cache
x-frame-options
DENY
access-control-max-age
3600
access-control-allow-methods
POST, GET, OPTIONS, DELETE
content-type
application/javascript
access-control-allow-origin
*
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
access-control-allow-headers
x-requested-with
expires
0

Redirect headers

Pragma
no-cache
Date
Thu, 05 May 2022 18:36:52 GMT
X-Proxy-Origin
80.255.7.108; 80.255.7.108; 728.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net; adnxs.com
AN-X-Request-Uuid
26d82ac7-fc6a-4004-a860-5d6bc28e8275
Server
nginx/1.21.3
Access-Control-Allow-Origin
*
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Location
https://trc.lhmos.com/uid/save/?uid=8450328796284604864&dgid=UNK&mcode=15710&mid=47
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
_itu.png
aim-tag.hcn.health/ Frame CFE4
103 B
466 B
XHR
General
Full URL
https://aim-tag.hcn.health/_itu.png
Requested by
Host: aim-tag.hcn.health
URL: https://aim-tag.hcn.health/iframe.html?client-origin=https%3A%2F%2Fwww.docwirenews.com&pageview-id=53864740-cca2-11ec-bddd-278631a15be6&stps=%7B%7D&timestamp=1651775809972
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.173.3.48 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-173-3-48.compute-1.amazonaws.com
Software
awselb/2.0 /
Resource Hash
3fe6ab95ddabc4672c242703c0efa334850f72b6f0c64bb36474b779144657d8

Request headers

accept-language
de-DE,de;q=0.9
Accept
image/png
Referer
https://aim-tag.hcn.health/iframe.html?client-origin=https%3A%2F%2Fwww.docwirenews.com&pageview-id=53864740-cca2-11ec-bddd-278631a15be6&stps=%7B%7D&timestamp=1651775809972
pageview-id
53864740-cca2-11ec-bddd-278631a15be6
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

pragma
private
date
Thu, 05 May 2022 18:36:52 GMT
last-modified
2010-01-01T00:00:00.000Z
server
awselb/2.0
etag
54b26b30-cca2-11ec-9b13-2f534fd6caa6
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
cache-control
no-transform, private, max-age=0, must-revalidate
content-type
image/png
content-length
103
x-cached
false
expires
-1
e1ehuoa
anchor.fm/api/v3/episodes/ Frame 1A58
186 KB
34 KB
Fetch
General
Full URL
https://anchor.fm/api/v3/episodes/e1ehuoa
Requested by
Host: d1rx8vrt2hn1hc.cloudfront.net
URL: https://d1rx8vrt2hn1hc.cloudfront.net/builds/bundle-8b03e8b9bcd02b6064f0.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.66.133 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/ Express
Resource Hash
36592a24a798c2bd2b67b31befbd118963a443283b07cea269cd69c9a20b06a6
Security Headers
Name Value
Strict-Transport-Security max-age=86400

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://anchor.fm/the-uromigos/embed/episodes/Episode-155-ASCO-GU-2022-ARASENS-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer-e1ehuoa
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:52 GMT
via
1.1 varnish, 1.1 varnish
vary
Accept-Encoding
age
82377
x-powered-by
Express
x-cache
HIT, MISS
content-encoding
gzip
content-length
35096
x-served-by
cache-iad-kiad7000036-IAD, cache-hhn4083-HHN
etag
W/"2e609-OY9QM1pWGb6i0GUU9cWOHOmOjng"
strict-transport-security
max-age=86400
content-language
en
cache-control
public, s-maxage=86400, max-age=300
accept-ranges
bytes
content-type
application/json; charset=utf-8
x-cache-hits
1, 0
status
anchor.fm/api/ Frame 1A58
56 B
203 B
Fetch
General
Full URL
https://anchor.fm/api/status
Requested by
Host: d1rx8vrt2hn1hc.cloudfront.net
URL: https://d1rx8vrt2hn1hc.cloudfront.net/builds/bundle-8b03e8b9bcd02b6064f0.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.66.133 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
Varnish /
Resource Hash
8e6ca9daa8b949e044fd864b5f526d2aa898ffd1ea1a19b6705b427a14f3bfab
Security Headers
Name Value
Strict-Transport-Security max-age=86400

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://anchor.fm/the-uromigos/embed/episodes/Episode-155-ASCO-GU-2022-ARASENS-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer-e1ehuoa
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:51 GMT
via
1.1 varnish
server
Varnish
x-timer
S1651775812.986381,VS0,VE0
x-served-by
cache-hhn4083-HHN
strict-transport-security
max-age=86400
x-isc
605
content-type
application/json
x-cache
HIT
accept-ranges
bytes
content-length
56
retry-after
0
x-cache-hits
0
region
anchor.fm/api/compliance/ Frame 1A58
36 B
122 B
Fetch
General
Full URL
https://anchor.fm/api/compliance/region
Requested by
Host: d1rx8vrt2hn1hc.cloudfront.net
URL: https://d1rx8vrt2hn1hc.cloudfront.net/builds/bundle-8b03e8b9bcd02b6064f0.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.66.133 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/ Express
Resource Hash
3f8db9f8e3feb54367dd7a9ed840e478670bf59a6a0a28f16058fa9f5318ebad
Security Headers
Name Value
Strict-Transport-Security max-age=86400

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://anchor.fm/the-uromigos/embed/episodes/Episode-155-ASCO-GU-2022-ARASENS-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer-e1ehuoa
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:52 GMT
via
1.1 varnish, 1.1 varnish
etag
W/"24-N0ykZzVcB7D4IXsvxTp2f5JmyjU"
x-powered-by
Express
x-served-by
cache-iad-kiad7000073-IAD, cache-hhn4083-HHN
vary
Accept-Encoding
x-cache
MISS, MISS
content-language
de
cache-control
private, max-age=86400
strict-transport-security
max-age=86400
accept-ranges
bytes
content-type
application/json; charset=utf-8
content-length
36
x-cache-hits
0, 0
region
anchor.fm/api/compliance/ Frame 1A58
36 B
107 B
Fetch
General
Full URL
https://anchor.fm/api/compliance/region
Requested by
Host: d1rx8vrt2hn1hc.cloudfront.net
URL: https://d1rx8vrt2hn1hc.cloudfront.net/builds/bundle-8b03e8b9bcd02b6064f0.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.66.133 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/ Express
Resource Hash
3f8db9f8e3feb54367dd7a9ed840e478670bf59a6a0a28f16058fa9f5318ebad
Security Headers
Name Value
Strict-Transport-Security max-age=86400

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://anchor.fm/the-uromigos/embed/episodes/Episode-155-ASCO-GU-2022-ARASENS-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer-e1ehuoa
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:52 GMT
via
1.1 varnish, 1.1 varnish
etag
W/"24-N0ykZzVcB7D4IXsvxTp2f5JmyjU"
x-powered-by
Express
x-served-by
cache-iad-kiad7000111-IAD, cache-hhn4083-HHN
vary
Accept-Encoding
x-cache
MISS, MISS
content-language
de
cache-control
private, max-age=86400
strict-transport-security
max-age=86400
accept-ranges
bytes
content-type
application/json; charset=utf-8
content-length
36
x-cache-hits
0, 0
metadata
anchor.fm/api/podcast/ Frame 1A58
0
0
Fetch
General
Full URL
https://anchor.fm/api/podcast/metadata
Requested by
Host: d1rx8vrt2hn1hc.cloudfront.net
URL: https://d1rx8vrt2hn1hc.cloudfront.net/builds/bundle-8b03e8b9bcd02b6064f0.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.66.133 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/ Express
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=86400

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://anchor.fm/the-uromigos/embed/episodes/Episode-155-ASCO-GU-2022-ARASENS-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer-e1ehuoa
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:52 GMT
via
1.1 varnish, 1.1 varnish
x-powered-by
Express
strict-transport-security
max-age=86400
x-cache
MISS, MISS
content-language
de
x-cache-hits
0, 0
accept-ranges
bytes
x-served-by
cache-iad-kiad7000083-IAD, cache-hhn4083-HHN
region
anchor.fm/api/compliance/ Frame 1A58
36 B
199 B
Fetch
General
Full URL
https://anchor.fm/api/compliance/region
Requested by
Host: d1rx8vrt2hn1hc.cloudfront.net
URL: https://d1rx8vrt2hn1hc.cloudfront.net/builds/bundle-8b03e8b9bcd02b6064f0.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.66.133 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/ Express
Resource Hash
3f8db9f8e3feb54367dd7a9ed840e478670bf59a6a0a28f16058fa9f5318ebad
Security Headers
Name Value
Strict-Transport-Security max-age=86400

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://anchor.fm/the-uromigos/embed/episodes/Episode-155-ASCO-GU-2022-ARASENS-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer-e1ehuoa
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:52 GMT
via
1.1 varnish, 1.1 varnish
etag
W/"24-N0ykZzVcB7D4IXsvxTp2f5JmyjU"
x-powered-by
Express
x-served-by
cache-iad-kjyo7100068-IAD, cache-hhn4083-HHN
vary
Accept-Encoding
x-cache
MISS, MISS
content-language
de
cache-control
private, max-age=86400
strict-transport-security
max-age=86400
accept-ranges
bytes
content-type
application/json; charset=utf-8
content-length
36
x-cache-hits
0, 0
currentuser
anchor.fm/api/ Frame 1A58
2 B
64 B
Fetch
General
Full URL
https://anchor.fm/api/currentuser
Requested by
Host: d1rx8vrt2hn1hc.cloudfront.net
URL: https://d1rx8vrt2hn1hc.cloudfront.net/builds/bundle-8b03e8b9bcd02b6064f0.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.66.133 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
Varnish /
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a
Security Headers
Name Value
Strict-Transport-Security max-age=86400

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://anchor.fm/the-uromigos/embed/episodes/Episode-155-ASCO-GU-2022-ARASENS-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer-e1ehuoa
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:51 GMT
via
1.1 varnish
server
Varnish
x-served-by
cache-hhn4083-HHN
strict-transport-security
max-age=86400
x-isc
607
content-type
application/json; charset=utf-8
x-cache
HIT
accept-ranges
bytes
content-length
2
retry-after
0
x-cache-hits
0
e591a043-2352-4d6b-b45d-d43caec0feb9
https://aim-tag.hcn.health/ Frame CFE4
103 B
0
Image
General
Full URL
blob:https://aim-tag.hcn.health/e591a043-2352-4d6b-b45d-d43caec0feb9
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
BLOB
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
3fe6ab95ddabc4672c242703c0efa334850f72b6f0c64bb36474b779144657d8

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

Content-Length
103
Content-Type
image/png
fingerprint.js
web-static.dmdtrueidentity.com/aim-tag/js/
84 KB
31 KB
Script
General
Full URL
https://web-static.dmdtrueidentity.com/aim-tag/js/fingerprint.js
Requested by
Host: aim-tag.hcn.health
URL: https://aim-tag.hcn.health/js/client.js?dl=aimDataLayer
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
143.204.98.79 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-98-79.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
4d8ac99a7ac13f5399712d3aa61e5d69fafb3f9ccb78e685382237a3aebff88b

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:52 GMT
content-encoding
gzip
last-modified
Thu, 14 Apr 2022 15:03:40 GMT
server
AmazonS3
age
1
etag
W/"759fff9568c7a52794f32827616cc176"
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
via
1.1 ea2e21f6a5c3ec2f96b0dac1b769e00e.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
ZFagmUD4AT6_zkRmJU32T4tdsPnUASV9PjX3ASNrxEpthGajzcAJAQ==
/
match.deepintent.com/identity/
11 B
47 B
Script
General
Full URL
https://match.deepintent.com/identity/?key=40d344a2bd75730b84c5ed85e7d46880e798cbd20d00dca40f2b2f91bb28a6d2&sid=54a5e810-cca2-11ec-8cdc-cb314e5edeb5&&cb=__v4jp0
Requested by
Host: aim-tag.hcn.health
URL: https://aim-tag.hcn.health/js/client.js?dl=aimDataLayer
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
38.91.45.7 , United States, ASN398989 (DEEPINTENT, US),
Reverse DNS
Software
c /
Resource Hash
bdd4801f07cb7af62e228e2d648c0a3f562fc706e291e1a0efb5a484fe675d0d

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:51 GMT
server
c
content-length
11
content-type
application/json
getuidp
secure.adnxs.com/
Redirect Chain
  • https://trc.lhmos.com/enrich/data/jsonp?mcode=15710&mid=47&&callback=__v4jp1
  • https://secure.adnxs.com/getuidp?callback=__v4jp1
38 B
865 B
Script
General
Full URL
https://secure.adnxs.com/getuidp?callback=__v4jp1
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
HTTP/1.1
Server
185.33.221.50 Amsterdam, Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
728.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.21.3 /
Resource Hash
638f6e8d7afa05b4929f092280fc3e362783508f4d5eb25a4f777f314146a2cb
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

Pragma
no-cache
Date
Thu, 05 May 2022 18:36:52 GMT
X-Proxy-Origin
80.255.7.108; 80.255.7.108; 728.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net; adnxs.com
AN-X-Request-Uuid
53a72618-70be-4011-99d2-fe01bf9dc70d
Server
nginx/1.21.3
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/javascript; charset=utf-8
Content-Length
38
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT

Redirect headers

date
Thu, 05 May 2022 18:36:51 GMT
via
1.1 google
x-content-type-options
nosniff
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
1; mode=block
pragma
no-cache
location
https://secure.adnxs.com/getuidp?callback=__v4jp1
x-frame-options
DENY
access-control-max-age
3600
access-control-allow-methods
POST, GET, OPTIONS, DELETE
content-language
de-DE
access-control-allow-origin
*
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
access-control-allow-headers
x-requested-with
expires
0
store
match.deepintent.com/usersync/114/
0
16 B
Image
General
Full URL
https://match.deepintent.com/usersync/114/store?ext1=54a5e810-cca2-11ec-8cdc-cb314e5edeb5&id=UNK
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
38.91.45.7 , United States, ASN398989 (DEEPINTENT, US),
Reverse DNS
Software
c /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:51 GMT
content-length
0
server
c
/
aim-tag.hcn.health/api/v4/aim-reader/hcp/54b26b30-cca2-11ec-9b13-2f534fd6caa6/ Frame CFE4
324 B
394 B
XHR
General
Full URL
https://aim-tag.hcn.health/api/v4/aim-reader/hcp/54b26b30-cca2-11ec-9b13-2f534fd6caa6/?data=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%3D%3D&signature=YmRiMjE5ZGQ0OTM5N2U2NzJhMTJhZDVkMjhkYWYwM2IxNzljYTRmZTU0MGVhMjljYWU2ZDhiZDU4MGY3ZGRhOQ%3D%3D
Requested by
Host: aim-tag.hcn.health
URL: https://aim-tag.hcn.health/iframe.html?client-origin=https%3A%2F%2Fwww.docwirenews.com&pageview-id=53864740-cca2-11ec-bddd-278631a15be6&stps=%7B%7D&timestamp=1651775809972
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.173.3.48 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-173-3-48.compute-1.amazonaws.com
Software
awselb/2.0 /
Resource Hash
a700c1d822f6143f232d41ae9f44c7379091791defb4608f61e17211f15d5d5b

Request headers

pageview-id
53864740-cca2-11ec-bddd-278631a15be6
Referer
https://aim-tag.hcn.health/iframe.html?client-origin=https%3A%2F%2Fwww.docwirenews.com&pageview-id=53864740-cca2-11ec-bddd-278631a15be6&stps=%7B%7D&timestamp=1651775809972
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:52 GMT
server
awselb/2.0
content-length
324
content-type
application/json
dom-content-loaded
aim-tag.hcn.health/api/v4/aim-reader/ Frame CFE4
12 B
90 B
XHR
General
Full URL
https://aim-tag.hcn.health/api/v4/aim-reader/dom-content-loaded
Requested by
Host: aim-tag.hcn.health
URL: https://aim-tag.hcn.health/iframe.html?client-origin=https%3A%2F%2Fwww.docwirenews.com&pageview-id=53864740-cca2-11ec-bddd-278631a15be6&stps=%7B%7D&timestamp=1651775809972
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.173.3.48 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-173-3-48.compute-1.amazonaws.com
Software
awselb/2.0 /
Resource Hash
772e10a0c0a795b97d1391d2d7c4b0cb1fde19ac5027c48de6008e10dede67e3

Request headers

Referer
https://aim-tag.hcn.health/iframe.html?client-origin=https%3A%2F%2Fwww.docwirenews.com&pageview-id=53864740-cca2-11ec-bddd-278631a15be6&stps=%7B%7D&timestamp=1651775809972
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
Content-Type
application/json

Response headers

date
Thu, 05 May 2022 18:36:52 GMT
server
awselb/2.0
content-length
12
content-type
application/octet-stream
dom-content-loaded
aim-tag.hcn.health/api/v4/aim-reader/ Frame CFE4
12 B
90 B
XHR
General
Full URL
https://aim-tag.hcn.health/api/v4/aim-reader/dom-content-loaded
Requested by
Host: aim-tag.hcn.health
URL: https://aim-tag.hcn.health/iframe.html?client-origin=https%3A%2F%2Fwww.docwirenews.com&pageview-id=53864740-cca2-11ec-bddd-278631a15be6&stps=%7B%7D&timestamp=1651775809972
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.173.3.48 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-173-3-48.compute-1.amazonaws.com
Software
awselb/2.0 /
Resource Hash
772e10a0c0a795b97d1391d2d7c4b0cb1fde19ac5027c48de6008e10dede67e3

Request headers

Referer
https://aim-tag.hcn.health/iframe.html?client-origin=https%3A%2F%2Fwww.docwirenews.com&pageview-id=53864740-cca2-11ec-bddd-278631a15be6&stps=%7B%7D&timestamp=1651775809972
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
Content-Type
application/json

Response headers

date
Thu, 05 May 2022 18:36:52 GMT
server
awselb/2.0
content-length
12
content-type
application/octet-stream
webStationId:13347ea8
anchor.fm/api/proxy/v3/userSocialUrl/station/ Frame 1A58
98 B
398 B
Fetch
General
Full URL
https://anchor.fm/api/proxy/v3/userSocialUrl/station/webStationId:13347ea8
Requested by
Host: d1rx8vrt2hn1hc.cloudfront.net
URL: https://d1rx8vrt2hn1hc.cloudfront.net/builds/bundle-8b03e8b9bcd02b6064f0.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.66.133 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/ Express
Resource Hash
91677d7ad6a34cae3b0ccd2f9bcf4269ae1f12b31d580044a1af1cd9e403c790
Security Headers
Name Value
Strict-Transport-Security max-age=86400

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://anchor.fm/the-uromigos/embed/episodes/Episode-155-ASCO-GU-2022-ARASENS-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer-e1ehuoa
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:52 GMT
via
1.1 varnish, 1.1 varnish
vary
Accept-Encoding
age
597
x-powered-by
Express
x-cache
HIT, MISS
content-length
98
x-served-by
cache-iad-kjyo7100055-IAD, cache-hhn4083-HHN
x-newrelic-app-data
PxQFUlZXAQoBR1VQBgcHUlIAAhFORDQHUjZKA1ZLVVFHDFYPHiRLEhZTRBIMEBd0dTBOTUECGBMXVERgDQUKA1w3Sg4XS0BTRwxWDx5bQBYFQl4OCCpcERxUTVIZAQdfVAQGBFNST0AJWhpOGl4DCgpUXQNVBVAGAgVUUV9BFFVRCBIHag==
etag
W/"62-+9ngaHIokQF0Xv1Z8gp4U4B50bA"
strict-transport-security
max-age=86400
content-language
en
cache-control
public, s-maxage=86400, max-age=0
accept-ranges
bytes
content-type
application/json; charset=utf-8
x-cache-hits
1, 0
3122074-1626815620474-d912b3a97e36e.jpg
d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo400/3122074/ Frame 1A58
25 KB
26 KB
Image
General
Full URL
https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo400/3122074/3122074-1626815620474-d912b3a97e36e.jpg
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2156:e600:7:c135:4380:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
05f043843f43cbdb6309cd8472f7df40ed735736990cde699f57a1af2df0cd13

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://anchor.fm/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:53 GMT
via
1.1 1b73451818d2dd47a574604c0b84f692.cloudfront.net (CloudFront)
last-modified
Tue, 20 Jul 2021 21:13:41 GMT
server
AmazonS3
x-amz-cf-pop
FRA50-C1
etag
"8d644295e7e547cfd496608ab0541804"
x-cache
Miss from cloudfront
content-type
image/jpg
x-amz-meta-content-type
image/jpg
accept-ranges
bytes
content-length
25955
x-amz-cf-id
Ez-4A_JMiqm-Db-QSnEyzU_NszxSeV2wDRJACBxZ4QBuDLE-6V2lAw==
maax-medium.woff2
d12xoj7p9moygp.cloudfront.net/fonts/maax/ Frame 1A58
65 KB
65 KB
Font
General
Full URL
https://d12xoj7p9moygp.cloudfront.net/fonts/maax/maax-medium.woff2
Requested by
Host: d1rx8vrt2hn1hc.cloudfront.net
URL: https://d1rx8vrt2hn1hc.cloudfront.net/builds/bundle-8b03e8b9bcd02b6064f0.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2156:6000:11:d2b:9e40:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
19c40d1b27af6942a1bed6a5b3df59834401e1e95252134e87965a64a9fa893c

Request headers

Referer
https://d1rx8vrt2hn1hc.cloudfront.net/
Origin
https://anchor.fm
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Wed, 13 Apr 2022 06:54:20 GMT
via
1.1 f6c241b75ae7d21ac836339454ab90b8.cloudfront.net (CloudFront)
vary
Origin,Access-Control-Request-Headers,Access-Control-Request-Method
age
1942953
x-cache
Hit from cloudfront
content-length
66096
last-modified
Mon, 11 Apr 2022 21:13:52 GMT
server
AmazonS3
etag
"08484121bb86b9868a1eadcf1c6db46d"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
font/woff2
access-control-allow-origin
https://anchor.fm
access-control-allow-credentials
true
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
jOdCy90y0p69nr31aI-7zR_QvEVvN9sLznSsIkkB-ck-nMSnt5wVCA==
partner-auth
aim-tag.hcn.health/api/v4/aim-reader/ Frame CFE4
0
68 B
XHR
General
Full URL
https://aim-tag.hcn.health/api/v4/aim-reader/partner-auth
Requested by
Host: aim-tag.hcn.health
URL: https://aim-tag.hcn.health/iframe.html?client-origin=https%3A%2F%2Fwww.docwirenews.com&pageview-id=53864740-cca2-11ec-bddd-278631a15be6&stps=%7B%7D&timestamp=1651775809972
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.173.3.48 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-173-3-48.compute-1.amazonaws.com
Software
awselb/2.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://aim-tag.hcn.health/iframe.html?client-origin=https%3A%2F%2Fwww.docwirenews.com&pageview-id=53864740-cca2-11ec-bddd-278631a15be6&stps=%7B%7D&timestamp=1651775809972
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
Content-Type
application/json

Response headers

date
Thu, 05 May 2022 18:36:52 GMT
server
awselb/2.0
content-length
0
content-type
application/octet-stream
auth_review
www.medtargetsystem.com/partner/ Frame 570C
0
158 B
XHR
General
Full URL
https://www.medtargetsystem.com/partner/auth_review
Requested by
Host: www.medtargetsystem.com
URL: https://www.medtargetsystem.com/js/build/iframe/signal.js?27&partners=deepIntent.1.1|lasso.2.2|
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.204.255.196 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-18-204-255-196.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D&_sid=8d27a7f7-ab48-49db-97f5-691b4c538684&_vid=b7b9c3f1-0936-4c7c-87c0-ab638be64bc3&_ak=45-381-6BCF239E&_flash=false&_th=1651775810|1651775810|1
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
Content-Type
application/json

Response headers

date
Thu, 05 May 2022 18:36:52 GMT
server
Apache/2.4.7 (Ubuntu)
x-robots-tag
noindex
x-powered-by
PHP/7.0.19-1+deb.sury.org~trusty+2
content-length
0
vary
X-Forwarded-Proto
content-type
text/html; charset=UTF-8
redir
trc.lhmos.com/enrich/data/
2 B
25 B
XHR
General
Full URL
https://trc.lhmos.com/enrich/data/redir?mcode=15710&mid=47&uid=0&
Requested by
Host: www.medtargetsystem.com
URL: https://www.medtargetsystem.com/javascript/beacon.js?1651775809615
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.102.246.198 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
198.246.102.34.bc.googleusercontent.com
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 1; mode=block

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.docwirenews.com/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:51 GMT
via
1.1 google
x-content-type-options
nosniff
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
2
x-xss-protection
1; mode=block
pragma
no-cache
x-frame-options
DENY
access-control-max-age
3600
access-control-allow-methods
POST, GET, OPTIONS, DELETE
content-type
application/json
access-control-allow-origin
*
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
access-control-allow-headers
x-requested-with
expires
0
close-button.png
www.docwirenews.com/wp-content/plugins/ad-inserter-pro/css/images/
919 B
1 KB
Image
General
Full URL
https://www.docwirenews.com/wp-content/plugins/ad-inserter-pro/css/images/close-button.png
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
75dbbfc189e434f0b547ddada879afced2b33bcc4c693108961f15ea35f9dd1e

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:52 GMT
cf-cache-status
HIT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age
116868
cf-polished
origSize=1434
content-length
919
last-modified
Tue, 28 Jan 2020 20:03:11 GMT
server
cloudflare
etag
"5e30937f-59a"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=Rm4DgqaPNs7YIbzbh9%2By%2B0ERP3BSGJEXRF1gsi6ULitvAfozq8iwGiVnj7LzLDWU66%2FrcbCDgi6gsscxENnrfsCLtuGi58a5VaUpeaK27%2FTfdJ%2Bs7k9OWIY0OKSlaOq8fCJnrdE%3D"}],"group":"cf-nel","max_age":604800}
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
cf-ray
706b958aaeb98fd1-FRA
cf-bgj
imgq:100,h2pri
fingerprint
aim-tag.hcn.health/api/v4/aim-reader/ Frame CFE4
12 B
90 B
XHR
General
Full URL
https://aim-tag.hcn.health/api/v4/aim-reader/fingerprint
Requested by
Host: aim-tag.hcn.health
URL: https://aim-tag.hcn.health/iframe.html?client-origin=https%3A%2F%2Fwww.docwirenews.com&pageview-id=53864740-cca2-11ec-bddd-278631a15be6&stps=%7B%7D&timestamp=1651775809972
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.173.3.48 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-173-3-48.compute-1.amazonaws.com
Software
awselb/2.0 /
Resource Hash
772e10a0c0a795b97d1391d2d7c4b0cb1fde19ac5027c48de6008e10dede67e3

Request headers

Referer
https://aim-tag.hcn.health/iframe.html?client-origin=https%3A%2F%2Fwww.docwirenews.com&pageview-id=53864740-cca2-11ec-bddd-278631a15be6&stps=%7B%7D&timestamp=1651775809972
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
Content-Type
application/json

Response headers

date
Thu, 05 May 2022 18:36:52 GMT
server
awselb/2.0
content-length
12
content-type
application/octet-stream
auth
www.medtargetsystem.com/partner/ Frame 570C
0
158 B
XHR
General
Full URL
https://www.medtargetsystem.com/partner/auth
Requested by
Host: www.medtargetsystem.com
URL: https://www.medtargetsystem.com/js/build/iframe/signal.js?27&partners=deepIntent.1.1|lasso.2.2|
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.204.255.196 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-18-204-255-196.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D&_sid=8d27a7f7-ab48-49db-97f5-691b4c538684&_vid=b7b9c3f1-0936-4c7c-87c0-ab638be64bc3&_ak=45-381-6BCF239E&_flash=false&_th=1651775810|1651775810|1
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
Content-Type
application/json

Response headers

date
Thu, 05 May 2022 18:36:52 GMT
server
Apache/2.4.7 (Ubuntu)
x-robots-tag
noindex
x-powered-by
PHP/7.0.19-1+deb.sury.org~trusty+2
content-length
0
vary
X-Forwarded-Proto
content-type
text/html; charset=UTF-8
redir
trc.lhmos.com/enrich/data/
2 B
25 B
XHR
General
Full URL
https://trc.lhmos.com/enrich/data/redir?mcode=15710&mid=47&uid=8450328796284604864&
Requested by
Host: aim-tag.hcn.health
URL: https://aim-tag.hcn.health/js/client.js?dl=aimDataLayer
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.102.246.198 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
198.246.102.34.bc.googleusercontent.com
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 1; mode=block

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.docwirenews.com/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:52 GMT
via
1.1 google
x-content-type-options
nosniff
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
2
x-xss-protection
1; mode=block
pragma
no-cache
x-frame-options
DENY
access-control-max-age
3600
access-control-allow-methods
POST, GET, OPTIONS, DELETE
content-type
application/json
access-control-allow-origin
*
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
access-control-allow-headers
x-requested-with
expires
0
user_activity.php
www.docwirenews.com/wp-content/themes/Newspaper-child/Scripts/
307 B
666 B
XHR
General
Full URL
https://www.docwirenews.com/wp-content/themes/Newspaper-child/Scripts/user_activity.php
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/wp-includes/js/jquery/jquery.min.js?ver=3.6.0
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare / WP Engine
Resource Hash
64baff739e06279fc2c63af27a66b1869205efc1fac32181638255a587d5ad11

Request headers

Accept
*/*
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
X-Requested-With
XMLHttpRequest
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

pragma
no-cache
date
Thu, 05 May 2022 18:36:53 GMT
content-encoding
br
cf-cache-status
DYNAMIC
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
x-powered-by
WP Engine
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=X0V9BT2WxpX5DDuKN8%2BarcwFc6ruUUhSBT0bLpvkskutXSOzv3rO8YrjeXkwxJXqeOjZZKGJVAXavZ4NBLlIYF3pmeNWj4MLOMgPiyFVlJzwcWxqzI2t8CU7fIEnwtKGjxajw8k%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/html; charset=UTF-8
cache-control
no-store, no-cache, must-revalidate
cf-ray
706b958e1b818fd1-FRA
expires
Thu, 19 Nov 1981 08:52:00 GMT
dw_tracker.php
www.docwirenews.com/wp-content/themes/Newspaper-child/Scripts/
118 B
395 B
XHR
General
Full URL
https://www.docwirenews.com/wp-content/themes/Newspaper-child/Scripts/dw_tracker.php
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/wp-includes/js/jquery/jquery.min.js?ver=3.6.0
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.73.241 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare / WP Engine
Resource Hash
54fc26aec3a86ae84cad0ca3960e0a1ea4fcf35bd6c4f577c5f5e727a4ad0102

Request headers

Accept
*/*
Referer
https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
X-Requested-With
XMLHttpRequest
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

pragma
no-cache
date
Thu, 05 May 2022 18:36:54 GMT
content-encoding
br
cf-cache-status
DYNAMIC
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
x-powered-by
WP Engine
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=9Lzlmt%2BsjGVOV2zd7zZQ2G2Pjs7EumfsHXX%2BVQKgdbq0FYl5Xsd6lzz50QaGxVQ1A%2Beqj9GhDEvlXi7LSeW2yLUGq9VHcmr0Z4oM7z3Qv1ZtrxGNxGcAHHYKyH78xxe1QKy2f%2BI%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/html; charset=UTF-8
cache-control
no-store, no-cache, must-revalidate
cf-ray
706b9591f9638fd1-FRA
expires
Thu, 19 Nov 1981 08:52:00 GMT
sodar
pagead2.googlesyndication.com/getconfig/
14 KB
10 KB
XHR
General
Full URL
https://pagead2.googlesyndication.com/getconfig/sodar?sv=200&tid=gda&tv=r20220503&st=env
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202204270101/show_ads_impl_with_ama_fy2019.js?client=ca-pub-3350439833258580&plah=www.docwirenews.com
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e5c5485e5508344d081645acffb6c421d1b848f1887f4f82a15543e95e29b973
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

timing-allow-origin
*
date
Thu, 05 May 2022 18:36:54 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/json; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
10564
x-xss-protection
0
blink_green.png
d10lpsik1i8c69.cloudfront.net/graphics/
1 KB
2 KB
Image
General
Full URL
https://d10lpsik1i8c69.cloudfront.net/graphics/blink_green.png
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
143.204.101.166 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-101-166.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
9746bbc8be1eacd912bb90f2226b3f9141b15938f7b0281825c74999c0040c9b

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Fri, 22 Apr 2022 15:23:17 GMT
via
1.1 32c8da10203574baccb74b8f771a7ffa.cloudfront.net (CloudFront)
last-modified
Tue, 01 Mar 2022 22:59:52 GMT
server
AmazonS3
age
1134818
etag
"2e4ff7ec8bf18d247ee942621e0f9d65"
x-cache
Hit from cloudfront
content-type
image/png
cache-control
max-age=31536000
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
content-length
1283
x-amz-cf-id
6h0SYRrMsrm4wDqNPj3NVKpJHb0GYQZc3d89W-PmSZUWUsLZeB5oJA==
logo-light.png
d10lpsik1i8c69.cloudfront.net/graphics/
1 KB
1 KB
Image
General
Full URL
https://d10lpsik1i8c69.cloudfront.net/graphics/logo-light.png
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
143.204.101.166 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-101-166.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
8c34bc7bc1985e63394c3c2afff88cdcfc06e501320432dd23eaff83ea6754eb

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Tue, 12 Apr 2022 03:51:35 GMT
via
1.1 32c8da10203574baccb74b8f771a7ffa.cloudfront.net (CloudFront)
last-modified
Tue, 01 Mar 2022 22:59:52 GMT
server
AmazonS3
age
2040320
etag
"35ce74c31e3ef54462a234340af702d7"
x-cache
Hit from cloudfront
content-type
image/png
cache-control
max-age=31536000
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
content-length
1143
x-amz-cf-id
Qn9izGktX1ANeMQIlt1l2yhbJX8V74nY0H8c9PwWG9b_djo822zNYw==
sound-on-white.png
d10lpsik1i8c69.cloudfront.net/graphics/
277 B
619 B
Image
General
Full URL
https://d10lpsik1i8c69.cloudfront.net/graphics/sound-on-white.png
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
143.204.101.166 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-101-166.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
da0c1bc51d4ebfa2570f3e7546d9d3ccfb3f9d3c1199b1ca49869510aa79392a

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Fri, 22 Apr 2022 15:23:17 GMT
via
1.1 32c8da10203574baccb74b8f771a7ffa.cloudfront.net (CloudFront)
last-modified
Tue, 01 Mar 2022 22:59:52 GMT
server
AmazonS3
age
1134818
etag
"76f1993de0fd323f67cece8d8e63bfa2"
x-cache
Hit from cloudfront
content-type
image/png
cache-control
max-age=31536000
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
content-length
277
x-amz-cf-id
wJVW0BZO1JBN0ZLxWKrm47X94gFPM2vkdQAbscUnsJ-AQo4yXAkYag==
metadata
anchor.fm/api/podcast/ Frame 1A58
0
0
Fetch
General
Full URL
https://anchor.fm/api/podcast/metadata
Requested by
Host: d1rx8vrt2hn1hc.cloudfront.net
URL: https://d1rx8vrt2hn1hc.cloudfront.net/builds/bundle-8b03e8b9bcd02b6064f0.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.66.133 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/ Express
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=86400

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://anchor.fm/the-uromigos/embed/episodes/Episode-155-ASCO-GU-2022-ARASENS-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer-e1ehuoa
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:54 GMT
via
1.1 varnish, 1.1 varnish
x-powered-by
Express
strict-transport-security
max-age=86400
x-cache
MISS, MISS
content-language
de
x-cache-hits
0, 0
accept-ranges
bytes
x-served-by
cache-iad-kcgs7200086-IAD, cache-hhn4083-HHN
gpt.js
www.googletagservices.com/tag/js/
80 KB
28 KB
Script
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-WR3NX75
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
9e5b60b6a5584a3168de36227dd068b049c18239b062553a682c5852c8aa3242
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:54 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
28353
x-xss-protection
0
server
sffe
etag
"1206 / 4 of 1000 / last-modified: 1651773693"
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Thu, 05 May 2022 18:36:54 GMT
partner-auth
aim-tag.hcn.health/api/v4/aim-reader/ Frame CFE4
0
69 B
XHR
General
Full URL
https://aim-tag.hcn.health/api/v4/aim-reader/partner-auth
Requested by
Host: aim-tag.hcn.health
URL: https://aim-tag.hcn.health/iframe.html?client-origin=https%3A%2F%2Fwww.docwirenews.com&pageview-id=53864740-cca2-11ec-bddd-278631a15be6&stps=%7B%7D&timestamp=1651775809972
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.173.3.48 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-173-3-48.compute-1.amazonaws.com
Software
awselb/2.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://aim-tag.hcn.health/iframe.html?client-origin=https%3A%2F%2Fwww.docwirenews.com&pageview-id=53864740-cca2-11ec-bddd-278631a15be6&stps=%7B%7D&timestamp=1651775809972
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
Content-Type
application/json

Response headers

date
Thu, 05 May 2022 18:36:54 GMT
server
awselb/2.0
content-length
0
content-type
application/octet-stream
sodar2.js
tpc.googlesyndication.com/sodar/
17 KB
7 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2.js
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202204270101/show_ads_impl_with_ama_fy2019.js?client=ca-pub-3350439833258580&plah=www.docwirenews.com
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:811::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
61c32059a5e94075a7ecff678b33907966fc9cfa384daa01aa057f872da14dbb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:54 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
6386
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
etag
"1637097310169751"
vary
Accept-Encoding
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
expires
Thu, 05 May 2022 18:36:54 GMT
runner.html
tpc.googlesyndication.com/sodar/sodar2/225/ Frame 8F5B
13 KB
5 KB
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:811::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
55a119c0394f901a8a297e109c17b5e5402689708b999ab10691c16179f32a4a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.docwirenews.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

accept-ranges
bytes
age
2194
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
cache-control
public, max-age=31536000
content-encoding
gzip
content-length
5046
content-type
text/html
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
cross-origin-resource-policy
cross-origin
date
Thu, 05 May 2022 18:00:20 GMT
expires
Fri, 05 May 2023 18:00:20 GMT
last-modified
Mon, 21 Jun 2021 20:47:05 GMT
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
server
sffe
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
aframe
www.google.com/recaptcha/api2/ Frame D60A
783 B
535 B
Document
General
Full URL
https://www.google.com/recaptcha/api2/aframe
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:803::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
d9e6fb6e200fdf2c1c789f30e7ad8ae58f508b7eeaa5a831fee52f7ac246589f
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-fPqEOL2Lh7J00cD2I97I2g' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.docwirenews.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
cache-control
private, max-age=300
content-encoding
gzip
content-length
513
content-security-policy
script-src 'report-sample' 'nonce-fPqEOL2Lh7J00cD2I97I2g' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Thu, 05 May 2022 18:36:54 GMT
expires
Thu, 05 May 2022 18:36:54 GMT
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
integrator.js
adservice.google.de/adsid/
107 B
122 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.docwirenews.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022050301.js?cb=31067407
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:803::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

timing-allow-origin
*
date
Thu, 05 May 2022 18:36:54 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3="googleads.g.doubleclick.net:443"; ma=2592000,h3=":443"; ma=2592000,h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
100
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
107 B
122 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.docwirenews.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022050301.js?cb=31067407
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

timing-allow-origin
*
date
Thu, 05 May 2022 18:36:54 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
100
x-xss-protection
0
ads
securepubads.g.doubleclick.net/gampad/
51 KB
20 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=1956160238184584&correlator=297198081336340&eid=31067407%2C31067412&output=ldjh&gdfp_req=1&vrg=2022050301&ptt=17&impl=fif&iu_parts=30017927%2Cdocwise%2Cdocwirenews.box.bottom&enc_prev_ius=%2F0%2F1%2F2&prev_iu_szs=300x250&ifi=2&adks=3824309862&sfv=1-0-38&ecs=20220505&fsapi=false&cust_params=docwirezone%3DUromigos_EP_155&sc=1&cookie=ID%3D7dd7c1272fac8dd5-229c6da18acd00b4%3AT%3D1651775810%3ART%3D1651775810%3AS%3DALNI_MZ_RpDs3nkNBfkdWAlwL-k005VVig&abxe=1&dt=1651775814543&lmt=1651775814&dlt=1651775809018&idt=1074&biw=1600&bih=1200&adxs=1010&adys=833&ucis=1&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&bc=31&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXSxmYWxzZV0.&url=https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D&frm=20&vis=1&scr_x=0&scr_y=0&psz=300x315&msz=300x-1&fws=4&ohw=1600&ga_vid=1837915677.1651775810&ga_sid=1651775810&ga_hid=733354313&ga_fc=true&btvi=0&topics=1&nvt=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022050301.js?cb=31067407
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.179.162 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
ams15s41-in-f2.1e100.net
Software
cafe /
Resource Hash
17a32c8ab9414c211ecaa7dd48841bb9b756f0891d390f420f149b9f70203f0a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:54 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
20153
x-xss-protection
0
google-lineitem-id
5961025849
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138385825844
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.docwirenews.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
container.html
d8de1464cb804dbfc0611e46f65d9c7b.safeframe.googlesyndication.com/safeframe/1-0-38/html/ Frame 0932
6 KB
4 KB
Document
General
Full URL
https://d8de1464cb804dbfc0611e46f65d9c7b.safeframe.googlesyndication.com/safeframe/1-0-38/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022050301.js?cb=31067407
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:828::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a73730123a43c3040d889aaee11ec35094277ce5f778076b262c23a293870adb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.docwirenews.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

accept-ranges
bytes
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
cache-control
public, immutable, max-age=31536000
content-encoding
gzip
content-length
3108
content-type
text/html
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
cross-origin-resource-policy
cross-origin
date
Thu, 05 May 2022 18:36:54 GMT
expires
Fri, 05 May 2023 18:36:54 GMT
last-modified
Tue, 02 Mar 2021 20:17:03 GMT
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
server
sffe
timing-allow-origin
*
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
ads
securepubads.g.doubleclick.net/gampad/
50 KB
20 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=1956160238184584&correlator=297198081336340&eid=31067407%2C31067412&output=ldjh&gdfp_req=1&vrg=2022050301&ptt=17&impl=fif&iu_parts=30017927%2Cdocwise%2Cdocwirenews.box&enc_prev_ius=%2F0%2F1%2F2&prev_iu_szs=300x250&ifi=3&adks=341906391&sfv=1-0-38&ecs=20220505&fsapi=false&cust_params=docwirezone%3DUromigos_EP_155&sc=1&cookie=ID%3D7dd7c1272fac8dd5-229c6da18acd00b4%3AT%3D1651775810%3ART%3D1651775810%3AS%3DALNI_MZ_RpDs3nkNBfkdWAlwL-k005VVig&abxe=1&dt=1651775814553&lmt=1651775814&dlt=1651775809018&idt=1074&biw=1600&bih=1200&adxs=1010&adys=514&ucis=2&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&bc=31&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXSxmYWxzZV0.&url=https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D&frm=20&vis=1&scr_x=0&scr_y=0&psz=324x271&msz=300x-1&fws=4&ohw=1600&ga_vid=1837915677.1651775810&ga_sid=1651775810&ga_hid=733354313&ga_fc=true&btvi=0&topics=1&nvt=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022050301.js?cb=31067407
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.179.162 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
ams15s41-in-f2.1e100.net
Software
cafe /
Resource Hash
49c32a597568c9cde4f73f240aaf864c93bd6905e6dd3a3f54fddab4a02a699d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:54 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
20075
x-xss-protection
0
google-lineitem-id
5959560630
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138385927113
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.docwirenews.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
51 KB
20 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=1956160238184584&correlator=297198081336340&eid=31067407%2C31067412&output=ldjh&gdfp_req=1&vrg=2022050301&ptt=17&impl=fif&iu_parts=30017927%2Cdocwise%2Cdocwirenews.leaderboard&enc_prev_ius=%2F0%2F1%2F2&prev_iu_szs=728x90&ifi=4&adks=204599538&sfv=1-0-38&ecs=20220505&fsapi=false&cust_params=docwirezone%3DUromigos_EP_155&sc=1&cookie=ID%3D7dd7c1272fac8dd5-229c6da18acd00b4%3AT%3D1651775810%3ART%3D1651775810%3AS%3DALNI_MZ_RpDs3nkNBfkdWAlwL-k005VVig&abxe=1&dt=1651775814556&lmt=1651775814&dlt=1651775809018&idt=1074&biw=1600&bih=1200&adxs=436&adys=1110&ucis=3&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&bc=31&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXSxmYWxzZV0.&url=https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D&frm=20&vis=1&scr_x=0&scr_y=0&psz=1600x-1&msz=728x-1&fws=512&ohw=0&ga_vid=1837915677.1651775810&ga_sid=1651775810&ga_hid=733354313&ga_fc=true&btvi=0&topics=1&nvt=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022050301.js?cb=31067407
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.179.162 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
ams15s41-in-f2.1e100.net
Software
cafe /
Resource Hash
699e2766eb87df25ad0631f3f0982a8f4b1d9cc4213c5527297c9691714b5cf0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:54 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
20136
x-xss-protection
0
google-lineitem-id
5961025849
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138385927332
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.docwirenews.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
reset.css
d10lpsik1i8c69.cloudfront.net/css/
2 KB
1 KB
Stylesheet
General
Full URL
https://d10lpsik1i8c69.cloudfront.net/css/reset.css
Requested by
Host: d10lpsik1i8c69.cloudfront.net
URL: https://d10lpsik1i8c69.cloudfront.net/js/clickstream.js?v=ce8f9a1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
143.204.101.166 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-101-166.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
401f533697cfb484598d2da76b5f4708bbca985a1fab42dbcfaa0741374d3245

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Fri, 22 Apr 2022 15:23:17 GMT
content-encoding
gzip
last-modified
Tue, 01 Mar 2022 22:59:52 GMT
server
AmazonS3
age
1134818
etag
W/"7144eaceff0b31347712515a6116074e"
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
via
1.1 32c8da10203574baccb74b8f771a7ffa.cloudfront.net (CloudFront)
cache-control
max-age=31536000
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
S4BejZ8P5sFHludtiCB3dEOCE5jdwueCif7GVDyhWKGn9_uOPEJjOg==
dFqp3r-NjKYIiZFGuMjg27V2y58JRdrnPk3CKLoufA4.js
pagead2.googlesyndication.com/bg/ Frame 8F5B
35 KB
13 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/dFqp3r-NjKYIiZFGuMjg27V2y58JRdrnPk3CKLoufA4.js
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
745aa9debf8d8ca608899146b8c8e0dbb576cb9f0945dae73e4dc228ba2e7c0e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 17:48:25 GMT
content-encoding
br
x-content-type-options
nosniff
age
2909
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13694
x-xss-protection
0
last-modified
Mon, 02 May 2022 13:48:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Fri, 05 May 2023 17:48:25 GMT
sodar
pagead2.googlesyndication.com/pagead/ Frame D60A
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=225&li=gda_r20220503&jk=1956160238184584&rc=
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

dc56cb87-8b90-43ec-aa4b-e6230b14482d
https://www.docwirenews.com/ Frame 3129
0
0
Other
General
Full URL
blob:https://www.docwirenews.com/dc56cb87-8b90-43ec-aa4b-e6230b14482d
Protocol
BLOB
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

Content-Length
0
0c1fa4ab-f1db-420c-a913-058ca8b0cdf1
https://www.docwirenews.com/ Frame 3129
30 KB
0
Other
General
Full URL
blob:https://www.docwirenews.com/0c1fa4ab-f1db-420c-a913-058ca8b0cdf1
Protocol
BLOB
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
fb5a1fff57218742c5c1e469970504556a10d235b2379872b4ffcef9901d3bc0

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

Content-Length
31224
generate_204
tpc.googlesyndication.com/ Frame 8F5B
0
9 B
Image
General
Full URL
https://tpc.googlesyndication.com/generate_204?2yRKsQ
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:811::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:54 GMT
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
view
securepubads.g.doubleclick.net/pcs/ Frame 7AD9
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvZczaxvfp4KRmyYIf3r3de7xwtxhlZxuBvldk2jzs2gRNbyiumlZGxlh5LM0UzeP2AbHVwIrvqASRKN9manBzKsNceB7oNZ0x-phyIk9PM5NHm8L9nPk-NSxxfRiyflkq4j_--vp1ycQ2yTnWNcTxqhu1fDdi00Tju4p9eyhIMk_fJ-KQeFyW9OQlnJLGypsBq_H1lQYt5b2s0RVW9f-G6-W2BQX3uUO7gCrXo7H8hkw4VOqyKEq6L8VdneOASQjBWbTl8OtNIDec7uDvvut-jruygb6tZ__JfDwgZz9iOYmBnKouii7TlER6OyuxJG87Q2q0W5Cp_&sig=Cg0ArKJSzIPFHFWXpIxHEAE&uach_m=[UACH]&adurl=
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.179.162 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
ams15s41-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

timing-allow-origin
*
date
Thu, 05 May 2022 18:36:54 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
abg_lite_fy2019.js
tpc.googlesyndication.com/pagead/js/r20220504/r20110914/ Frame 7AD9
19 KB
8 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20220504/r20110914/abg_lite_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022050301.js?cb=31067407
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:811::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
b83149463619a5f4bbee21909e8a99a085f15713e48d6522d0a3173b94a20e1e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:35:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
102
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
8007
x-xss-protection
0
server
cafe
etag
8765308293129799388
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Thu, 19 May 2022 18:35:12 GMT
window_focus_fy2019.js
tpc.googlesyndication.com/pagead/js/r20220504/r20110914/client/ Frame 7AD9
3 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20220504/r20110914/client/window_focus_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022050301.js?cb=31067407
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:811::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
8aa048082094d36080fc028ab1584264596c64fb5b362038c4761ac9838d6b14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 17:53:52 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
2582
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1359
x-xss-protection
0
server
cafe
etag
1484984001845508991
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Thu, 19 May 2022 17:53:52 GMT
rx_lidar.js
www.googletagservices.com/activeview/js/current/ Frame 7AD9
120 KB
37 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022050301.js?cb=31067407
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
f1b2415f02c89234a4b94896afa68c68db82465563711b8b05f0c1b8b3ba580b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:54 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
37409
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1651664140737961"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
expires
Thu, 05 May 2022 18:36:54 GMT
l
www.google.com/ads/measurement/ Frame 7AD9
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaSPgoMB2J16B0U2lZCT9FFlobUHMkz1st1Q4y2lAlNLuzR0xRwZr9mYoR3vK1KLx7AAOfZkjHJJQXKaPcWKMo63rrB8BQ
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022050301.js?cb=31067407
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:803::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

13441476020633382177
tpc.googlesyndication.com/simgad/ Frame 7AD9
55 KB
55 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/13441476020633382177
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022050301.js?cb=31067407
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:811::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
02743e6a82fe585c38974c8abccfddfd3c4d1957c045922a473333fb45611bfb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Fri, 29 Apr 2022 11:42:10 GMT
x-content-type-options
nosniff
age
543284
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
56040
x-xss-protection
0
last-modified
Thu, 24 Mar 2022 18:45:31 GMT
server
sffe
report-to
{"group":"content-ads-owners","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/content-ads-owners"}]}
content-type
image/gif
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="content-ads-owners"
expires
Sat, 29 Apr 2023 11:42:10 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame A68B
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvk_o19ikuU2eiC0GaZhDnmjBn1_0KWWN1T-uwS3Agewu6xZNsIDlbw28FFrX1MnS8-WNunZYcgXA7cr6DAjX9JfZ_5phTzE7UkMXzAuuZRb24YyI737j9YMv4Vo1rtUhJmuAA4-r3WgbKH5V4HcowOQ7AuKyXQlE37XyZ_lEupDVV8NWGbDtTenIr9CRCKZ3kfUYPX8XE56fWYmz-tHTRDe3xIt2U2iSewABo5ciyTK7MlQ25dduneh6PfIySH6xE0raKRae2_MEHGdTjI5_9PpiDCOttfyQfnWNttISBGg3wEX_FEncmY12W9mYSull7BOjCs6ReAAJ_FuH8RHtE&sig=Cg0ArKJSzN2ewoalDCeYEAE&uach_m=[UACH]&adurl=
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.179.162 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
ams15s41-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

timing-allow-origin
*
date
Thu, 05 May 2022 18:36:54 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
abg_lite_fy2019.js
tpc.googlesyndication.com/pagead/js/r20220504/r20110914/ Frame A68B
19 KB
8 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20220504/r20110914/abg_lite_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022050301.js?cb=31067407
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:811::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
b83149463619a5f4bbee21909e8a99a085f15713e48d6522d0a3173b94a20e1e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:35:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
102
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
8007
x-xss-protection
0
server
cafe
etag
8765308293129799388
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Thu, 19 May 2022 18:35:12 GMT
window_focus_fy2019.js
tpc.googlesyndication.com/pagead/js/r20220504/r20110914/client/ Frame A68B
3 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20220504/r20110914/client/window_focus_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022050301.js?cb=31067407
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:811::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
8aa048082094d36080fc028ab1584264596c64fb5b362038c4761ac9838d6b14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 17:53:52 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
2582
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1359
x-xss-protection
0
server
cafe
etag
1484984001845508991
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Thu, 19 May 2022 17:53:52 GMT
l
www.google.com/ads/measurement/ Frame A68B
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaSxQqIgOdlYHQS7O07zYR82PuvTI78fdjr-IhfsWQV36g0v9nchSqEYlEOq3nhrOIg85mIuTqDRzzFybEVya5DZbPDH1A
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022050301.js?cb=31067407
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:803::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

rx_lidar.js
www.googletagservices.com/activeview/js/current/ Frame A68B
120 KB
37 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022050301.js?cb=31067407
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
f1b2415f02c89234a4b94896afa68c68db82465563711b8b05f0c1b8b3ba580b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:54 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
37409
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1651664140737961"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
expires
Thu, 05 May 2022 18:36:54 GMT
11034922864367087208
tpc.googlesyndication.com/simgad/ Frame A68B
28 KB
28 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/11034922864367087208
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022050301.js?cb=31067407
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:811::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
e70f972d66fd041a866c8241948a3fcff13f53c2e96974ad5098c64e7124fa23
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 17:26:10 GMT
x-content-type-options
nosniff
age
4244
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
28902
x-xss-protection
0
last-modified
Thu, 24 Mar 2022 18:40:59 GMT
server
sffe
report-to
{"group":"content-ads-owners","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/content-ads-owners"}]}
content-type
image/gif
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="content-ads-owners"
expires
Fri, 05 May 2023 17:26:10 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame B316
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvQabmylq4-_Tf5EpkpmE0ucE7o_Dkpn529rca5_R4Jzn9zvu2zECrLQhRs0zC3FUeX9eK7bi8dE2nZumQMLoWlJI6Gi8_gBBF1BAzsBzwRks5J62Qu9Yk4y9-ow89-1z5qv8h_nCT0eIRfeHcB8_JfKitJ-d6CcBOdOg3TLxRjDYRqYfKT05AZFa5ZhCg_3wDGdiBhbtuD3X7UeJirZ-fdUpjvW_116RxlQCbdhuwMUqOjep1KzTADudjIT97PdaDF2g9lk9GeFLUw7jebWJeY680MoQNIbVEnxtg2QVScZgk0MQdcJ7gYc7uJ8PAnYiP6Js-7tVeHWak8nSe_UQ&sig=Cg0ArKJSzJxI0SNYT8EPEAE&uach_m=[UACH]&adurl=
Requested by
Host: www.docwirenews.com
URL: https://www.docwirenews.com/gu-oncology-now/the-uromigos/uromigos-a-podcast/episode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer/?utm_source=SendGrid&utm_medium=DWEmail&utm_campaign=%7B%7Bsubject_line%7D%7D&utm_term=%7B%7Bemail%7D%7D
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.179.162 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
ams15s41-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

timing-allow-origin
*
date
Thu, 05 May 2022 18:36:54 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
abg_lite_fy2019.js
tpc.googlesyndication.com/pagead/js/r20220504/r20110914/ Frame B316
19 KB
8 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20220504/r20110914/abg_lite_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022050301.js?cb=31067407
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:811::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
b83149463619a5f4bbee21909e8a99a085f15713e48d6522d0a3173b94a20e1e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:35:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
102
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
8007
x-xss-protection
0
server
cafe
etag
8765308293129799388
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Thu, 19 May 2022 18:35:12 GMT
window_focus_fy2019.js
tpc.googlesyndication.com/pagead/js/r20220504/r20110914/client/ Frame B316
3 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20220504/r20110914/client/window_focus_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022050301.js?cb=31067407
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:811::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
8aa048082094d36080fc028ab1584264596c64fb5b362038c4761ac9838d6b14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 17:53:52 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
2582
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1359
x-xss-protection
0
server
cafe
etag
1484984001845508991
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Thu, 19 May 2022 17:53:52 GMT
rx_lidar.js
www.googletagservices.com/activeview/js/current/ Frame B316
120 KB
37 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022050301.js?cb=31067407
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
f1b2415f02c89234a4b94896afa68c68db82465563711b8b05f0c1b8b3ba580b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:54 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
37409
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1651664140737961"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
expires
Thu, 05 May 2022 18:36:54 GMT
l
www.google.com/ads/measurement/ Frame B316
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaRS9Zqvm9sZqZ-yvSBbbN9xOD6L0MOI-zFXQ1w2-uwYZU2zBjE7kXPX2RpqsQSTAwEXAxEhOk9A9oyjbcF87aPjkEFAZA
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022050301.js?cb=31067407
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:803::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

16101462156171428838
tpc.googlesyndication.com/simgad/ Frame B316
43 KB
43 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/16101462156171428838
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022050301.js?cb=31067407
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:811::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
65152767e600c1585f0b466bd68135bf5b3ad4801e739c859de7c7db7b7441a4
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Wed, 04 May 2022 15:57:49 GMT
x-content-type-options
nosniff
age
95945
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
43735
x-xss-protection
0
last-modified
Thu, 24 Mar 2022 18:41:53 GMT
server
sffe
report-to
{"group":"content-ads-owners","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/content-ads-owners"}]}
content-type
image/gif
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="content-ads-owners"
expires
Thu, 04 May 2023 15:57:49 GMT
truncated
/ Frame A68B
214 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
ca4d2d411509bed7f454a0731bf4ba394195168e5a85587448477db9c9a7358c

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

Content-Type
image/png
view
securepubads.g.doubleclick.net/pcs/ Frame 7AD9
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsudnZzCaOtUCoVafaic0qwtbEq8JQ7jGenv6Hbo4E6L3SIibkeCP7l7luaXsXnyKUrV7JemtrfXq8OkhbYMMSp6dYREeUjStzCAHCrCd7bUkp_RBfYnkISMdIXl4oy4puL75DhQkoAfpXUh2jTTIb1HR8khbJv6BJtQQe8fbc43734Qr6mGc5ILPHDmk-Ns9U8vk_-F7SblPjXjkaFqbk18QKGE-JL1_LsRxk5HuMrmCd-LxLYb_BvUQe8Uvk04vjIH5iEMN4m555mVo3IVheT0bIrtKV08QMODt1jn0bpPu3WrmI6CNeCCsR1tCYaMORC9grRiQO_BMhg&sig=Cg0ArKJSzOZdbwgjpY5rEAE&uach_m=[UACH]&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.179.162 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
ams15s41-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

timing-allow-origin
*
date
Thu, 05 May 2022 18:36:55 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
expires
Thu, 05 May 2022 18:36:55 GMT
truncated
/ Frame 7AD9
215 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
f45091a22115e0955c6a252a193ac7536f0021109c137004b06cd30a535e8783

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

Content-Type
image/png
view
securepubads.g.doubleclick.net/pcs/ Frame B316
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvGmXuLQI1b66ozwEGP3DoLzJJaV78csgp3zNejDmHlHCXlus5Dsh5mD8_u1ASlmDSW6G7_hBOWEYFIMPuk4ltJ7kwnZ0hh4_Y5g_h4olU-r8wxuy0LRY_Y-0npceLR9PvGg6X5RS7qEQHwW8B4uy49HG79q0F5t-Yrwr7SzTjV478ERhlqaq2nEzFkzZGSufR-QokJfbxsgmcuuZSX0DEGFitWawJ_Azr3Dkk8SMJVYQudra62ltNDbwS-htA7SMT1sCXK9NRYHLa8GWx60zbVhLS4jtyHmeY8JefxjlpclTs1G6sZBozhsNWu4_7S6xbS_22V6IlyvDXl_YBp8S_9&sig=Cg0ArKJSzHwOjVD-ZbOXEAE&uach_m=[UACH]&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.179.162 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
ams15s41-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

timing-allow-origin
*
date
Thu, 05 May 2022 18:36:54 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
expires
Thu, 05 May 2022 18:36:54 GMT
truncated
/ Frame B316
213 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
1f2417661801aac4582c6acafd664befe47063d6b645520486f60b6ed54fb100

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

Content-Type
image/png
view
securepubads.g.doubleclick.net/pcs/ Frame A68B
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssFI5oMS4PejRA8WGhQjSTTk0L6h3Ud_U9ofjFyE-EkQYR-4QmLgbt8ywx-hFHTulyOyJrGttuFidLc4e4uTYF6GPY4oFYRXpII0_XfGZpQvQUemYR0AEj6nrBZudbf9qHERUuKbm63TTr2HEOa6HNtAXpBB5sfAGpOt0quUp6rONPI4suf7_U5-YcWusZmh6izc8_oikNlQ-l-ezW2rnfzZJWhtVORAF_z18YDWxtCYJzGqo43QLR17lPZJHQuLFQgDKihD1-8PpjddDw4oTCq-m9K09pThzFOGT8ukWNYQ3MAZAMbzl0Px4EBhGVPLkZd0o59bJTzHWC5bjNuLuJIEQ&sig=Cg0ArKJSzJuYK56-msdGEAE&uach_m=[UACH]&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.179.162 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
ams15s41-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

timing-allow-origin
*
date
Thu, 05 May 2022 18:36:54 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
expires
Thu, 05 May 2022 18:36:54 GMT
sodar
pagead2.googlesyndication.com/pagead/
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=225&t=2&li=gda_r20220503&jk=1956160238184584&bg=!ra6lrurNAAZX5TVhd-U7ACkAdvg8WjDoF8dTCbL9dgLeF90kjhrclvhf_S-y_uYmjARtBWwMDfQ40wIAAABLUgAAAAFoAQcKAJxXJ57-SqfkPpSrMyhzitvwP4ozi1H5R3IDj17mP7TXqS33_OUTJOIdG6Tzy-aMQ83hHSF6KTjvUAZyQEfJJkI-AlsYaQ2zBtqblLNbw1J5tvNvPm7GVoJuykXmA_ntIGT6FvMYuOS2p2ORp1IuYYCpqRGnVPpRFlI-Ys4jiQxLJByj9-kOqwRl1HlESd96lk5n5SjBJ7jyW_P3QtqZAqtI0yqKaGlT0jZJFXfZuAdXsL1JQ7OFx1Hdg2dQ0z-F6s3V26mxPW01rmGutvmUd4ZJZkQukVLmA62JYA1HJE07GJr5BCQ0aI243tHShsMs1-WK5c5ux5dCCBA9ZDzqzD6V3JP9wL-E5b2fqkfrk7tNb51nqroONXPBZy6jzMk8QcgCpekBJ0SWt1FQSl0yOYSWkKRZKICzd9X051qCDwJuoyQXU6bcC_0H-LZhNqqXWs8kXgUJ5Ep653DiLSOd_9ZHI2W-IPF9SZ9eRS2v88ZDdcJdy2Y2Mwg_9dKb_mZGsAWKMjhLfYwnax7VS2Kg3uCkLthF-HAblP6-JNpYiPuFj4gramPlMX2Xli0_6DXoDLukP5MHeIIENwo63AFawyAneZ0RI3cvNGurvwPjO-3P3gN_SzeHv-aNsvzHdz7-LyR0IGJ6E8W24N4A_642iWcrY9dCv5h2L7dGOFU2f-SwhWtFaXLCQmFd9a5CXnmUz2CWS6rPLw0ZBIDtBeRSg6WtxXvzPUTEmxlK-yy_rPrQ2CBAr9-Vo2nH_zN-FDwo831l0FCnbUyNc0JDY1bKrJosdsikMDes-6WYjtnLz7AqdHnCh-bWl2mQoPKAaf9f4nMUIWMaagiMp35cWO3uYDsFOpbyw4gzW4AhT4GT7e7Z2ULI9sZk9xlyxC2zSxfIXM3wS_xyC6f2tBFCZQvHeC0Tled2WbesuDUpUwC2it0PHbJNdbcif1BN8z-jBuyKhoGBCtsDr1O28m_NuAhIk4KlkBUJ-wJV5bnpif1JqrLIzK7-M_ufnGjEJvWq2sqdF2OUjNj5__FB6955gX08KkifR9dFd8Ih_qumRfQgWdeyJqZVTO8nAS6FMEhnKcVws_OclNePsFRwh1-OMf_9ZakkxoROFQBX0lvv2Q
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

activeview
pagead2.googlesyndication.com/pcs/ Frame 7AD9
42 B
64 B
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjsv-VIAK6Sxndalqr0ocYYqoCmlM5OfRHuoIRnsFuIPdkBOlvJAUJ-Jo5FX51MLJOMRNCtRwW8RcvohtBcSggJIV2eqQuAuD7CI1XGaFS16cR2LqwPkH&sig=Cg0ArKJSzHrJGJTm4owbEAE&id=lidar2&mcvt=1000&p=514,1010,764,1310&mtos=1000,1000,1000,1000,1000&tos=1000,0,0,0,0&v=20220504&bin=7&avms=nio&bs=1600,1200&mc=1&vu=1&app=0&itpl=3&adk=341906391&rs=4&la=0&cr=0&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXSxmYWxzZV0%3D&vs=4&r=v&rst=1651775814754&rpt=104&isd=0&lsd=0&met=mue&wmsd=0
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 05 May 2022 18:36:55 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
activeview
pagead2.googlesyndication.com/pcs/ Frame B316
42 B
64 B
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjstduFmvCPxk_t8vB1oXRPzuXZwjaes30WlC_yjgDCTnF9Q3i5VYo5r50lNeY8tzrCNCXUSJJP-8P22ewkJc4KlY1vejKJN6nUzhYOVMWqw1i7oOjSXm&sig=Cg0ArKJSzEwyQbjCRgmsEAE&id=lidar2&mcvt=1000&p=833,1010,1083,1310&mtos=1000,1000,1000,1000,1000&tos=1000,0,0,0,0&v=20220504&bin=7&avms=nio&bs=1600,1200&mc=1&vu=1&app=0&itpl=3&adk=3824309862&rs=4&la=0&cr=0&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXSxmYWxzZV0%3D&vs=4&r=v&rst=1651775814792&rpt=104&isd=0&lsd=0&met=mue&wmsd=0
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 05 May 2022 18:36:55 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
activeview
pagead2.googlesyndication.com/pcs/ Frame A68B
42 B
64 B
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjsuxY1CljTg43RzwfVKtrzjSoCNeA0p9FBXtzNzHTOpKncENfOH_Dk_n1PrUq1pmtYW8BSdAQBB7EuSsmhi70xTc0adekcA1dst-jJkdAmWNp8ZqsteB&sig=Cg0ArKJSzJnKqL5wz5faEAE&id=lidar2&mcvt=1001&p=1110,436,1200,1164&mtos=1001,1001,1001,1001,1001&tos=1001,0,0,0,0&v=20220504&bin=7&avms=nio&bs=1600,1200&mc=1&vu=1&app=0&itpl=3&adk=204599538&rs=4&la=0&cr=0&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXSxmYWxzZV0%3D&vs=4&r=v&rst=1651775814786&rpt=123&isd=0&lsd=0&met=mue&wmsd=0
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.docwirenews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 05 May 2022 18:36:55 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
metadata
anchor.fm/api/podcast/ Frame 1A58
0
0
Fetch
General
Full URL
https://anchor.fm/api/podcast/metadata
Requested by
Host: d1rx8vrt2hn1hc.cloudfront.net
URL: https://d1rx8vrt2hn1hc.cloudfront.net/builds/bundle-8b03e8b9bcd02b6064f0.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.66.133 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/ Express
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=86400

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://anchor.fm/the-uromigos/embed/episodes/Episode-155-ASCO-GU-2022-ARASENS-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer-e1ehuoa
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:36:56 GMT
via
1.1 varnish, 1.1 varnish
x-powered-by
Express
strict-transport-security
max-age=86400
x-cache
MISS, MISS
content-language
de
x-cache-hits
0, 0
accept-ranges
bytes
x-served-by
cache-iad-kcgs7200177-IAD, cache-hhn4083-HHN
metadata
anchor.fm/api/podcast/ Frame 1A58
0
0
Fetch
General
Full URL
https://anchor.fm/api/podcast/metadata
Requested by
Host: d1rx8vrt2hn1hc.cloudfront.net
URL: https://d1rx8vrt2hn1hc.cloudfront.net/builds/bundle-8b03e8b9bcd02b6064f0.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.66.133 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/ Express
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=86400

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://anchor.fm/the-uromigos/embed/episodes/Episode-155-ASCO-GU-2022-ARASENS-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer-e1ehuoa
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/101.0.4951.41 Safari/537.36

Response headers

date
Thu, 05 May 2022 18:37:00 GMT
via
1.1 varnish, 1.1 varnish
x-powered-by
Express
strict-transport-security
max-age=86400
x-cache
MISS, MISS
content-language
de
x-cache-hits
0, 0
accept-ranges
bytes
x-served-by
cache-iad-kiad7000130-IAD, cache-hhn4083-HHN

Verdicts & Comments Add Verdict or Comment

217 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| 0 object| 1 object| 2 object| 3 object| 4 object| 5 object| 6 object| 7 object| 8 object| 9 object| 10 object| 11 object| 12 object| oncontextlost object| oncontextrestored function| structuredClone function| getScreenDetails function| Cookies function| iFrameResize object| _wpemojiSettings undefined| $ function| jQuery function| ai_insert function| ai_insert_viewport object| html5 object| Modernizr function| yepnope object| classie function| Keeper function| powerpress_pinw object| tdBlocksArray function| tdBlock object| tdLocalCache object| td_viewport_interval_list string| td_animation_stack_effect boolean| tds_animation_stack string| td_animation_stack_specific_selectors string| td_animation_stack_general_selectors string| tds_general_modal_image string| td_ajax_url string| td_get_template_directory_uri string| tds_snap_menu string| tds_logo_on_sticky string| tds_header_style string| td_please_wait string| td_email_user_pass_incorrect string| td_email_user_incorrect string| td_email_incorrect string| tds_more_articles_on_post_enable string| tds_more_articles_on_post_time_to_wait number| tds_more_articles_on_post_pages_distance_from_top string| tds_theme_color_site_wide string| tds_smart_sidebar string| tdThemeName string| td_magnific_popup_translation_tPrev string| td_magnific_popup_translation_tNext string| td_magnific_popup_translation_tCounter string| td_magnific_popup_translation_ajax_tError string| td_magnific_popup_translation_image_tError object| tdDateNamesI18n string| td_ad_background_click_link string| td_ad_background_click_target function| fbq function| _fbq object| com object| googletag function| getUrlVars object| AIM function| aimTag object| aimDataLayer function| searchFunction object| dataLayer object| adsbygoogle number| __lo_site_id object| twemoji object| wp boolean| __lo_csr_added object| ggeac object| google_tag_data object| google_js_reporting_queue object| google_tag_manager string| GoogleAnalyticsObject function| ga number| google_srt object| google_logging_queue number| tmod object| google_ad_modifications object| google_persistent_state_async boolean| google_measure_js_timing object| google_reactive_ads_global_state boolean| _gfp_a_ object| google_sa_queue function| google_process_slots function| google_spfd number| google_unique_id object| google_sv_map string| google_user_agent_client_hint object| block_td_uid_7_627417cbf2161 object| block_td_uid_8_627417cc415e9 object| PT_CV_PUBLIC object| PT_CV_PAGINATION object| tdDetect object| tdViewport object| tdMenu object| tdUtil object| tdAffix function| td_smart_list_dropdown object| td_more_articles_box undefined| td_resize_timer_id function| td_done_resizing function| td_resize_videos function| td_mobile_menu function| td_mobile_menu_toogle function| td_retina function| td_read_site_cookie function| td_set_cookies_life boolean| tdIsScrollingAnimation boolean| td_mouse_wheel_or_touch_moved boolean| td_scroll_to_top_is_visible function| td_events_scroll_scroll_to_top function| td_post_template_6_title function| td_smart_lists_magnific_popup function| td_get_document_width function| td_get_document_height function| setMenuMinHeight function| td_comments_form_validation function| td_scroll_to_class object| tdLoadingBox object| tdAjaxSearch string| tdModalImageLastEl function| tdModalImage object| tdBlocks object| tdLogin object| tdLoginMob object| tdDemoMenu object| tdTrendingNow object| td_history object| tdSmartSidebar object| tdInfiniteLoader function| Froogaloop object| tdCustomEvents object| tdEvents object| tdAjaxCount object| tdYoutubePlayers object| tdVimeoPlayers function| td_resize_smartlist_slides function| td_resize_smartlist_sliders_and_update function| td_resize_normal_slide function| td_resize_normal_slide_and_update object| tdPullDown object| td_fps object| tdAnimationScroll object| tdHomepageFull object| tdBackstr object| tdAnimationStack object| td_backstretch_items function| td_compute_parallax_background function| td_compute_backstretch_item object| tdAjaxLoop object| tdWeather object| tdAnimationSprite function| td_date_i18n object| tdSocialSharing function| $f object| addComment object| gaplugins object| gaGlobal object| gaData function| google_sa_impl object| googleToken object| googleIMState boolean| _gfp_p_ object| google_image_requests function| processGoogleToken number| google_global_correlator object| google_prev_clients object| ampInaboxIframes object| ampInaboxPendingMessages object| _omapp function| OptinMonsterApp boolean| om_loaded object| dmd_user undefined| _identity_type undefined| _dgid undefined| _me_number undefined| _npi_number undefined| _last_name undefined| _firt_name string| _guest_id string| _get_time_date string| _user_page_location undefined| _user_specialty undefined| _designation object| omapi_data function| twq object| _0x5762 function| _0x2ca5 object| twttr object| WTW_Watcher object| LO string| clientId undefined| userId function| __jp0 function| __jp1 string| _exsource function| __v4jp0 function| __v4jp1 object| a0a function| a0b function| ClientJS object| _loq object| GoogleGcLKhOms undefined| uhEmailClick string| otGroup string| otID boolean| isMobile function| updateSlotStatus

29 Cookies

Domain/Path Name / Value
.magnetmail.net/ Name: _rm_tk
Value: 1giBzDfUuZU
.magnetmail.net/ Name: _rm_ts
Value: 1giBzDfUuZU
.docwirenews.com/ Name: _ga
Value: GA1.2.1837915677.1651775810
.docwirenews.com/ Name: _gid
Value: GA1.2.1655574837.1651775810
.docwirenews.com/ Name: _gat_UA-117435438-1
Value: 1
.docwirenews.com/ Name: _fbp
Value: fb.1.1651775810053.2063725742
www.docwirenews.com/ Name: _sess
Value: 8d27a7f7-ab48-49db-97f5-691b4c538684.b7b9c3f1-0936-4c7c-87c0-ab638be64bc3.1651775810.1
www.docwirenews.com/ Name: dmd-vid
Value: b7b9c3f1-0936-4c7c-87c0-ab638be64bc3
www.docwirenews.com/ Name: dmd-sid
Value: 8d27a7f7-ab48-49db-97f5-691b4c538684
.t.co/ Name: muc_ads
Value: 1327c809-656a-4257-9ad5-13cde2a90913
.twitter.com/ Name: personalization_id
Value: "v1_+NKiZsYYS1BimXrWgZ6KGQ=="
.www.medtargetsystem.com/ Name: s-DMDSESSID
Value: 64121e0040557ba5977ac2094458a945
aim-tag.hcn.health/ Name: dmd-pids
Value: %5B%7B%22id%22%3A1%2C%22name%22%3A%22DeepIntent%22%2C%22signature%22%3A%2240d344a2bd75730b84c5ed85e7d46880e798cbd20d00dca40f2b2f91bb28a6d2%22%7D%2C%7B%22id%22%3A2%2C%22name%22%3A%22Lasso%22%7D%5D
.aim-tag.hcn.health/ Name: dmd-sid4
Value: {%22id%22:%2254a5e810-cca2-11ec-8cdc-cb314e5edeb5%22%2C%22timestamp%22:1651775809972}
www.docwirenews.com/ Name: dmd-ahk
Value: c85d29af9b
www.docwirenews.com/ Name: dmd-signal-45-381-6BCF239E-8d27a7f7-ab48-49db-97f5-691b4c538684
Value: e30=
aim-tag.hcn.health/ Name: dmd-tag
Value: 54b26b30-cca2-11ec-9b13-2f534fd6caa6
.hcn.health/ Name: dmd-tag
Value: 54b26b30-cca2-11ec-9b13-2f534fd6caa6
.www.docwirenews.com/ Name: dmd-tag
Value: 54b26b30-cca2-11ec-9b13-2f534fd6caa6
.www.docwirenews.com/ Name: dmd-sid4
Value: {%22id%22:%2254a5e810-cca2-11ec-8cdc-cb314e5edeb5%22%2C%22timestamp%22:1651775809972}
.adnxs.com/ Name: uuid2
Value: 8450328796284604864
.aim-tag.hcn.health/ Name: 66dae177-a73d-4af3-896c-598e53263f2d
Value: {%22lastUpdated%22:1651775812220%2C%22signalData%22:{%22aim_version%22:%224.8.0%22%2C%22event_timestamp%22:%222022-05-05%2018:36:52%22%2C%22country%22:%22%22%2C%22country_code%22:%22%22%2C%22dgid%22:%22%22%2C%22first_name%22:%22%22%2C%22identity_type%22:%22UNK%22%2C%22last_name%22:%22%22%2C%22npi_number%22:%22%22%2C%22hcp_type%22:%22%22%2C%22professional_designation%22:%22%22%2C%22dmd_specialty_code%22:%22%22%2C%22specialty%22:%22%22%2C%22state%22:%22%22%2C%22tag_id%22:%2254b26b30-cca2-11ec-9b13-2f534fd6caa6%22}}
www.docwirenews.com/ Name: PHPSESSID
Value: 9ab52f184f2c397de2e8cd4a31d794ef
.docwirenews.com/ Name: _lo_uid
Value: 218254-1651775809973-766229104653d7de
.docwirenews.com/ Name: _lorid
Value: 218254-1651775809973-42a9a8e52f413057
.docwirenews.com/ Name: _lo_v
Value: 1
.docwirenews.com/ Name: __lotl
Value: https%3A%2F%2Fwww.docwirenews.com%2Fgu-oncology-now%2Fthe-uromigos%2Furomigos-a-podcast%2Fepisode-155-asco-gu-2022-arasens-trial-of-daralutamide-and-chemo-vs-chemo-alone-in-hormone-sensitive-advanced-prostate-cancer%2F%3Futm_source%3DSendGrid%26utm_medium%3DDWEmail%26utm_campaign%3D%257B%257Bsubject_line%257D%257D%26utm_term%3D%257B%257Bemail%257D%257D
.docwirenews.com/ Name: __gads
Value: ID=7dd7c1272fac8dd5:T=1651775810:S=ALNI_MZe8SLcgXPvr5yc8fQLziCYDyz98w
.doubleclick.net/ Name: IDE
Value: AHWqTUm8fxprsb98o_VyS4l7VrCdizvAlh13NmLLuvWJS_wQey-qlwy7Cw6V8RfM-zE

4 Console Messages

Source Level URL
Text
network error URL: https://anchor.fm/api/podcast/metadata
Message:
Failed to load resource: the server responded with a status of 401 ()
network error URL: https://anchor.fm/api/podcast/metadata
Message:
Failed to load resource: the server responded with a status of 401 ()
network error URL: https://anchor.fm/api/podcast/metadata
Message:
Failed to load resource: the server responded with a status of 401 ()
network error URL: https://anchor.fm/api/podcast/metadata
Message:
Failed to load resource: the server responded with a status of 401 ()

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

a.omappapi.com
adservice.google.com
adservice.google.de
aim-tag.hcn.health
analytics.twitter.com
anchor.fm
cdn.embed.ly
cdn.jsdelivr.net
connect.facebook.net
d10lpsik1i8c69.cloudfront.net
d12xoj7p9moygp.cloudfront.net
d1rx8vrt2hn1hc.cloudfront.net
d3t3ozftmdmh3i.cloudfront.net
d8de1464cb804dbfc0611e46f65d9c7b.safeframe.googlesyndication.com
fonts.googleapis.com
fonts.gstatic.com
googleads.g.doubleclick.net
match.deepintent.com
pagead2.googlesyndication.com
partner.googleadservices.com
pro.fontawesome.com
secure.adnxs.com
securepubads.g.doubleclick.net
sentry.io
settings.luckyorange.net
stackpath.bootstrapcdn.com
static.ads-twitter.com
stats.g.doubleclick.net
t.co
tpc.googlesyndication.com
tracking.magnetmail.net
trc.lhmos.com
url1224.newsletter1.docwirenews.com
web-static.dmdtrueidentity.com
www.docwirenews.com
www.facebook.com
www.google-analytics.com
www.google.com
www.google.de
www.googletagmanager.com
www.googletagservices.com
www.medtargetsystem.com
104.16.90.50
104.244.42.197
104.244.42.3
104.26.11.16
142.250.179.162
143.204.101.166
143.204.98.79
151.101.66.133
167.89.118.83
172.67.73.241
18.204.255.196
185.33.221.50
199.232.188.157
205.201.46.12
2600:9000:2156:2200:1e:f77c:1000:21
2600:9000:2156:6000:11:d2b:9e40:21
2600:9000:2156:e600:7:c135:4380:21
2606:4700::6810:5914
2606:4700::6812:1734
2606:4700::6812:acf
2a00:1450:4001:803::2002
2a00:1450:4001:803::2004
2a00:1450:4001:808::200e
2a00:1450:4001:80e::2002
2a00:1450:4001:80e::2003
2a00:1450:4001:80f::2002
2a00:1450:4001:80f::200a
2a00:1450:4001:811::2001
2a00:1450:4001:828::2001
2a00:1450:4001:828::2002
2a00:1450:4001:82a::2008
2a00:1450:4001:82b::2002
2a00:1450:4001:831::2003
2a00:1450:400c:c0b::9c
2a03:2880:f02d:100:face:b00c:0:3
2a03:2880:f12d:181:face:b00c:0:25de
34.102.246.198
35.188.42.15
38.91.45.7
54.173.3.48
84.17.46.53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